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This thesis describes studies on immune responses and immunosuppression during experimental Trypanosoma
evansi infections in sheep. The studies were initiated by investigations into: 1) routine parasitology and haematology, 2) cell
population dynamics in blood and. 3) assessment of parasite-specific antibody responses. Investigations into the role of T.
evansi in suppression of immune responses to heterologous antigens were carried out using Pasteurella haemolytica vaccine
as a model antigen and involved: 1) assessment of local inflammation, and measurement of skin thickness, at the site of
vaccination. 2) cell phenotype dynamics in blood and in efferent lymph draining the site of vaccination, 3) assay of anti-
Pasteurella antibodies, 4) cellular responses to T and B cell mitogens, Pasteurella and homologous tiypanosomal antigens in
vitro and, 5) cell depletion experiments to try and identify the cell phenotype(s) responsible for immunosuppression.
T. evansi infections in sheep produced scanty and frequently cryptic parasitaemia, ending in selfcure in some cases.
There was marked lymphocytic leucocytosis from day 22 post infection (p.i.). Indirect immunofluorescence and flow cytometry
revealed decreases in the proportions of CD5+, CD4+, CD8+ and SBU-T19"1" (yS) T cells, which were paralleled by increases in
the slg+, CD45R+, CD 1+ cells and cells expressing the MHC Class II antigen. These changes were relatively minor in the
selfcured sheep except that there was a greater decrease in CD8+ than CD4+ cells resulting in increased CD4:CD8 ratio.
Trypanosome-specific IgG and IgM antibodies were detected in ail infected animals by enzyme immunoassays. However, the
levels of these antibodies were greater in the selfcured animals.
T. evansi infection actively suppressed the local inflammation and skin thickness normally induced in uninfected
control sheep by subcutaneous inoculation of Pasteurella vaccine. Moreover, early systemic mobilisation of neutrophils as
seen in uninfected controls was suppressed. Analysis of cell dynamics in the blood of infected, vaccinated sheep revealed that
vaccination did not reverse the changes in the proportions of T cell subsets and B cells which was induced by T. evansi in the
infected sheep. Two-colour flow cytometry also showed that T. evansi induced increases of up to 70 percent in B cells
expressing the CD5 antigen (CD5+ B cells) which persisted after vaccination but was minimal in the selfcured animals.
Vaccination caused little alteration in the normal expression of these lymphocyte subsets in the uninfected control sheep. In
efferent lymph draining vaccination sites there were no major changes in the proportion of the T cell subsets in either group of
sheep. However, two-colour flow cytometry revealed that infection was accompanied by the appearance of CD4+CD8+ (double
positive, DP) cells. These increased in proportion upon vaccination, with up to 30 and 60 percent of CD4+ and CD8+ cells
respectively being DP. Moreover, between 40 to 90 percent of B cells were CD5+. In contrast, in uninfected control sheep, the
changes resulting in the co-expression of various T cell subsets and CD5 antigen on B cells were observed to a very limited
extent. Anti-Pasteurella antibodies of the isotypes IgGl, IgG2 and IgM were produced in all immunised sheep, including those
infected with T. evansi However, infection of sheep prior to vaccination resulted in the suppression of IgG antibody responses
and production of non-specific IgM antibodies in that substantial level of this antibody was detected in the scrum collected
from these animals prior to vaccine administrations. In contrast, the selfcurcd sheep responded to secondary vaccination and
produced IgG antibodies at levels similar to those seen in vaccinated, uninfected control sheep.
In vitro cell culture systems revealed that the proliferative responses of lymphocytes from infected sheep were
depressed when stimulated with T or B cell mitogens, Concanavalin A (Con A) or bacterial lipopofysaccharide (LPS)
respectively. Active infection also suppressed the responses of cells to specific stimulation with Pasteurella and homologous
trypanosomal antigens. Treatment with trypanocidal drug restored these proliferative responses. These suppressive effects
were not observed with cells collected from uninfected control sheep, even when 5 x 10^ trypanosomes ml" ^ or ultrasonicated
trypanosomal antigens were added to the cultures. Cell depletion prior to culture showed that although CD8+ T cells and
cells of the monocyte/macrophage lineage play a significant role in the suppression of lymphoproliferative responses, the
latter cell type seems to play the more predominant role. Removal of either of these cell types restored the responsiveness of
the cells to mitogcnic or specific antigenic stimulus to varying degrees. The responses were enhanced further by
simultaneous removal of both cell types from the cell population.




Trypanosomes are obligate haemoflagellate parasites which occur in all
classes of the phylum vertebrata. However, it is in mammals that they assume
immense veterinary and medical importance. Most species of pathogenic
tiypanosomes are carried by haematophagous dipteran flies of the genus Glossiria
which inhabit well over 10 million km2 of Africa (FAO/WHO, 1969; Kershaw, 1970;
Jordan, 1986).
Trypanosoma rhodesiense and T. gambiense are responsible for
trypanosomosis in humans, causing East and West African sleeping sickness
respectively. T. brucei, T. congolense and T. uivax are the causative agents of the
livestock tiypanosomoses commonly known as nagana. These species, in
partnership with their arthropod vector have been responsible for the deaths of tens
of thousands of people and hundreds of thousands of their domesticated livestock.
In addition, they have played a prime role in limiting the pace and extent of rural
development in much of tropical Africa (Nash, 1969; Jordan, 1986).
In contrast, T. evansi, the aetiological agent of the disease known as
surra, while also affecting a wide range of domestic animal hosts is, unlike the
nagana species, more widely distributed as a result of its adaptation to the
mechanical mode of transmission, occurring in countries in South America and
South East Asia (Hoare, 1972; Stephen, 1986; Urquhart and Holmes, 1987). T.
vivax has also spread beyond the tsetse infested areas of Africa to the West Indies,
Central and South America and Mauritius (Hoare, 1972). The spread is also
facilitated by the ease with which T. vivax, despite its biological transmission by
Glossina, adapts itself to mechanical vectors. This adaptation is probably
determined by its primitive cycle of development in Glossina.
Although trypanosomes and the disease they cause have been known for
over 100 years and despite the fact that much effort has gone into attempts at
controlling them, nothing much has changed. Thus, in Africa, trypanosomoses still
deny vast areas of land to all domestic livestock except poultiy and it is estimated
that 45 million people, 147 million cattle, 125 million goats and over 103 million
sheep remain under threat of the disease (Hornby, 1952; FAO/WHO/OIE, 1982;
UNDP/WORLD BANK/WHO, 1983; Dwinger, 1985). In South America and South
East Asia where the mechanically transmitted tiypanosomoses occur, there is a vast
livestock population (Table 1.1). Although trypanosomosis is widespread in these
areas the actual number of animals at risk is not known. However, what little data
is available indicates that the possible scale of disease is substantial. For example,
in Indonesia with a buffalo, cattle and horse population of 3.4, 10.6 and 0.74 million
respectively (FAO/WHO/OIE, 1990), the number of surra cases diagnosed increased
from a total of 14,000 in 1983 to 28,000 in 1984 (Anonymous, 1985: cited by Payne
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et ai, 1991). Similarly, in Argentina with a horse population of 3 million (FAO,
1989; FAO/WHO/OIE, 1990) and where T. evansi parasitosis is widely distributed,
surra constitutes a disease of great economic importance (Monzon and Mancebo,
1986) with a prevalence rate of 20 percent (Monzon and Villavicencio, 1990).
Table 1.1 Estimates of livestock populations in the surra zones of South
America and South East Asia (based on FAO, 1989; FAO/WHO/OIE,
1982; 1990). All figures are in millions.
Buffaloes Camels Cattle Goats Sheep Horses
South
America
1.2 15 292 84 439 54
South East
Asia
441 3 1200 826 889 25
The term 'trypanosomosis' [plural = tiypanosomoses] (Kassai et al, 1988)
describes a complex of allied diseases, each of which is due to infection with one
species or several species of pathogenic tiypanosome(s). In tsetse-transmitted
trypanosomosis, the trypanosomes, after ingestion by the fly in the blood from an
infected host, undergo a cycle of development in the fly's digestive tract which
terminates in the production of infective forms termed metacyclic tiypanosomes.
Infection is transferred to a new and susceptible host by inoculative means when it
is fed upon by an infected fly. There are characteristic cycles of biological
development in Glossina which depend on the species of tiypanosomes. For
example, in the Salivarian tiypanosomes, development commences in the fly midgut
and terminates in the salivary gland for the brucei group (T. brucei brucei, T.b.
gambiense and T.b. rhodesiense), and in the proboscis for T. congolense, T. simiae
and T. suis. The entire cycle of development of T. unijorme and T. vivax is restricted
to the proboscis. On the other hand, the cycle of development of the Stercorarian
trypanosomes e.g. T. cruzi, commences in the midgut of the vector and terminates in
the faecal medium of the hindgut. In contrast, T. evansi has lost its capacity for
cyclical development in arthropod vectors and is transmitted mechanically from one
susceptible host to another during interrupted blood meals by haematophagous (lies
other than Glossina. Principal among several of such mechanical disseminators of
T. evansi are the 'Horse' or 'Breeze' fly, Tabanus and the 'stable' fly, Stomoxys.
Over the years, considerable effort has gone into tsetse and
tiypanosomosis research in the hope of finding effective means of controlling and
eradicating the disease. This is rationalised by the concept that tsetse and
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trypanosomosis eradication will directly improve the protein-deficient diets of the
majority of the African rural population through improved livestock production. In
consequence, various radical tiypanosomosis control measures, some of which later
resulted in massive land degradation and environmental pollution, were instituted in
various parts of Africa (Jordan, 1986). Such measures fall into three broad
categories namely: those directed against the parasites, those directed against the
vectors (Glossiria) and those centred on the hosts.
Measures directed against the parasites include chemotherapy and
chemoprophylaxis. Chemotherapy is the most widely employed and perhaps the
most successful approach to trypanosomosis control. In many countries it is the
only and most sensible approach because in the short term, it is cheaper and easier
to kill the parasite than it is to attempt to kill the vector (Jordan, 1986). However, in
the long term, chemotherapy can become veiy expensive (Dwinger, 1985) and does
not have any permanent effect on the cycle of the disease. On the contrary, if
treatment is relaxed, the incidence of disease could soon return to pretreatment
levels due to the existence of animal reservoirs of the parasite (Jordan, 1986).
Moreover, in many countries, the extent of current reliance on drugs for the control
of animal trypanosomosis is alarming. Since only a limited number of drugs is
available and their use often abused due to inadequate veterinary supervision, drug
resistant strains of tiypanosomes have evolved in many areas. Chemoprophylaxis,
an alternative to chemotherapy has been employed in several countries where
trypanosomosis occurs. To be successful however, it requires even stricter
supervision than chemotherapy. If it is to work, a prophylactic drug must be
administered and readministered before the level of the first dose drops to a critical
level below which the tiypanosome can survive, multiply and possibly develop
resistance. Such a regime requires the presence of trained staff, reliable transport
and easy access to the animals involved (Leach and Roberts, 1981).
Chemoprophylaxis is thus inappropriate for use with nomadic or semi-nomadic
livestock in pastoral systems of management but can be successfully employed with
stock maintained on well organised ranches (Putt et ai, 1980; Jordan, 1986).
Measures directed against the vectors (principally Glossina) include (a)
the destruction of game (reservoir) animals upon which they feed, (b) the clearing of
vegetation and destruction of tsetse breeding habitats, (c) the application of
insecticides, (d) the use of traps and insect-impregnated targets and (e) the breeding
and release of sterile male tsetse flies to compete with wild males. In recent years,
most tsetse control and eradication campaigns have been effected almost exclusively
by aerial application of insecticides. Opinions differ as to the relative advantages of
this measure over those directed against the parasite, given the environmental
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consequences. A major attraction of the campaigns to stop the transmission of
trypanosomosis by elimination of Glosstna spp is the economic advantage of
eradication over control. Despite the economic advantage of tsetse eradication, in
comparison with a commitment to repeated long-term control measures, this radical
solution is only feasible over a relatively small proportion of the area of Africa
infected by tsetse flies (Jordan, 1986). This notwithstanding, tsetse eradication
campaigns have in the past been executed with a reasonable degree of success in
Zululand (Du Toit, 1954), on the Island of Principe (De Azevedo et al., 1962), over
extensive areas of Northern Nigeria (Davies, 1964; 1971; MacLennan and Na'isa,
1971; Nigeria, 1973-75; 1976-77; Spielberger et al. , 1977/ Jordan, 1986), in
Zimbabwe (Chapman, 1976) and in Botswana (Davies and Bowles, 1979).
Control measures involving the host include avoiding or restricting the
movement of animals into areas of risk, movement of animals out of endemic areas
and breeding of animals for tiypanotolerance. There is potential in the use of breeds
which are resistant to trypanosomosis such as the Mutura, N'dama and other West
African cattle breeds as well as East and West African indigenous sheep and goats
(Griffin and Allonby, 1979; ILCA, 1979). Trypanotolerant animals are known to
survive infections without trypanocidal drug intervention and remain as productive
as other breeds (Roberts and Gray, 1973; ILCA, 1979, Murray et ai, 1981).
Moreover, trypanotolerant N'dama and Muturu cattle are also less susceptible to
other diseases such as anaplasmosis, babesiosis and heartwater (Epstein, 1971),
streptothricosis (Coleman, 1967) and helminthosis (Murray, Morrison and Whitelaw,
1982). However, the population of trypanotolerant animals is low, with a restricted
distribution. For them to have an impact on the control of trypanosomosis there
needs to be a large increase in their numbers and distribution. Given that these
animals are often kept as status symbols, it will require radical sociological changes
as well as enormous financial commitment to multiply and introduce these
trypanotolerant livestock into the vast areas presently at risk from trypanosomoses.
T. euansi, which occurs in countries of Africa, the Americas, Asia, parts of
Europe, the middle and far Eastern countries (Hoare, 1972; Stephen, 1986) is the
least researched of all pathogenic trypanosomes despite being the first pathogenic
mammalian trypanosome species to be discovered. This fact is probably a result of
its much argued phylogenetic releationship with T. brucei (Leese, 1911; 1927) and
the assumption that information obtained from T. brucei studies could be applicable
to T. evansL In a series of papers, later collated in 1972, Hoare provided strong and
impressive arguments in support of this phylogenetic relation. However, the loss by
T. euansi of the ability of cyclical development in Glossina and its adaptation
exclusively to mechanical means of transmission have imposed basic, albeit
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important biological differences between the two, negating direct extrapolation of
results derived from the study of one to the other, irrespective of phylogenetic
relationships. For instance, although T, brucei loses its pleomorphism and the
ability to develop cyclically in Glossina following serial syringe passage in
experimental animals there has been no evidence of sustained natural maintenance
and transmission of the parasite in the absence of Glossina. In addition, cyclical
development in the vector engenders certain morphological, ultrastructural and
biochemical changes in the parasite. These changes do not occur in T. evansi since
its multiplication is restricted to the vertebrate host. Moreover, the adaptation to
exclusive mechanical transmission has facilitated an extremely wide distribution of
T. evansi among a wide range of hosts, and although Tabanid flies are its main
transmitters, several other haematophagous arthropods as well as vampire bats are
known to transmit it (Leese, 1909; Nieschulz, 1930; Dunn, 1932). This fact further
presents basic epizootiological differences between T. brucei and T. evansi which
negates the application of similar control strategies. For instance, whereas control
programmes designed to eliminate Glossina could have radical impact on curbing
the maintenance and transmission of T. brucei, such measures may have little or no
impact on the control of T. evansi whose mechanical vectors possess different
biology and patterns of life cycles from Glossina.
It is generally accepted that T. evansi does not cause serious disease in
cattle, goats, sheep, pigs and buffaloes, although this is not in fact the case. Its
most severe manifestation of disease is produced in horses and camels. This may
explain why so little attention has been paid in the recent past to this parasite by
research scientists and veterinarians since there is limited interest in horses and
camels compared with other livestock. Nevertheless, it is often overlooked that
trypanosomes in general produce their most far-reaching effect through their
restrictions on the keeping of livestock used for draught power. This in turn has
limited the development of farming systems utilising animal traction and the
availability of farmyard manure for boosting foodcrop production. The use of
donkeys, mules, cattle, buffaloes and horses for draught purposes offers the best
possible means for increased food crop production to farmers in most third world
countries. They can greatly increase the area that can be cleared and cultivated by
one man at much less expense than by any mechanized means (Connor, 1989). T.
evansi is known to have played a significant role in limiting the use and performance
of transport and draught animals in countries of the Mediterranean littoral,
Northern regions of West Africa, Euroasia, India as well as islands of the Indian and
Pacific oceans (Adiwinata and Dachlan, 1969). Such animals, even though the
infections are supposedly mild and chronic, often succumb as a result of the added
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stress of work and frequent marginal planes of nutrition. Hence, mortalities of 60,
90 and 100 percent have been reported in goats, buffaloes and horses respectively
(Rodenwaldt and Doewes, 1921; Bakkar, 1930; Mahmoud and Malik, 1978; Wells,
1982).
Irrespective of these facts, research in and control campaigns against T.
evansi have not attracted the degree of coordination, discussion and international
cooperation comparable to its tsetse-transmitted counterparts. However, the early
recognition of the importance of its infection as a serious constraint to livestock
development and food crop production prompted countries such as India as far back
as 1940, to establish centres for the monitoring of the infections and treatment of
infected livestock (Luckins, 1988). In addition, recent awareness of, and increased
interest in, the significance of T. evansi in livestock development and food
production has motivated the establishment of an international working group of T.
evansi by the Office Internationale des Epizooties (OIE), which provides a regular
opportunity for researchers and field workers to discuss recent developments in the
epizootiology, treatment, immunology and economic significance of the parasite.
Despite such international collaborative efforts on T. evansi and
notwithstanding the large body of information currently available on various aspects
of the tsetse-transmitted trypanosomes, the scourge of trypanosomosis remains.
Part of the reason for this is that unlike many bacterial and viral diseases, the
prospect of controlling the infection by the development and administration of
vaccines using trypanosomes or their products remains an elusive and remote
dream. This is because of the antigenic diversity of the parasites and their ability to
vary antigens during the course of infection (Vickerman, 1969; Gray and Luckins,
1976; Cross, 1978; 1979b; 1990). This phenomenon, known as antigenic variation,
precludes the development of an immunoprophylactic agent, and largely accounts
for the success of the organisms as parasites (Ritz, 1916; Gray, 1965a).
Antigenic variation, whereby trypanosomes sequentially express and shed
a series of different surface glycoproteins (VSGs) enables them to evade the hosts
protective immune responses. These surface antigens, upon contact with the hosts
immune effector cells, induce a rapid and highly efficient immune response capable
of destroying the trypanosomes. However, this response is also highly specific for
tiypanosomes possessing a particular VSG and invariably fails to affect any
trypanosomes having different VSGs (Murray et al., 1979) which then repopulate the
infected hosts in cycles of parasitaemic waves. In addition, trypanosomes produce
alterations in the functioning of the hosts immune system which can result in a
state of generalised immunosuppression. Thus, not only are infected animals
unable to reach a state of sterile immunity against the invading tiypanosomes but
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they might also eventually fail to mount specific protective immunity against other
pathogens to which they become more susceptible. The implication and
consequences of this phenomenon in trypanosome enzootic areas can be veiy
serious since in the tropical and subtropical regions, many diseases occur in
domestic animals and control depends on massive vaccination campaigns.
The first experimental evidence of trypanosome-induced immuno¬
suppression came from the observation that T. brucei-infected mice showed impaired
antibody response to sheep red blood cells [SRBC] (Goodwin, 1970, Goodwin et aL,
1972). This was corroborated by several other workers establishing
immunosuppression as an important feature of African tiypanosomosis (Holmes et
aL, 1974; Murray etal, 1974a; 1974b; Corsini etal, 1977; Roelants et aL, 1979a,
b). However, it was not clear how, and by what means, trypanosome infection
caused immunosuppression. Thus, the mechanism of trypanosome-induced
immunosuppression became a completely new chapter on the subject which in the
past two decades has been intensively researched. Various studies have shown that
polyclonal B cell activation, generation of suppressor T cells and macrophages and
altered antigen handling and presentation (Esuruoso, 1976; Eardley and
Jayawardena, 1977; Mansfield and Bagasra, 1978; Roelants and Pinder, 1984) are
all mechanisms which could be involved in trypanosome mediated
immunosuppression. However, the bulk of these studies have been done on
laboratory rodents using either T. brucei, T. congolense, T. gambiense or T.
rhodesien.se and have concentrated on in vitro studies of responses of either spleen
or lymph node cells from infected and uninfected rodents to various mitogens. So
far, no comparable work in rodents has been done using T. evansi and information
is lacking on this important aspect of the immunopathology of T. evansi infection.
As regards the tsetse-borne tiypanosomoses, little work has been done on
generalised immunosuppression in livestock. Hence, it is not clear whether the
immunosuppression seen in experimental rodents and the mechanisms suggested
for its induction occur also in infected livestock. There is even less information
available on the subject in the case of T. evansi infected livestock. In any case,
considerable differences exist between the pathogenic effects of infection in mice and
cattle. It was thought therefore, that immunosuppression might not be a feature of
livestock tiypanosomosis, especially as the enlargement and destruction of lymphoid
architecture in large animals is not as dramatic as in rodent trypanosomosis.
However, limited studies have been carried out to determine the immune status in
infected livestock and the results have not been unequivocal (reviewed by Vickerman
and Barry, 1982; Urquhart and Holmes, 1987). Although, often conflicting, evidence
points to suppressed immune responses to various bacterial and viral vaccine
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antigens. For example, profound reductions in antibody responses to a polyvalent
clostridial vaccine were seen in cattle experimentally infected with T. congolertse
(Holmes et al., 1974), to louping-ill vaccine in cattle infected with T. brucei, T.
congolense and T. vivax (Whitelaw et al., 1979) and to Brucella abortus vaccine in
cattle infected with T. congolense (Rurangirwa et al, 1983). In contrast, with foot
and mouth disease (FMD) vaccine, Scott et al. (1977) showed that although the
antibody responses were reduced in cattle harbouring natural trypanosome
infection, almost all antibody titres were above those considered necessary to give
more than 95 percent protection against challenge with infectious virus within 10
days of the second vaccination. This result was corroborated by results of a similar
work in which cattle, experimentally infected with T. congolense, and vaccinated
with FMD vaccine were subsequently challenged with the live virus (Sharpe et al,
1982). This suggests that while there is distinct evidence for a quantitative
reduction of anti-FMDV antibody response in the parasite-infected cattle, it is
unlikely to interfere with the effectiveness of the vaccination programmes. However,
the possibility that such immunosuppression may be prejudicial to an adequate
duration of immunity is likely since a combination of accelerated immunoglobulin
catabolism (Nielsen et al., 1978a) and lower antibody titres is unlikely to be
conducive to a sustained, efficient immune response. Moreover, in animals existing
on a marginal plane of nutrition, subjected to repeated tiypanosome challenge and
exposed to a wide variety of other pathogens, even a modest reduction of the
antibody levels could have serious effects on efficient immune responses to vaccines
as well as on resistance to the tiypanosomes and other pathogens (Urquhart and
Holmes, 1987). It is pertinent to emphasize that this fact is often overlooked in
considerations of the impact of tiypanosomosis on livestock performance in Africa
and other regions of the world where the disease is a problem. Significantly, it is
also a fact that livestock in most of these areas is more likely to be kept on a
marginal nutritional plane, trekked for long distances in search of water and pasture
and exposed to a variety of other stress factors. Such conditions amplify the effects
of trypanosome infections which may therefore render futile any attempts at
controlling other diseases by vaccination.
Marked lymphoid organ hyperplasia, altered cellular demographics and
hypergammaglobulinaemia are consistent features of trypanosomosis in large
animals which may have significant implications in the immunopathology of the
disease. Despite this, however, the mechanisms of the tiypanosome-induced
immune dysfunction in domestic livestock are more obscure and ill-defined than in
rodents. It may be possible that some of the mechanisms suggested for laboratory
rodents also operate in large animals. The few studies in which the response to
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mitogen of leucocytes from infected cattle were examined failed to demonstrate any
evidence of dysfunction (Sollod and Frank, 1979; Masake et al., 1981; Masake and
Morrison, 1981). In contrast, Emery, etal. (1980c) and Morrison et al. (1985) were
able to demonstrate in vitro proliferative responses of peripheral blood leucocytes
(PBLs) to ultrasonicated trypanosomal antigen in cattle which had been cured of
trypanosome infection by chemotherapy. However PBLs taken from infected animals
showed no response. Thus they argued that the effector cells of infected cattle were
sensitised to trypanosome antigen(s) but their proliferative response was suppressed
during infection. Although not presented, they claimed in conclusion that
preliminary results from their laboratory indicated that the suppressed responses
were those of T cells (Morrison et al. , 1985). Similarly, PBLs from T. evansi-
infected ponies failed to respond to stimulation in vitro with either living T. evansi
soluble T. evansi antigens or isolated VSG. Following treatment, cells from these
animals responded only to large amounts of the soluble antigens while living T.
evansi and purified VSG had no effect (Ahmed etal, 1988; 1990).
Detailed studies of the cytological changes in infected livestock and their
immunological implications was not possible until recently due to the lack of cell
typing reagents for large animals. This obstacle has been overcome by hybridoma
technology and the development of monoclonal antibodies (mAbs) to cell surface
antigens which has revolutionised the approach and techniques of studying the
immune systems and responses of mammals. These mAbs have permitted the
identification of the surface molecules (antigens) of immune cells and their
characterisation into functionally distinct subsets recently codified as cluster of
differentiation (CD) antigens. These differentiation antigens in normal
immunocompetent vertebrates are expressed in various proportions and ratios
which allows them to cooperate in association with accessory cells in mounting a
specific sterile immune response against foreign antigens. The recent development
of mAbs with specificities for bovine leucocyte surface antigens (Baldwin et al., 1986;
Ellis et al., 1986; Lalor et al., 1986; Davis et al., 1988) and ovine leucocyte surface
antigens (Gogolin-Ewens et al., 1985; Mackay el al., 1985; 1986; 1987; Maddox et
al., 1985a, b; Puri et al., 1985; Hopkins et al., 1986) has allowed the identification
and characterisation of the human and murine analogues of various lymphocyte CD
antigens in these species. Thus using these mAbs, attempts have been made to
study the dynamics and roles of different lymphocyte subsets in immune responses
in various diseases in which immune dysfunction is a feature. It has been revealed
through such studies that there is significant alteration in the expression kinetics of
the lymphocyte phenotypes in disease and that particular alterations may modulate
the immunological resistance of the host to the disease. A classic example of the
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immunological implication of altered expression of lymphocyte CD antigens in
infection is the depletion of the CD4+ T cells by the human immunodeficiency virus
(HIV) with an accompanied increase in the expression of CD8+ T cells which results
in subsequent destruction of the patient's immune defences and the development of
the acquired immunodeficiency syndrome [AIDS] (Kornfeld et al, 1982; Fahey et al.,
1984; Cavaille-Coll et al, 1984; Lewis et al, 1985; Melbye et al, 1986; Cooper et al,
1988; Edelman and Zolla-Pazner, 1989; Aiuti et al, 1989). Similarly, there is
marked alteration in the expression and ratios of CD4+ and CD8+ T cell subsets in
patients suffering from lepromatous leprosy (Bach et al, 1981).
As in African human trypanosomosis, Chagas' disease caused by T. cruzi
is also accompanied by severe immunosuppression (Teixeira et al., 1978; Voltarelli,
Donadi and Falcao, 1987) which undermines resistance to the establishment and
dissemination of the organism in man. In tiying to elucidate the mechanisms
involved in T. cruzi-induced immunosuppression, Beltz et al (1988) and Stein et al.
(1990) provided evidence that altered expression of certain lymphocyte surface
molecules was responsible for the immune dysfunction seen. Using in vitro culture
systems they demonstrated that T. cruzi induced the suppression of interleukin 2
receptor (IL-2R) expression by phytohaemagglutinin (PHA) or monoclonal anti-CD3
stimulated human peripheral blood mononuclear cells (PBMC). This T. cruzi-
mediated suppression of IL-2R expression was also accompanied by, and correlated
with, a marked reduction in the expression of surface CD3, CD4 and CD8 as well as
a significant decrease in the percentage of CD3+, CD4+ and CD8+ cells. CD3 is a
critical component of the TcR-CD3 complex which is involved in transduction of
signals generated by specific antigen binding. CD4 and CD8 apart from
contributing to lymphocyte activation through interaction with the TcR-CD3
complex (Allison and Lanier, 1987; Schrezenmeier and Fleischer, 1988; Parnes,
1989) are also involved critically with MHC interaction and signal transduction. IL-
2R expression by CD4+ and CD8+ cells is required for lymphocyte activation and for
activated lymphocytes to be able to complete their cell division and function
properly. Thus, inhibition of expression of IL-2R, CD3, CD4 and CD8 molecules by
T cells underlies the immunosuppression seen in Chagas' disease, since the
immunological functions of B and natural killer cells would be adversely affected,
thereby extending the repercussions of the initial T cell defects (Kierszenbaum and
Sztein, 1990).
Limited attempts have been made recently to determine the dynamics of
lymphocyte phenotypes in tiypanosome-infected livestock and assess their possible
immunological roles. Comparative studies of the circulating PBL subpopulations in
both trypanotolerant N'dama and trypanosusceptible Boran breeds of cattle exposed
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to tsetse-transmitted infection with T. congolense, showed that N'dama had
significantly higher numbers of B cells than Boran although both breeds showed
parallel significant decreases in the number of CD4+ and CD8+ T cells from the pre-
infection levels to the first peak of parasitaemia (Ellis et al., 1987). In contrast,
Williams et al. (1991) found no differences in the increase in the number of
circulating B cells in either N'dama and Boran cattle rechallenged with homologous
T. congolense. However, significant differences were observed between the two
breeds in the number of CD4+ T cells which decreased in the Boran group while
remaining within pre-infection levels in the N'dama. In addition, the CD5 antigen
was detected on 50-90 percent of circulating B cells in all infected animals compared
with 5-10 percent of B cells in uninfected animals. Mwangi (1991) has also
demonstrated marked decreases in all T cell subsets as well as increases in B cells
in the PBL of sheep experimentally infected with cultured metacyclic T. congolense.
Changes in the kinetics of various lymphocyte subsets were also observed in the
skin, lymph nodes and peripheral afferent and efferent lymph draining from the site
of tiypanosome challenge (Mwangi, Hopkins and Luckins, 1990; Mwangi, 1991). No
comparable work has so far been done employing T. evansi in any of its varied
livestock hosts.
The above studies have provided useful insights into the cellular
alterations which might underlie tiypanosome-induced immunosuppression in
domestic livestock. However, the changes in cellular phenotypes were not studied in
association with humoral responses either to the trypanosomes themselves or to a
heterologous antigen challenge during the infection. Such studies could provide
better understanding of whether, and how, the alterations in the immune effector
molecules affect the generation of sterile immunity.
This thesis is concerned with trypanosome-induced immunosuppression
and its mechanisms in domestic livestock. T. evansi is naturally infective to the
sheep in which it produces a chronic infection. The sheep-T. evansi model therefore
offers an opportunity for extended studies of disease without recourse to
chemotherapy. The experiments make use of P. haemolytica serotype Al vaccine
suspended in aluminium hydroxide gel (alhydrogel) as a model antigen because of
its high immunogenicity (Gilmour et al., 1979). Four different criteria of
immunological responsiveness were examined:
1. Cell kinetics and phenotypes using a panel of mAbs with specificities for
ovine lymphocyte antigens firstly, in sheep infected with T. evansi and
secondly in infected and uninfected sheep following primary and
secondary vaccine challenge.
2. Changes at the site of vaccine antigen inoculation, examining
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inflammatory and hypersensitivity reactions.
3. Measurement of cellular reactivity to the model antigens as assessed by
in vitro proliferative assays and
4. Measurement of specific antitrypanosomal and anti-Pasteurella
antibodies in serum.
Hence, the aim of these studies is to investigate whether T. evansi causes
immunosuppression in one of its natural hosts and if so to explore the possible
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2A 1 Historical Background, Classification and Speciation of
Trypanosomes
2A 1.1 Historical Background
Trypanosomes are eukaryotic digenetic protozoan parasites believed to
have been recognised by scientists more than 300 years ago. Valentin (1841)
observed what is believed to be the first tiypanosomes in the blood of trout (Salmo
fario), which he described as motile elongated organisms, and likened them to
amoebae. However, the true nature of his organism was disputed by other workers
including Gluge (1842) and Mayer (1843) who observed flagellates in the blood of
various amphibians. At the same time Gruby (1843) observed and studied these
amphibian haemoparasites and created the generic name Trypanosoma
(Tripanosoma) for them.
The first mammalian trypanosomes were discovered by Lewis (1878) in
the blood of black and brown rats in India. These parasites, which were later named
Trypanosoma lewisi proved to be cosmopolitan, non-pathogenic parasites of their
mammalian hosts. The discovery of the first pathogenic mammalian trypanosomes
was also made in India by Griffith Evans in 1880 while investigating a disease of
horses known by the local Indians as 'Surra' (meaning low and rotten in spirit). He
observed the parasites in the blood of horses suffering from surra and implicated
them as the aetiological agent of the disease. Evans' pioneering work (Evans, 1880;
1881-1882) was ridiculed, largely because not only was the 'microbial' nature of
diseases still very controversial and then in its infancy, but also because the
parasite he described resembled the inocuous commensal previously described by
Lewis in rats. Notwithstanding, Evans proved beyond doubt that the tiypanosomes
he saw were pathogenic to domestic animals. Although his work stimulated little
interest at the time, it undoubtedly was the basis of all subsequent investigations
which incriminated other species of tiypanosomes as the causative agents of human
and animal trypanosomoses. Evans described unequivocally the clinical disease
and gross pathology in a number of different animal hosts. He also demonstrated
experimentally that the disease was transmitted by haematophagous flies (Evans,
1880; 1881-1882). This finding was corroborated by Rogers (1901) whose work also
proved that the transmission was mechanical in nature. Bruce (1895) working in
Africa, investigated a cattle disease in Zululand called 'Nagana' and reported "the
constant occurrence in the blood, of an infusorial parasite either identical with or
closely resembling the T. evansi found in Surra, a disease of India and Burma". He
also claimed incorrectly, that the tiypanosomes (later named Trypanosoma brucei
(brucii) by Plimmer and Bradford (1899) were mechanically transmitted by tsetse
flies. It was Kleine (1909) who showed that the transmission of pathogenic African
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trypanosomes is not mechanical but biological since they undergo cyclical
development in the tsetse fly vector prior to transmission.
Bruce's discovery was followed by those of Dutton (1902) and of Stephens
and Fantham (1910) who discovered trypanosomes in human patients suffering
from sleeping sickness in West Africa and Rhodesia and which they named T.
gambiense and T. rhod.esien.se respectively. Earlier in that decade, Doflein (1901)
proposed the name T. equiperdum for the causative agent of Dourine in horses
whose nature and disease had been earlier described by Rouget (1896) in Algeria. In
the Congo, an unusually small parasite lacking a free flagellum was discovered in
the blood of sheep and a donkey and named T. congolense by Broden (1904). T.
vivax and T. suis were discovered by Ziemann (1905) and Ochmann (1905)
respectively, while a pathogenic pig trypanosome was first described by Montgomery
and Kinghorn (1909) and was named T. simiae by Bruce et al. (1912). Also in 1909,
Carlos Chagas discovered an epimastigote form of a flagellate in the gut of a
Reduviid bug (Panstrongylus megistus) and showed that monkeys fed on by these
bugs developed trypanosome (T. cruzi) infection. Chagas suspected that the
tiypanosomes might be responsible for a disease (Chagas' disease) of unknown
aetiology which afflicted the local people. He searched for the parasite in human
subjects, finally finding it in a child living in a bug-infested house. T. cruzi thus
became one of the first examples of a parasite discovered in its insect vector before
its vertebrate host became known.
2A 1.2 Classification
The taxomony and systematic classification of trypanosomes since Gruby
(1843) created the genus Trypanosoma has presented zoologists, systematists and
geneticists with its share of controversy and criticism. Thus, while over a dozen
generic names have been proposed for trypanosomes the generic name Trypanosoma
has retained its taxonomic status as the valid type-genus with all other proposed
generic names falling into oblivion. According to the classification proposed by the
Committee on Systematics and Evolution of the Society of Protozoologists, published
by Levine et al. (1980) and cited by Soulsby (1982), the systematic position of
pathogenic trypanosomes is as follows:
SUB KINGDOM: PROTOZOA Goldfuss, 1818; emend. Sielbold, 1845
PHYLUM: SARCOMASTIGOPHORA Honigberg & Balamuth, 1963
SIJBPHYLUM: MASTIGOPHORA Diesing, 1866
CLASS: ZOOMASTIGOPHOREA Calkins, 1909
ORDER: KINETOPLASTIDA Honigberg, 1963
SUBORDER: TRYPANOSOMATINA Kent, 1880
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FAMILY: TRYPANOSOMATIDAE Donein, 1901; emend. Grobben, 1905
GENUS: TRYPANOSOMA Gruby, 1843
2A 1.3 Speciation
With the general acceptance of Trypanosoma as the valid generic name,
the speciation and accordance of formal recognition to the heterogeneity of
trypanosome organisms remained for sometime controversial since the concept of
species is classically restricted to organisms with sexual reproduction. Although
trypanosomes are agamous reproducers, Hoare (1972) has argued that the difficulty
of assigning species status to them can be overcome by redefining 'species' in
general terms as 'assemblages of organisms descended from a common ancestor and
segregated from other populations by natural selection, determined by the
environment and struggle for existence'. Therefore, since trypanosomes can be
grouped into assemblages or biotypes of similar individuals, which presumably
possess a closely related genetic pattern and occupy a common habitat (= hosts)
and/or area of distribution (= host range), they satisfy the fundamental
requirements for the recognition of a population as species. Thus, well-defined
clones of tiypanosomes are entitled to be classified in the conventional manner
(Poljansky, 1957; Dogiel etal., 1965).
The first real attempt to differentiate between the diverse mammalian
tiypanosomes was made by Laveran (1911) who grouped the organisms according to
their pathogenicity. However, the first sound biological criteria for the speciation of
pathogenic trypanosomes were independently proposed by Duke (1913) and
Roubaud (1913) and entailed the separation of trypanosomes into three groups
according to their mode of development. Bruce (1914), as well as Knuth and du Toit
(1921) improved and extended these criteria thus enabling the non-tsetse
transmitted T. euansi and T. equiperdum to be grouped with the tsetse transmitted T.
brucei. The work of these authors was later collated and rationalised by Wenyon
(1926) who grouped the different species according to the site of termination of their
development in the vector. Hoare (1957; 1964; 1966), drew upon these earlier
studies and developed a classification of trypanosomes on phylogenetic lines based
on both morphological and biological criteria. This mode of classification not only
gave expression to the affinities of the tiypanosomes but also brought together
related species that exhibited similarities in their physiology, antigenic constitution
and host-parasite relationship. In the case of pathogenic tiypanosomes, these
characteristics have direct bearing on their response to chemotherapy, on the
immunological reactions of the host and on the clinical manifestation of the diseases
caused by them (Hoare, 1972).
a
FIGURE 2.1 Developmental fonns of salivarian trypanosomes
(Trypanosoma (Trypanozoon) brucei). a-d. Bloodstream trypo-
mastigote forms: a. Slender form; b. Intermediate form; c'.
Stumpy form; d. Stumpy posterionuclear form. e-h.
Developmental stages in Tsetse fly: e. Trypomastigote in fly
stomach: f. Proventricular tiypomastigote (Promastigote) in
cardia; g. Epimastigote and h. Metacyclic forms in the salivary
gland. (Redrawn from Hoare, 1949).
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Mammalian trypanosomes fall naturally into two major groups known as
Section A and B. These are distinguished by their mode of development primarily in
the vector and secondarily in their mammalian host. Hoare (1964) applied the
descriptive terms of Stercoraria and Salivaria to the two sections respectively.
Section A (Stercoraria) contains species in which the entire invertebrate cycle of
development is confined to the gut of the vector with the final production of infective
metatrypanosomes in the faecal medium of the hind-gut. Transmission from the
faeces of the insect to the body of the primaiy host is contaminative and
trypanosomes belonging to this group are said to undergo 'posterior station'
development. Morphologically, a free flagellum is always present, kinetoplasts are
large, posterior end is generally pointed and multiplication in the mammalian host is
discontinuous and usually occurs in the amastigote or epimastigote stages. Section
B (Salivaria) comprises species whose cyclical development in the vector is
completed in the 'anterior station'; that is to say, only the initial stages of
development take place in the mid-gut of the vector. The final stages, which
terminate in the production of the infective trypanosomes (Figure 2.1), occur either
in the proboscis or the salivary glands of the vector. The entire invertebrate cycle of
development for T. uivax and T. uniforme is restricted to the proboscis.
Transmission to the mammalian host is by the inoculative means through the bite of
an infected fly. Morphologically (Table 2.1) a free flagellum may or may not be
present. The kinetoplast is relatively small, terminal or sub-terminal, the posterior
end is often blunt and multiplication in the vertebrate host is continuous in the
tiypomastigote stage (Figure) 2.1. Most pathogenic African trypanosomes belong to
this section. Details of the speciation of members of the genus Trypanosoma is
given in Table 2.2 and is based on Molyneux and Ashford (1983). As can be seen,
even this system is not wholly satisfactory since non-pathogenic trypanosomes such
as T. lewisi, are grouped with pathogenic T. cruzi while T. evansi and T. equiperdum
transmitted mechanically and by coitus respectively are grouped with cyclically
transmitted T. congolense, T. vivax and T. simiae.
However, analysis of their biochemical relationships based on
electrophoretic patterns of various isoenzymes (Godfrey and Kilgour, 1976; Gibson,
Marshall and Godfrey, 1980) and restriction endonuclease analysis of mitochondrial
(kinetoplast) DNA have been used to characterise species of the T. brucei group
(Borst et ai, 1980; 1982). In addition, the development and use of species-specific
DNA probes (Massamba and Williams, 1984; Gibson, Dukes and Gashumba, 1988)
and species-specific monoclonal antibodies (Nantulya et ai, 1987; Frame, 1989) is
likely to provide more precise techniques for speciation and subspeciation within the































































































































































FIGURE 2.2a. Ultrastructural features of the trypanosome: The
Flagellum
I. Longitudinal plane
II. Transverse sections, showing arrangement of microtubules
III. Three-dimensional view of longitudinal section in various
zones
Ai-A3. Basal body: Intracytoplasmic zone
Basal body: extracytoplasmic (transitional) zone
C^-C3, D1, D2. Axoneme or flagellum seen at proximal (C3) and distal (D2)
parts
D1. Attachment of flagellum to body, with desmosomes (de) and
surface coat (sc)
ct. central microtubules; fs. flagellar sheath; pt. peripheral
doublet microtubules; tt. triplet microtubules, (adapted from
Hoare, 1972).
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2A 2 The Parasite and the Disease
2A 2.1 Morphology
2A 2.1.1 General Morphology of Trypanosomes
Much of the knowledge of the morphology of mammalian tiypanosomes
has been based on examination of diy-fixed blood film preparations stained by the
Romanovsky method. This technique has revealed that typical bloodstream forms of
mammalian trypanosomes have an elongated, spindle-shaped and flattened body
which is usually curved and varies in length from 8-39 pm (Table 2.1; Mulligan,
1970; Hoare, 1972). These features vary according to species and can be modulated
by the orientation of the parasite at the time of fixation during the slide preparation
and staining. Organelles such as the flagellum, the kinetoplast and the nucleus can
also be demonstrated by this method. However, much greater detail of the
cytomorphology of the mammalian tiypanosomes has been obtained through more
recent studies using phase contrast and electron microscopy. These studies have
shown that the trypomastigote is encased in a strong and resistant three-layer
membranous envelope known as the pellicle (Figure 2.2a: D^pe). This membrane is
enveloped by a surface coat (Figure 2.2a: D^sc) of amorphous material which is the
location of the variable antigens present in the metacyclic and bloodstream forms
(Rudzinska and Vickerman, 1968; Vickerman, 1970).
The flagellum (Figure 2.2a) represents the organ of locomotion and is a
whip-like filamentous structure shown by EM to be composed of two parallel rod¬
like structures, the axial filament complex or axoneme and the accessory filament
complex or paraxial cord, all of which are encased in a flagellar sheath (Figure 2.2a).
The axoneme consists of nine peripheral doublet and two single central
microtubules (Figure 2.2a, C1-C3,B3). It originates from the basal body (also known
as the blepharoplast or kinetosome) whose form and overall plan are akin to the
flagellum, except for the presence of nine peripheral triplet and the absence of the
two central microtubules (Figure 2.2a, A'-a-^B^B2). The paraxial cord (Figure 2.2a,
D1pc;D2pc) occurs only in the region where the flagellum emerges to form the
undulating membrane and it is thought to strengthen the propulsive action of the
flagellum (Hoare, 1972).
The kinetoplast, when seen under light microscopy (LM), may appear
disc-shaped, round or rod-shaped and its shape and size as well as the position in
the body is characteristic in certain species. It is always situated close to the basal
body. EM has revealed that the kinetoplast is a DNA-containing disc of
longitudinally orientated fibres enveloped by a two membrane capsule. It is
continuous with, and forms an integral part of, a canal system. It has a typical
mitochondrial structure with the inner membrane of the double membranous wall
FIGURE 2.2b. Ultrastructure of the trypanosome: The Kinetoplast (T. evansfl
i. Schematic ultrastructure of the kinetoplast mitochondrion in
three dimensional view showing the DNA-fibrils drawn into
cristae.
h- T. evansi kinetoplast as revealed by electron microscopy
(adapted from Hoare, 1972).
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drawn into cristae (Figure 2.2b; Clark and Wallace, 1960; Vickerman, 1965;
Vickerman and Tetley, 1979). The single mitochondrion which extends the entire
length of the organism (Figure 2.2c/2.2d) has the primary function of oxidative
phosphorylation and provision of energy for the parasite. The complexity of the
structure of this organelle and the degree of the function it performs depends on
whether the parasite is in the bloodstream or in the fly. Bloodstream forms derive
much energy from massive glucose and oxygen supply within the host's blood and
thus have simple mitochondrion of a single canal tube and very few cristae (Figure
2.2c). Fly midgut forms, which find themselves in stagnant blood and diminishing
glucose and oxygen supply develop an expanded and functionally more active
mitochondrial network with more branches and abundant cristae (Figure 2.2d;
Vickerman, 1965; 1970; Vickerman and Tetley, 1977).
The nucleus as seen under LM is a vesicular body, spherical or ellipsoidal
in shape and is bounded by a nuclear membrane. EM has revealed that the nuclear
membrane is double layered and punctured by pores with the outer layer being
continuous with the endoplasmic reticulum (Figure 2.2c). There is a dense mass at
the centre of the nucleus which is the nucleolus (endosome or karyosome). This
consists of closely packed electron-dense ribosome-like granules. Ribosomes are
also scattered throughout the cytoplasmic matrix (Vickerman, 1970).
2A 2.1.2 Morphology of T. evansi
In the blood of its mammalian hosts T. evansi is represented almost
exclusively by long, thin tiypomastigotes comprising the slender and intermediate
forms indistinguishable from those of the bloodstream forms of T. bnicei and the
allied human parasites. Although typically monomorphic, there is evidence that
some strains occasionally exhibit the same type and degree of pleomorphism as T.
brucei (Bruce, 1911; Frior et at, 1916; Velu, 1918; Lavier, 1933; Hoare, 1956)
including the presence of typical posteronuclear stumpy forms (Figure 2.2e).
However, since stumpy forms are usually absent or occur only sporadically and in
insignificant numbers (Hoare, 1972), in typical strains, T. evansi is almost
exclusively monomorphic. There is a long free flagellum and a more or less drawn-
out narrow posterior extremity. This may be rounded or truncated, with the
kinetoplast situated at some distance (subterminal position) from the tip (Figure
2.2e). The intermediate forms have a shorter free flagellum and a short, frequently
pointed posterior extremity, with the kinetoplast lying near to this end (marginal
position. Figure 2.2e). The kinetoplast, as in other tiypanosomes of the sub-genus
Tnjpanozoon, is small and usually rod-shaped. Sometimes mutant individuals
occur in which the organelle appears to be lacking. These sometimes give rise to
FIGURE 2.2c Diagram of trypomastigote intermediate bloodstream form of
Trypanosoma rhodesiense as seen at the level of the electron
microscope. The arrows along the flagellum indicate the direction of
travel of flagellar waves. Pellicular microtubules are shown only at
the anterior end of the flagellate. Note the single mitochondrial canal
(after Vickerman, 1970).
FIGURE 2.2d Diagram of epimastigote stage of Trypanosoma rhodesiense as seen at
the level of the electron microscope. Pellicular microtubules are
shown only at the posterior end of the body. Note that the
mitochondrion is now a well developed network of canals (after
Vickerman, 1970).




7-8 Stumpy, posterionuclear, dyskinetoplastic forms
(adapted from Hoare, 1972).
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permanently dyskinetoplastic strains (Figure 2.2e; Hoare and Bennet, 1937). There
is considerable variation in the dimensions of various strains and populations of
typical T. evansi but its overall length distribution is 15-34 pm : mean = 24 pm
(Hoare, 1956).
2A 2.2 Life Cycle and Transmission of T. evansi
Unlike tsetse-borne tiypanosomes, whose life cycle involves a defined
cycle of development in the insect vector prior to natural transmission, T. evansi
does not undergo any cycle of development in an intermediate host before
transmission. Multiplication of the parasite is restricted to the vertebrate host in
which they proliferate by longitudinal binaiy fission in the trypomastigote stage.
T. evansi is therefore normally transmitted from infected to susceptible
animals by mechanical inoculators represented by blood sucking Diptera other than
Glossiria, (especially Tabanid flies). The most convincing experimental confirmation
of the role of mechanical inoculators as vectors of T. evansi was provided by
Nieschulz (1930), who carried out comprehensive investigation on the subject in
Indonesia, where equine surra was prevalent. He used thousands of insects,
including species of Tabanus, Chrysops, Haematopota, Stomoxys, Lyperosia, Musca
and some mosquitoes in these experiments. By feeding the insects on infected
horses or buffaloes, then interrupting their meal at various time intervals and again
feeding them on healthy horses, dogs and laboratory rodents, he demonstrated that
the most efficient vectors were the horse-flies (Tabanus spp). The effectiveness of
Chrysops and Haematopota was negligible while Stomoxys and Lyperosia failed to
transmit the infection. However, in Africa, both the horse-flies and stable-flies
(Stomoxys) have been incriminated in transmission of T. evansi (Barotte, 1925;
Curasson, 1943). Also, since surra occurs in camels very close to the 'tsetse belt' in
West Africa, Godfrey and Killick-Kendrick (1962) suspected that T. evansi might be
capable of undergoing cyclical development in Glossina. However, it was
demonstrated experimentally by Hoare (1948), who fed G. morsitans on animals
infected with T. evansi, that they are incapable of developing in Glossina since the
trypanosomes are killed in the gut of the flies during the first hours following
ingestion.
As a rule, the shorter the interval between the two feeds by a vector, the
greater the chances of successful mechanical transmission since this depends on
the length of time the trypanosomes survive in the mouth-parts of the vector (Hoare,
1972). The longer the time within the vector, the less infectious the tiypanosomes
become. Even the most efficient vector, the horsefly, fails to successfully transmit T.
evansi when the interval from the time of the infective feed on an infected host to the
FIGURE 2.3 Diagram of life cycle of Trypanosoma evansi in Latin America.
Circulation of the parasite is shown by arrows: continuous lines
indicate main cycle (metaxeny) involving insect-vector; interrupted
lines indicate parallel cycle (paraxeny) involving Vampire bat. (From
Hoare, 1965).
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time of the second feed on the susceptible host exceeds 8 hours.
In Central and South America, T. euansi is usually transmitted
mechanically by Tabanid flies (Boehringer and Prosen, 1961). However, the
maintenance and opportunity for transmission of the parasite is considerably
enhanced by other vector species. In addition to biting flies, the sanguivorous
vampire bat, Desmodus rotundus has been demonstrated to transmit this disease.
These bats are ideal vectors, for even when feeding on hosts such as cattle with very
scanty parasitaemia, their infection is ensured by the large amount of blood
consumed, while the proliferation of the tiypanosomes in their own blood increases
the chances of successful transmission to new hosts. Thus Hoare (1965) pointed
out that the host-parasite relations between the vampire bats and T. evansi present
an unusual combination of vector and host in the same animal. The implication of
this dual role is that the success of transmission of T. evansi by bats does not
depend on the temporary survival of the parasites during the intervals between
interrupted meals, rather, the establishment and persistence of the infection in the
bats make them capable of transmitting the parasites for long periods of time to a
wide range of hosts. Yet the bats differ from specific biological (cyclical) vectors in
that the parasites do not undergo in them a development characteristic of a true
vector but multiply in their blood in much the same manner as they do in the
natural vertebrate host. Thus Hoare (1965) proposed two types of life cycle and
transmission patterns for T. evansi in the region, known as metaxenic and paraxenic
live cycles (Figure 2.3). Finally, the tranmission of T. evansi to carnivores, especially
dogs, is effected by the ingestion of raw meat from infected animal carcasses
(Mulligan, 1970).
2A 2.3 Host Range, Pathogenesis and Pathology of T. evansi
T. evansi has a wide host range in which it causes disease. Among
domesticated animals it affects horses, donkeys, mules, camels, the Indian elephant,
cattle, buffaloes, sheep, goats, dogs, cats and pigs (Stephen, 1986). In addition, it
affects a wide range of wild animals including various felines, canines and
ruminants. These wild animals are as much victims of the disease as domesticated
livestock and they probably acquire the infection secondarily from domesticated
animals. Many are highly susceptible to T. evansi which has severe pathological
effects on them. They are therefore not normally regarded as reservoir hosts
through which domestic animals are infected (Hoare, 1972).
Whilst T. evansi causes disease in most domestic animals there is a
considerable degree of variation in the severity of its pathological effects. This is
probably due to variations in the virulence of a parasite strain and the degree of
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susceptibility of the particular host animal. The clinical pattern of the disease is
usually similar to nagana caused by T. brucei and is characterised by fever and
anaemia, followed by oedema, cachexia and death. The disease usually assumes its
most severe form in camels, horses and Asian elephants (Curasson, 1943).
However, mild chronic infections which sometimes end in selfcure may occur in
cattle, sheep and goats while in pigs, the disease, is as a rule, asymptomatic
(Hornby, 1953; Mulligan, 1970).
The manner in which pathogenic tiypanosomes produce disease and
eventual death has been the subject of considerable research and controversy. It
was believed that toxic substances detrimental to the host are liberated into the
blood circulation from large numbers of dead and disintegrating trypanosomes.
This, coupled with rapid exhaustion of blood glucose and uncompensated acidosis
were thought to be central to the pathogenesis of tiypanosome infections. However,
Randall (1934) studied the blood chemistry of horses infected with T. evansi and
noted that there was no evidence that the death of a large number of tiypanosomes
in the blood circulation liberated an endotoxin injurious to the animal. Also, studies
of fluctuations in blood sugar levels in equines and camels infected with T. evansi
showed that while blood sugar levels were lower at the time of crisis, they rose after
the crisis and were at times higher than normal. In addition hypoglycaemia at time
of death was not a marked feature (Randall, 1934). Conversely, it was demonstrated
that experimentally infected animals were continuously in a state of acidosis which
varied according to the number of trypanosomes in the blood, and that the end
products of massive glucose consumption caused an uncompensated acidosis and
exhaustion of alkali reserves which was further affected by the destruction of
erythrocytes (Randall, 1934). This caused an anoxemia that manifested as
accelerated and laboured respirations.
Surra is associated with changes in serum proteins in infected camels
and buffaloes (Jatkar et al., 1973; Verma and Gautam, 1977; Boid et al., 1980). In
experimentally and naturally infected Sudanese camels for instance, Boid et al.
(1980) found that the total plasma protein concentration of infected animals
increased above normal values although albumin levels decreased in both the
natural and experimental infections. Although the significance of alterations in the
levels of serum enzymes in the pathogenesis of T. evansi infections is not clear, it
has been shown that in dogs and camels infected with T. evansi there is a significant
increase in serum glutamate oxaloacetate transaminases (SGOT), glutamate
pyruvate transaminase (SGPT), sorbitol dehydrogenase and alkaline phosphatase
(Dwivedi etaL, 1977; Boid etal, 1980).
In comparison to its tsetse-transmitted counterparts, the pathological
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changes engendered by T. evansi in domestic animal hosts have received little
attention from investigators (Stephen, 1986). Although leucocytosis is a consistent
feature in naturally infected camels, decreases in erythrocyte counts, haemoglobin
concentrations, lymphocyte and basophil counts have also been reported. However,
there are concurrent increases in neutrophils, eosinophils and monocytes (Nadim
and Soliman, 1967). Splenic and lymph node lymphoid hyperplasia with periportal
accumulations of lymphohistiocytic cells in the liver has been seen in horses
infected with T. evansi (Seiler et al., 1981). In addition, scattered nonsuppurative
myocarditis as well as evidence of haemosiderosis in phagocytic cells of the spleen,
lymph nodes, liver and lungs has been observed. Histopathological studies of the
central nervous system of infected horses showed a generalised, nonsuppurative
meningo-encephalitis affecting the grey and white matter at all levels of the brain,
with the severity of brain lesions varying from one animal to the other. Typically,
broad perivascular cuffs of mononuclear inflammatory cells including large
lymphocytes, histiocytes and some plasma cells were evident. Patchy gliosis which
was often severe, accompanied the perivascular cuffing (Seiler etal, 1981).
2A 2.4 Geographical Distribution of the Disease
The non-cyclical mode of transmission of T. evansi facilitated its
dissemination throughout the tropical and sub-tropical regions of the world and the
parasite has a very extensive geographical distribution. In the Old World, the
disease is prevalent in countries lining the Atlantic and Mediterranean littorals such
as Morocco, Algeria, Tunisia, Libya and Egypt, and extends south across the Sahara
into Senegal, Mali, Chad and parts of the northern belts of West Africa from 13°-
16°N. Eastwards the disease occurs in the Sudan to latitude 13°N and almost to
the Equator in parts of northern Kenya and Somalia (Hoare, 1957).
The distribution of Surra on the Eurasian continent is rather uneven and
patchy. It has been reported from Israel, Lebanon and Syria, the northern half of
the Arabian Peninsula, Iraq and Iran. The trans-Volga region of the former Soviet
Union is the area chiefly affected by 'Su-auru' in Europe, spanning areas from
Kuibyshev (53°N) to the Caucasus (44°N). It then passes into Turkestan and
extends into Burma, India, the Malay Peninsula, Indochina and parts of southern
China (Hoare, 1972). The disease also occurs in Turkey and an isolated case has
been recorded in Bulgaria. On the islands of the Indian Ocean the disease is
prevalent in Mauritius and on the archipelagoes of Indonesia and the Philippines.
In the New World, T. evansi diseases known as Mai de caderas,
Derrengadera and Murina occur in Central America and in parts of South America
including Mexico, Venezuela, Columbia and Brazil (Hoare, 1972). Figure 2.4 shows
FIGURE2.4Geographicaldistribution—animaltrypanoso iasis
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the distribution of surra in the Old and New world.
2A 2.5 Antigenic Variation in African Trypanosomes
In the face of attack by specific and nonspecific immune systems,
parasites use four evasion techniques to ensure survival: 1) sequestration in cells or
body sanctuaries where immune attack is less effective, 2) deceit or mimicry by
adsorption of host protein or immitation of host surface proteins, 3) rendering the
attack futile by immune suppression and 4) antigenic variation, that is changing
spontaneously the target of immune attack (Borst, 1991).
Antigenic variation is one of the most effective of the strategies developed
by parasites to escape destruction. This strategy requires a large wardrobe of
surface coats and mechanisms to exchange one coat for an unrelated one before the
host's antibodies have destroyed the entire parasite population. No other parasite
has developed and perfected this evasion strategy to the same high degree of
sophistication as the pathogenic trypanosomes.
The success of pathogenic tiypanosomes as parasites and the inability to
develop an effective immunoprophylactic agent against them are largely as a result
of their remarkable ability to undergo antigenic variation (Franke, 1905; Rodet and
Vellet, 1906; Ritz, 1916; Leupold, 1928; Russell, 1936; Gray, 1962; 1965a; 1965b).
The entire surface of the trypanosome, including the flagellum, is covered with a
dense protein coat that consists of a single protein species known as the variant
surface glycoprotein (VSG) (Vickerman, 1969; 1978; Cross, 1975; 1990). Antigenic
variation in tiypanosomes is a process whereby the parasites sequentially express
and shed a series of different VSGs which then enables them to evade the host's
protective immune responses. These surface antigens are capable of inducing
protective immunity, and the immune response to each variant, although rapid and
highly efficient in destroying any tiypanosomes that possess that particular antigen,
is invariably too late to affect tiypanosomes which have altered their surface
antigenic identity. Although antigenic variation in trypanosomes probably occurs
when the organisms start dividing at the site of infection, in the chancre, it is in the
systemic phase, as bloodstream forms, that the tiypanosomes undergo extensive
variation of surface antigens.
2A 2.5.1 The role of Antigenic Variation in the Establishment of
Infection
The highly immunogenic VSGs determine the antigenic characteristics of
the trypanosomes, known as variable antigen types (VATs) against which variant-
specific immunity is induced (Barry and Turner, 1991). During an infection,
although an immune response is elicited against a particular VAT, the trypanosomes
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are able to express new and immunologically distinct VSG (Cross, 1978) which
generates different VATs and results in the establishment of persistent chronic
infection (Van Meirvenne et ai, 1975b). Clinically, this is manifested as fluctuating
or successive waves of parasitaemia with the parasite staying one step ahead of the
immune response. Each parasitaemic peak is a mixture of mainly predominant
(homotype) VAT population and a small fraction of switched minor (heterotype) VAT
population (McNeillage etai, 1969; Van Meirvenne et al., 1975a; Vickerman, 1978;
Vickerman and Bany, 1982; Borst, 1991). The switching of the exposed variant-
specific antigen in a subfraction of the parasite population and the expression of the
surface antigen genes occur in a certain order which avoids simultaneous gross
population heterogeneity. This in turn avoids rapid induction of antibodies against
all members of the surface antigen repertoire which otherwise would ensure the
ablation of the entire parasite population by the antibodies (Borst, 1991).
The total VAT repertoire and the genes encoding for them in a given clone
of trypanosome is as yet undefined for any trypanosome species, but probably
exceeds 100, as the VAT repertoire of a cloned isolate of T. equiperdum has been
shown to do (Capbern et ai, 1977). However, to succeed as a means of self defence,
ensuring establishment and prolongation of infection, the manner of expression of
the VAT repertoire is perhaps more crucial to the tiypanosome than the number of
VATs generated. Thus, VATs from the repertoire must appear consecutively rather
than simultaneously. If there were to be simultaneous expression of all VATs early
in infection, it would dictate, either that the host becomes overwhelmed rapidly by
fulminating parasitaemia or that effective immune responses would be generated
against all VATs simultaneously. This does not happen and in fact, in bloodstream
trypomastigotes, VATs appear in a certain hierarchical fashion. This hierarchy does
not involve a simple, defined and nondiverging sequence of VAT expression. Such a
simple, nondiverging sequence would reduce the establishment and longevity of
infections initiated for instance, by trypanosome populations inoculated into
partially immune reservoir hosts in the field. In such situations, the existing
antibodies against individual VATs would simply terminate the sequence (Gray,
1965b; Capbern etai, 1977; Miller and Turner, 1981; Barry and Turner, 1991).
VSG expression and antigenic variation, are features peculiar to
bloodstream tiypomastigotes. Following ingestion by Glossina there is cessation of
this process during transformation from the bloodstream to the procyclic forms in
the fly midgut (Ehlers, Czichos and Overath, 1987). In most salivarian
tiypanosomes, VSG is re-expressed in the infective metacyclic forms. In the case of
T. brucei for instance, this starts in the metatrypanosomes in the tsetse salivary
gland after the cessation of cyclical cell divisions (Tetley et ai, 1987). Upon
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introduction into a new host, the manner of expression of the metacyclic VAT
(mVAT) repertoire and their interaction with the host's initial immune responses in
the chancre could determine whether an infection is established or aborted.
Although comprising only a limited proportion of the entire VAT repertoire
of the bloodstream form, the metacyclic population is similarly antigenically
heterogeneous and predictable (Le Ray, Barry and Vickerman, 1978). For example,
there is limited mVAT repertoire in T. rhodesiense (Barry, Crowe and Vickerman,
1983; Turner et al., 1988) and, in T. congolense, only 12 mVATs have been identified
(Crowe el al., 1983). The re-expression of mVATs following introduction into a host
varies according to the species of trypanosome. For instance, mVATs of T. brucei are
expressed only for a very short period following introduction into a new host (Barry
et al, 1983; Esser and Schrenbechler, 1985). In contrast, the mVAT of T.
congolense continues to be expressed in chancres for up to six days after infection of
rabbits and sheep (Luckins et al., 1990; Sutherland, Ross and Luckins, 1991). The
re-expression of mVATs is however, not restricted to infections initiated with
metacyclic forms of trypanosomes but can also be seen later in infections initiated
with bloodstream forms. This has been demonstrated for T. rhodesiense (Barry et
al., 1983), T. congolense (Nantulya et al., 1984) and T. vivax (Nantulya, Musoke and
Moloo, 1986), and indicates that despite antigenic variation, bloodstream
trypanosomes are still able to re-express VATs which possess surface antigenic
determinants identical to those of their metacyclic ancestors. This however, may not
be to the advantage of the trypanosome, as such VATs would be easy prey to effector
mechanisms which had been previously sensitised against them.
2A 2.5.2 The Variant Surface Glycoprotein
The VSG is a major cell product of the trypanosome and accounts for up
to 10 percent of protein synthesised by the parasite (Cross, 1975; Bangs et al., 1985;
Ferguson et al., 1986). It consists of a single polypeptide chain with an apparent
molecular weight of 53 to 65 kD, but species differ widely in VSG isoelectric points,
amino acid composition/sequence and carbohydrate content (Cross, 1975; 1977;
Johnson and Cross, 1977; Hoeijmakers et al, 1980b). The VSGs of T. brucei contain
up to 470 amino acid residues (Allen, Dickens and Cross, 1982; Boothroyd et al,
1982) in contrast to the 372 seen in T. congolense (Strickler et al, 1987), while the
carbohydrate component of various VSG species may vary from 7 to 17 percent
(Johnson and Cross, 1977). Limited tryptic digestion cleaves all VSGs into two
'domains': an N-terminal (variable) fragment of MW 40-52 kD and a smaller C-
terminal (constant) domain of MW 13 to 17 kD (Figure 2.5a; Johnson and Cross,
1979). There are no disulphide links between them and the entire molecule appears
(b)
i/.y.'.v.i
VARIABLE REGION CONSTANT REGION HYDROPHOBIC
TAIL
Fig 2-5 Line diagram of trypanosome VSG showing the
hydrophobic tail
FIGURE 2.5 A dimeric unit model of trypanosome VSG based on EM and X-ray
crystallographic studies (Cohen et al, 1984; Freymann et al., 1984;
Metcalf et al., 1987).
CHO = inaccessible oligosaccharide (carbohydrate) moieties
linked to terminal amino acid asparginine.
CRD = cross reacting determinants which forms part of the
membrane glycolipid attachment.
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to be folded so that the N-terminal two-thirds and C-terminal third form the two
distinct domains (Figure 2.5a).
Amino acid and nucleotide sequencing studies indicate that the
immunological uniqueness of each glycoprotein resides in the variable N-terminal
portion of the VSGs (Bridgen et al, 1976; Rice-Ficht et al., 1981; Miller et al., 1984).
Trypsinisation of living T. brucei releases the projecting N-terminus leaving the C-
terminus (which is conserved) attached to the tiypanosome membrane (Cross and
Johnson, 1976). As shown by lectin binding studies on such live tiypanosomes and
by cytochemical staining as seen by EM, it appears that the oligosaccharide groups
in T. brucei are located close to the membrane proper (Figure 2.5a; Wright and
Hales, 1970; Steiger, 1973; Cross and Johnson, 1976; Seed et al., 1976; Renwrantz
and Schottelius, 1977). The inability of lectin to bind to the intact trypanosome
suggests that the carbohydrate groups are inaccessible and therefore play no role in
the antigenic specificity of the VSG molecule and thus no part in host-parasite
interactions. It would therefore appear that cross reactivity between VSGs do not
occur because of the hypervariability of the amino terminus. However, the work of
Baltz et al. (1977) on lectin binding to T. equiperdum suggests that in the brucei-
group there may be exceptions to this rule. In fact, although the amino acid
sequence of the N-terminus confers great diversity of epitopes on each VSG
molecule, some antigenic cross-reaction has been detected among various VSGs
(Vickerman and Barry, 1982). Studies employing radioimmunoassay and
microcomplement fixation tests have revealed cross-reacting groups which appear to
be located in the C-terminus (Figure 2.5a) and involve carbohydrate moieties
attached at, or very close to, the terminal amino acid, asparagine, aspartic acid or
serine (Barbet and McGuire, 1978; Barbet et al., 1979; Cross, 1979a; Holder and
Cross, 1981). The conservation of sequence as shown by Rice-Ficht et al. (1981)
within the C-terminal fifth of the protein would presumably also give rise to
antigenic cross-reaction. Indeed, cross-reactions involving the entire VSG molecule
have been known to occur in iso-VATs, which are common VSGs occurring in many
serodemes as shown by competition radioimmunoassay, and by peptide mapping
(Vervoort et al., 1981). Serodemes are cloned stocks of a single tiypanosome which
express the same VAT repertoire (Anon, 1978).
It is not yet clear how the VSG is anchored to the membrane lipid bilayer
although some affinity of purified VSG for cholesterol has been reported (Klein et al,
1982). However, Johnson and Cross (1979) studying the soluble glycoprotein failed
to demonstrate a hydrophobic segment which might serve to anchor the C-terminus
to the membrane. Nevertheless, studies on the nucleotide sequence of VSG genes by
recombinant DNA techniques, have suggested, that the primary translation product
29
contains a C-terminal hydrophobic 'tail' which is missing from the purified
glycoprotein, (Figure 2.5a, b; Boothroyd et al., 1980; Holder and Cross, 1981;
Matthyssens et al., 1981; Rice-Ficht et al., 1981; Pays et al, 1983). This loss may
occur during intracellular processing but the tail may provide a VSG anchor in the
intact cell and be shed only when VSG is released from the surface.
2A 2.5.3 The Mechanism of Antigenic Variation
Antigenic variation was originally conceived as an orderly programmed
sequence of VATs, with VAT-specific host antibody probably acting as inducer of
antigenic change in some of the tiypanosomes before a relapse (Gray, 1965a).
However, the detection of several heterotype VATs alongside the homotype, suggests
that antigenic variation may be a spontaneous process, able to generate a large
number of VATs in a given tiypanosome population not necessarily in a programmed
sequence. Moreover, host antibody response cannot be responsible for VSG
switching since antigenic variation occurs in T. brucei and T. congolense in vitro
(Doyle et aL, 1980; Luckins etai, 1986) and in immunosuppressed infected animals
(Mansfield, 1990). Host antibody pressure however, may be able to enhance
antigenic variation by selecting for low numbers of new variant (heterotype)
tiypanosomes present in a population. In fact, the waning of antibody against a
particular VAT might be expected to allow reappearance of that VAT in the same
host. Such a situation has been reported in cattle infected with T. brucei (Nantulya
etal, 1979).
The rate and spontaneity of generation of heterotypes in a tiypanosome
population are suggestive of a background mutational mechanism for antigenic
variation (Cantrell, 1958; Watkins, 1964; Seed and Gam, 1966). However,
tendencies for variants of each strain of T. brucei to revert to a 'parent' antigenic
type, and for variant antigens of cyclically transmitted strains to develop in an
orderly sequence, argue against mutation as the basis of antigenic variation (Gray
and Luckins, 1976). Moreover, the observed conservation of VAT repertoires and the
VSG N-terminal amino acid analysis data demand that antigenic variation in the
individual host has its basis in phenotypic rather than genotypic change (Vickerman
and Barry, 1982).
It is now well established that sequential expression of a large series of
different VSG genes is responsible for antigenic variation in pathogenic
trypanosomes (Williams et al., 1979; Hoeijmakers et al., 1980a, b; Pays et al., 1981).
There is a separate gene for each VSG, which is present in each trypanosome of a
serodeme regardless of whether the gene is being expressed or not. Estimates based



































FIGURE 2.6 The various pathways for activating a variant-specific surface
glycoprotein gene in T. brucei. 1) Boxes A, B and C are nontelomeric
genes; X is a telomeric gene. Duplicative transposition of B displaces
X and brings B under the expression site promoter (flag). The vertical
bars mark the end of a chromosome. 2) Activation by duplicative
transposition of the silent telomeric VSG gene, D. into a telomeric
expression site. Because of considerable sequence homology between
telomeres, large block sequence may be cotransposed, hence the
name, telomere conversion. 3) Activation of an inactive telomeric
expression site and concomitant Luactivation of the previously active
site. These two processes are spontaneous and independent of each
other. Although gene rearrangements near the promoter are not
involved, it is likely that further upstream, gene rearrangements may
occur (from Borst, P., 1991).
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1000-2000 VSG genes (Van der Ploeg et al., 1982). The expression of a new VSG
gene in some VATs is preceded by gene rearrangements in which formation of an
expression-linked copy (ELC) from an existing basic copy of the VSG gene occurs.
The ELC is subsequently transposed (Bernards et al., 1981) to a telomeric
expression site on one of the trypanosome's chromosomes, which contains an
upstream promoter site (Figure 2.6). If a VSG gene already is in residence at the
new telomeric transcription site, it is lost, degraded or inactivated when the new
VSG gene is inserted into the telomeric expression site (Mansfield, 1990).
Subsequently, the newly inserted VSG gene is transcribed, and the translational
events ultimately result in the expression of a new VSG surface coat phenotype. In
some variants, activation of a VSG gene that is already within a telomeric expression
site occurs to produce a new surface coat. Also, a new VSG gene may be
constructed not from a basic copy of the gene but through a recombinational event
involving two different telomere-associated VSG genes (Borst, 1991).
The events regulating VSG genes within an expression site are not yet
known (Borst and Cross, 1982; Mansfield, 1990) but as stated earlier, switching
from one VSG to another is independent of antibody pressure (Doyle et al., 1980;
Luckins et al., 1986). The pattern of antigenic variation at the cellular and
molecular levels involving the frequency of switching between VSGs and VSG genes
of a particular VAT population has been studied. By estimating the number of
trypanosomes surviving antibody treatment it was shown that the number of
switched trypanosomes ranged between 1CT4 to 10"5 changes per cell per generation
(Van Meirvenne et al., 1975a; Doyle, 1977). However, since these figures only
represent the number of switched trypanosomes in the population at a particular
time, they cannot be judged to be accurate representatives of the frequency of VSG
switching. A more accurate method would be estimates taking into account the
growth rate of the newly expressed antigenic types, the proportion of switched
trypanosomes and the number of generations from the original antigenically
homogeneous population. Using this method, the frequency of switching from a
defined VSG type to another was reported to range from 1.4 x 10"7 to 3.5 x 1CT6
switches cell"1 generation-1 (Kosinski, 1980; Lamont, Tucker and Cross, 1986).
The genetic basis of antigenic variation, which leads to the switch in the
VSG surface coat phenotype is thus the key to the success of tiypanosomes as
parasites. Since several copies of different VSG genes exist in a genetically
homogenous tiypanosome population (clone), the parasites are ensured of extended
survival in an immunologically hostile environment. Certainly in nature, survival
time of the parasite within the host is sufficient to result in transmission of the
disease by the fly vectors before death of the host occurs.
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It had been hoped that a multivalent VSG vaccine might be effective in
controlling African tiypanosomosis. However, this hope has been dashed because
the sequence in VSG gene expression is virtually random, making it impossible to
predict potential target antigen VSGs. The heterogeneity of VATs and the
unpredictable VSG expression sequences in infected hosts therefore preclude
development of multivalent VSG vaccines. Vaccination with the metacyclic
trypomastigote VATs that are infected by tsetse flies is also problematic because
similar metacyclic VSG gene heterogeneity and instability occur (Mansfield, 1990).
2A 3 Immune Responses and Immunity to Trypanosomes
The infection of humans, domestic livestock or laboratory animals with
pathogenic African trypanosomes is invariably fatal if untreated as a result of the
inability of the host to achieve a sterile immunity (Bancroft and Askonas, 1985).
Nevertheless, it has been demonstrated experimentally that both domestic and
laboratory animals can be rendered resistant to subsequent challenge with
homologous tiypanosomes by either needle or fly infection followed by drug
treatment or by inoculation with irradiated trypanosomes (Whiteside, 1962;
Wiesenhutter, 1970; Wilson et al, 1975; 1976; Murray and Urquhart, 1977;
Nantulya et al., 1980; 1984; Welde etal, 1981; Morrison et al, 1982; Luckins, Rae
and Gray, 1983). In naturally infected animals however, there is a wide variation in
the immune response against trypanosomes. Thus, when cattle are infected with a
single trypanosome serodeme they are sometimes able to eliminate the parasites and
to recover (Morrison et al., 1985). Even within the cattle population certain breeds
such as the Muturu and N'dama indigenous to West and Central Africa have a
greater capacity to control the level and duration of parasitaemia and thus survive
(Murray, Morrison and Whitelaw, 1982). Immunity to tiypanosomes is mediated by
antibody responses against the VSG (Murray and Urquhart, 1977). The immunity is
rapid and strong but because of antigenic variation is effective only against the VAT
that elicited it (Vickerman and Barry, 1982; Morrison, et al. , 1985). A major
feature of the immune response in trypanosome infections in domestic and
laboratory animals is the alteration in cellularity and architecture of various
lymphoid organs (Losos and Ikede, 1972; Mansfield, 1982; Bancroft and Askonas,
1985). In view of the importance of lymphocytes, their recirculation and the
interaction between lymphoid cells, macrophages and other antigen presenting cells
(APCs), it is to be expected that these changes would interfere with normal immune
functions. Thus, one of the hallmarks of pathogenic African tiypanosomes is the
modulation of the host's immune system which results in generalised
immunosuppression (Goodwin, 1970; Goodwin et al, 1972; Murray et al, 1974a).
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Pathogenic tiypanosomes are therefore able to elicit on one hand, responses which
mediate protective (albeit nonsterile) immune response and on the other hand, those
which modulate and compromise the immune competence of the host and ensure
establishment and dissemination of the trypanosomes.
2A 3.1 Humoral Immune Responses to Trypanosomoses
The injection of tiypanosomes by needle into a host triggers a rapid and
strong antibody response. However, the typical primary humoral immune response
of mammalian hosts, in which initial IgM synthesis is replaced by the synthesis of
IgG antibodies, is somewhat modified in trypanosome infected hosts in that IgM
production is greatly enhanced and prolonged. Serum hypergammaglobulinaemia of
mainly the IgM isotype has been consistently found in trypanosome infections of
laboratory rodents, humans, monkeys, bush buck, cattle and sheep (Houba et al,
1969; Seed et al, 1969; Luckins, 1972; 1975; Clarkson and Penhale, 1973;
Greenwood, 1974; Hudson etal, 1976; Mattern etal., 1978; Mackenzie etal., 1979).
These elevations in IgM form the basis of a diagnostic test for human sleeping
sickness. There is evidence that the increased level of immunoglobulins is not
entirely parasite specific but consists of antibodies directed against both the
trypanosomes and unrelated antigens as well as some autoantibodies. Thus, Houba
et al. (1969) demonstrated the presence of heterophile antibodies in the serum of T.
gambiense-infected monkeys. Much of the IgM is considered to be non-specific
possibly resulting from polyclonal activation of B cells (Hudson et al, 1976; Terry et
al., 1980). In mice infected with T. brucei for instance, less than 10 percent of the
increased immunoglobulin produced is trypanosome specific (Corsini et al., 1977).
However, more recent work suggests that there is in fact a greater degree of parasite
specific antibody since careful absorption with a wide range of tiypanosome VATs
can remove most of the IgM in serum of sleeping sickness patients (Herbert et al,
1980) and T. brucei-infected cattle (Musoke et al, 1981).
Despite conflicting views on the specificity of the IgM, there is ample
evidence that the susceptibility or survival of tiypanosome-infected hosts depends
on their ability to mount an early IgM response. For instance, estimation of the
immunoglobulin concentrations in C57B1 and A/J mice infected with T. congolense
showed that the more resistant C57B1 strain developed a pronounced IgM response
during the first parasitaemic wave. The more susceptible A/J mice not only failed in
this but in addition, showed a fall in total IgG concentrations as well until death
supervened 10 days after infection (MacAskill et al, 1983). This result suggests that
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the greater tiypanoresistance of C57B1 mice largely depends upon its more efficient
and earlier antibody responses (Whitelaw et al, 1983). It is supported by the work
of Mahan et al. (1986), who also showed that the ability of C57B1/6 mice to control
the initial wave of parasitaemia following T. vivax infection and the failure of
C3H/He mice to do so depended on the superior early and high levels of antibody
production by the former mouse strain.
Trypanosome-specific antibodies are primarily directed against the VSG of
the tiypanosome surface coat (Black, Hewett and Sendashonga, 1982) but
protection against the homologous clone can also be acquired by immunisation with
the purified VSG (Cross, 1975). The primaiy antibody response of laboratory and
domestic animals to trypanosome-bound VSG usually reaches a maximum 7-14
days after infection and then declines slowly, being detectable for more than 100
days (Seed et al., 1969; Wilson and Cunningham, 1972; Herbert et al., 1980; Pinder
et al., 1983). However, there appears to be a variation in the duration of the actual
in vivo protection by these primary antibodies in animals, ranging in cattle from 35
days (Wiesenhutter, 1970) to 14 months (Wellde et al., 1973). Similarly, the type of
immunoglobulin produced during primaiy responses seems to vary. Hence, several
workers using trypanosome agglutination test have reported that the primary
response of rabbits to T. gambiense and rats or cattle to T. bnicei is predominantly
IgM (Seed et al., 1969; Zahalsky and Weinberg, 1976). In addition, following
primary challenge of mice with T. gambiense, purified IgM is 200-fold more efficient
in a neutralisation of infectivity and 20-fold more effective in agglutination than IgG
(Takayanagi and Enriquez, 1973). On the other hand, other investigators have
shown that the primaiy antibody response of mice and cattle to T. brucei or mice to
T. rhodesiense is predominantly IgG (Campbell, Esser and Phillips, 1978; Nantulya
etal, 1979; Sacks and Askonas, 1980; Mansfield etal, 1981).
Few reports are available on the secondary antibody response to host
reinfection with the same stock or clone of tiypanosome. It appears, however, that
the antibody kinetics, peak titre, and duration of detectable activity are similar to
those after primary challenge in for example, rats infected with T. brucei (Zahalsky
and Weinberg, 1976), mice inoculated with T. gambiense homogenate (Oka et al,
1981), or in cattle infected with T. brucei (Pinder et al., 1983). There is evidence that
IgM antibody still predominates in secondaiy responses in cattle, although an
appreciable amount of IgG is also produced (Roelants and Pinder, 1984). It was
demonstrated by Musoke el al. (1981) that after both primaiy and secondary
challenge VSG-specific IgM and IgGj but not IgG2 were produced. In contrast,
Pinder et al. (1983) observed both IgGj and IgG2 during these challenges.
Cattle infected with T. brucei may, during the course of the infection, show
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two peaks of antibody titre to the infecting organisms with the second peak possibly
being higher than the first. These antibody peaks presumably arise because of the
reappearance of organisms with the same or similar VSG (Nantulya et al, 1979).
2A 3.2 Cellular Immune Responses in Trypanosomoses
Because of strong evidence that immunity to trypanosome infections is
mediated by antibody, limited effort has been made to investigate cell-mediated
immune (CMI) responses to trypanosomes. The result is that cell-mediated
mechanisms directed specifically against trypanosome determinants and their
relevance to protection are less well characterised than the humoral responses.
However, the available evidence suggests that cell-mediated immunity against
tiypanosomes is either absent or relatively unimportant. Athymic nude mice and
irradiated thymectomised mice are able to mount functional and in some cases
enhanced immune response to T. brucei infection (Campbell et al, 1978; Clayton et
al, 1979; Askonas et al, 1979). In addition, immunity is not transferred adoptively
with T cell-enriched spleen cell population (Takayanagi and Nakatake, 1975;
Campbell and Phillips, 1976) and treatment of immune spleen cells in vitro with
anti-thymic cell antiserum does not inhibit their capacity to transfer immunity
(Takayanagi and Nakatake, 1975). In contrast, mice deprived of B cells are unable
to mount an effective response (Campbell et al., 1977) although immune mouse
thymic cells can transfer immunity to thymectomised irradiated recipients
(Tagayanagi and Nakatake, 1976).
It seems unlikely that effector T cells play a direct role in attacking the
tiypanosomes but there are significant changes in regulatoiy T cells and T cell
functions which undoubtedly have a profound effect on immune function during
infection. For instance, T cells from A/J mice primed by subcutaneous
administration of live T. brucei (Gasbarre, Hug and Louis, 1980) or by immunisation
with irradiated T. rhodesiense (Campbell et al, 1978) will subsequently proliferate
specifically in vitro in the presence of trypanosome antigens. This T cell proliferative
response is however, abolished if active infection precedes immunisation by as few
as 3 days (Gasbarre et al, 1981). This suggests that T cell function is impaired by
infection. Since the specific in vitro proliferation occurred after 5 and 10 days from
the time of priming, and dropped or disappeared after 15 days, it was suggested that
this was apparently as a result of T cell and macrophage unresponsiveness
(Gasbarre et al, 1981). However, the subcutaneous priming of mice is effective only
when the live tiypanosome is given with complete Freund's adjuvant (CFA). It is
therefore difficult to assess the validity or importance of this in vitro T cell reactivity
in relation to natural infections.
35
Studies of delayed type hypersensitivity (DTH) reaction have also been
used to investigate T cell responses in rodent tiypanosomosis. Tizard and Soltys
(1971) found that rabbits infected with T. brucei or T. rhod.esien.se showed signs of
DTH based on skin thickness and histologic examination of skin sections. Similarly,
Finerty, Krehl and McKevin (1978) reported evidence of DTH in mice infected with T.
rhodesiense, but the specificity for trypanosomes was not demonstrated. On the
contrary, Mansfield and Kreier (1972) found hypersensitivity of the Arthus type in T.
congolense infected and treated rabbits to intradermal challenge with sonically lysed
homologous trypanosome antigen, but no evidence of DTH.
Similar observations of CMI responses have been made in trypanosome
infected livestock. Emery et al. (1980) demonstrated that cattle which had been
infected with T. congolense and treated with Berenil, developed characteristic DTH
skin reaction when inoculated intradermally with ultrasonicated T. congolense
antigen. Moreover, a marked proliferative response was obtained in vitro when PBLs
from these animals were cultured in the presence of ultrasonicated homologous
antigen. This PBL responsiveness was observed when the cells were collected from
cattle infected with T. congolense either during the early stages of infection, before
the development of chancre, or after the elimination of the parasites by
chemotherapy (Emery et al., 1980a). However, no response was detected in cattle
with active infection.
Another aspect of cellular immune response to trypanosomes is the
development of a skin reaction at the site of inoculation of the metatrypanosomes,
which usually starts at about 5 to 7 days and peaks at about 9 to 12 days after the
inoculation (Fairbairn and Godfrey, 1957; Bolton, 1965; Roberts, Gray and Gray,
1969; Gray and Luckins, 1980; Emery and Moloo, 1980; 1981; Akol and Murray,
1982; Dwinger etal, 1987; 1988; 1989; Mwangi, Hopkins and Luckins, 1990). The
histological appearance of the 'chancre', as it has been termed, has been described
by different investigators as that of a polymorphonuclear, lymphocyte, lymphoblast,
macrophage and plasma cell infiltration, (Emeiy et al, 1980a; Gray and Luckins,
1980; Emery and Moloo, 1981; Akol and Murray, 1982; Morrison et al., 1985;
Mwangi, et al, 1990; Taiwo et al, 1990). The immunological role of the chancre is
not clear but there are indications that tiypanosome infected animals do not develop
a chancre upon homologous (Emery et al., 1980a; Mwangi et al., 1990) or
heterologous (Morrison et al, 1982; Luckins and Gray, 1983; Dwinger et al, 1989)
challenge, while animals of low susceptibility develop smaller chancres.
Furthermore, immunisation of goats with tsetse-transmitted T. congolense infection
by drug treatment on day 13 p.i. after chancre development, gave rise to the
development of protection to homologous challenge (Taiwo et al, 1990). In contrast.
immunisation by intravenous inoculation of the metacyclics or treatment of the
tsetse infected goats prior to development of chancre failed to induce such protection
(Taiwo et al., 1990). Thus chancre formation and the cellular changes which occur
are vital for the induction of comprehensive immune recognition of metacyclic
variable antigen repertoire deposited in the skin by infected tsetse, and hence the
development of protective immunity.
2A 3.3 Induction of Protective Immunity Against Trypanosomes
Specific immunity, which results from specific recognition of antigen such
that antibody or primed lymphocytes can react with that antigen, plays a significant
role in determining the course and outcome of trypanosome infections. Numerous
studies have shown that protective immunity can be induced in animals against
specific populations of tiypanosomes. The most commonly used methods for
induction of immunity, as already mentioned, have been establishment of infection
followed by chemotherapy or inoculation of irradiated non-infective trypanosomes.
Several early field studies with trypanocidal drugs showed that animals
which had been treated were immune or partially immune to reinfection although
the acquisition of immunity usually depended on the degree of trypanosome
challenge and efficacy of drug treatment (Bevan, 1936; Whiteside, 1962; Wilson et
al., 1975; 1976; Leach and Roberts, 1981). Subsequently, it was demonstrated
experimentally that cattle could be made immune to homologous challenge by a
brief period of infection followed by trypanocidal drug treatment (Morrison et al,
1985). Thus, Cunningham (1968) reported that 3 of 4 cattle which had been
infected from a T. brucei stabilate and treated with Berenil were fully immune when
challenged with the same stabilate 2 to 3 months after treatment. Wilson (1971)
obtained similar results in five cattle infected with a T. congolense stabilate and
treated with Berenil. However, Wellde et al. (1981) failed to induce protective
immunity in nine cattle by treatment with Berenil at varying intervals after infection
with T. congolense and challenge with the parent stock 28 to 128 weeks after
treatment.
There is ample evidence that protective immunity induced against
tiypanosomes by infection and trypanocidal therapy is VAT specific and effective
against VATs which develop during the course of the infection (Nantulya et al., 1980;
Luckins et al., 1983; Akol and Murray, 1985). Mice primed by multiple bites from
tsetse infected with a clone of T. congolense over an eight day period and treated 10
days after the first tsetse bite were fully immunised against the homologous clone
when challenged on two occasions 21 days apart (Nantulya et al., 1980). However,
the immunity elicited in these mice was shortlived, lasting for only seven months.
37
Similar results were obtained by Luckins et al. (1983) in rabbits immunised by
cyclical infection and treatment with homodium chloride seven days after the
development of chancre. In this case, the immunity was of greater longevity, lasting
for about 10 months. Studies by Akol and Murray (1985) showed that cattle
infected with a cloned derivative of T. congolense and treated with Berenil 3 to 4
weeks later were immune to cyclical challenge with homologous clones 3 to 5 weeks
later. However, immunity induced against stocks was not effective when the
animals were challenged with the parent stock from which the clones were derived.
These results were in agreement with those of Wellde et al (1981) and emphasise
the desirability of using cloned stocks in such studies. It indicates that the parent
stock probably contained more than one serodeme, hence the immunity induced
was specific only for the cloned VAT used. Similar results have also been obtained
in goats infected with T. brucei (Emery et al, 1980b), in sheep infected with T.
congolense (Uilenberg, Maillot and Giret, 1973) and in cattle inoculated
intradermally with cultured metacyclic forms of T. congolense (Akol and Murray,
1985).
Unlike infection and trypanocidal drug therapy, studies on induction of
protective immunity by inoculation of irradiated noninfective trypanosomes
indicated that large numbers of organisms were required to induce immunity. Thus,
Duxbury et al. (1972) failed to immunise cattle against T. congolense following four
to seven weekly doses of irradiated trypanosomes ranging from 108 to 109
organisms. When the animals were challenged with 104 to 105 trypanosomes, the
only effect seen was an increase of about 3 days in the prepatent period. Using T.
brucei, similar results were obtained in cattle by Duxbury et al (1973). However, in
further studies with T. rhodesiense, the same group was able to induce complete
immunity in five cattle given six weekly i.v. inoculations of irradiated trypanosomes
totalling from 3.5 to 6 x 1010 and challenged one week later (Wellde et al, 1973). At
face value therefore, it appears from these results that dead trypanosomes are not
particularly immunogenic and that complete immunity against challenge with the
homologous trypanosome population is not readily achieved. But a major flaw in all
of these studies is the fact that they utilised uncharacterised stocks of
trypanosomes. On the contrary, in a series of experiments examining the
immunogenicity of either irradiated trypanosome or purified VSG from a well defined
clone of T. brucei (ILT at 1.3), Morrison et al. (1982) found that a single i.v. inoculum
of as few as 107 irradiated parasites in cattle conferred complete protection against
challenge with 103 trypanosomes 14 days later. They further confirmed that
immunity was mediated by antibodies to the VSG by immunising cattle with purified
VSG. 200 pg of the purified VSG when administered on its own failed to immunise
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the cattle but the same amount of VSG when incorporated in several different
adjuvants resulted in immunity against challenge with 104 trypanosomes (Morrison
etai, 1982; Wells etal, 1982).
Animals which recover spontaneously by self-cure also develop protective
immunity to subsequent homologous challenge. Cattle which had undergone self-
cure from a primary T. congolense infection after periods of 30-61 weeks of infection
became fully immune when challenged with the same stock 25 to 54 weeks after
parasitaemia had disappeared (Wellde et al., 1981). Similarly, cattle experimentally
infected i.v. with bloodstream forms of T. brucei and T. congolense self-cured 16 to
32 weeks after infection (Nantulya et al., 1984). Sera from these animals contained
neutralising antibodies against all mVATs of the infecting clones of T. brucei or T.
congolense. All the animals were immune to challenge by bites of G.m. morsitans
infected with the same clone or another clone of the same serodeme but they were
susceptible to tsetse transmitted challenge with heterologous serodemes of T. brucei
and T. congolense. It is interesting that sera from these animals contained
neutralising antibodies to the mVATs of the infecting clones since it indicates that
bloodstream trypanosomes are capable of expressing VATs which possess surface
antigenic determinants identical to those of their metacyclic ancestor.
The relative ease with which protective immunity is induced against T.
brucei and T. congolense contrasts with the situation in T. vivax. For instance, goats
infected by tsetse-transmitted T. vivax and treated with a trypanocide failed to
develop comprehensive immunity to homologous challenge (Vos, Moloo and
Gardiner, 1988). Similarly, although cattle which had recovered from syringe-
induced T. vivax infections developed resistance to subsequent tsetse-transmitted
homologous challenge, Nantulya et al. (1986) failed to demonstrate neutralising
antibodies to metacyclic forms of the T. vivax in serum of recovered animals at the
time of challenge, suggesting that the immunity induced was specific for
bloodstream rather than mVATs.
Most of the evidence for the role of antibodies in protective immunity
during tiypanosomosis derive from studies in small laboratory animals. However,
there are now increasing data available from studies carried out in large livestock.
In vitro, VAT-specific antibodies are known to bind readily to tiypanosomes and
cause various destructive effects such as agglutination (Cunningham and
Vickerman, 1962), decrease in respiratory rate (Desowitz, 1956; Thurston, 1958),
opsonisation (Lumsden and Herbert, 1967; Takayanagi et al, 1974) and lysis (Lourie
and O'Connor, 1936; Van Meirvenne et al., 1975a). In mice, immunity can be
transferred passively with serum from immunised animals (Seed, 1963; Watkins,
1964; Campbell and Phillips, 1976) as well as by adoptive transfer of spleen cells
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from Immunised to recipient mice (Luckins, 1972; Takayanagi and Nakatake, 1975;
Campbell and Phillips, 1976). In large animals, there are major difficulties in
studying the role of antibodies in protective immunity by carrying out passive or
adoptive transfer experiments. However, Morrison et al. (1982) and Wells et aL
(1982) found a strong correlation between protection and the level of neutralising
antibody in infected cattle.
Of all the methods used in inducing specific protective immunity, the use
of intact trypanosomes (i.e. irradiated tiypanosomes or live trypanosomes followed
by treatment) is the more effective method. The level, specificity and class of
antibody elicited by inoculation of irradiated T. brucei were found to be similar to
those produced by infection with the living parasites followed by treatment (Morrison
et aL, 1982). In both cases IgM and IgG antibodies were produced which were
specific mainly for determinants on the surface of the live tiypanosomes. This
contrasts with results obtained with purified VSG which proved to be much less
immunogenic unless it was potentiated by the use of adjuvants (Morrison et aL,
1982; Wells et al., 1982). These results further emphasise the fact that
immunological recongition of the VSG occurs mainly at the level of the intact
tiypanosome rather than the released soluble VSG.
As regards immune responses and induction of protective immunity to the
non-tsetse-transmitted T. evansu there are few studies of comparable detail. The
presence of circulating antibodies in the sera of camels, goats and sheep infected
with T. evansi has been demonstrated using passive haemaglutination, ELISA and
complement fixation test (Schoening, 1924; Jatkar and Singh, 1971; Boid et aL,
1981). There is limited information on Ig class production in T. evansi infections but
these indicate the predominance of IgM as seen in other trypanosome infections
(Luckins, 1977; Luckins et aL, 1978; 1979; Boid et al., 1985). In contrast, Uche
(1989) using sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-
PAGE) and 'Western' blotting showed that although IgA, IgG and IgM were produced
during primary and secondary experimental T. evansi infection in rabbits, IgG was
the predominant antibody produced on both occasions. In camels experimentally
infected with T. evansi, there were two-fold increases in serum IgM levels 22 to 29
days after infection which persisted for up to 42 days after treatment. In others,
increase in IgM levels occurred 16 to 29 days after infection but the values fell below
significant levels before treatment with quinapyramine (Luckins et aL, 1979). In
naturally infected camels, IgM levels were low although the direct relationship
between overt infection and the presence of antibody in the serum was good
(Luckins et aL, 1979). Similarly, the levels of IgM in both naturally and
experimentally infected camels increased significantly by as much as five times pre-
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infection levels and remained high despite drug treatment (Boid, et al, 1980). These
workers found that IgG antibodies showed little significant change during infection.
There are few studies on the role of cellular immune responses in T.
euansi infections. Gomez Rodriguez (1956) suggested that the cellular components
of the host's immune system was important in the destruction of T. evansi and
emphasised the importance of the phagocytic cells found within the leucocyte
population, the liver and the spleen in the removal of the parasites. However, recent
studies have shown that PBLs from T. euansi-infected and treated ponies showed
strong in vitro responses to soluble homologous T. evansi antigen, but failed to
respond to either the homologous live organisms or the purified VSG (Ahmed et ai,
1988). Upon stimulation, the cells were able to produce interleukin 2(IL-2) and
express IL-2 receptor (IL-2R) (Ahmed, Schmid and Horchner, 1990). As in cattle
infected with T. congolense, these responses were not observed in the ponies during
active infection.
There is a dearth of information on the induction of protective immunity in
T. euansi-infected animals. However, there is evidence of the existence of natural
resistance to infection from both field observations and laboratory investigations.
Field observations have shown that after recovery from infection, the host may
acquire some immunity to reinfection with the homologous tiypanosome while
remaining susceptible to challenge with a heterologous one (Laveran and Mesnil,
1912: cited by Hoare, 1972). Bennet (1933) studied surra in camels in the Sudan
and noted that recovery from the infection resulted in the development of specific
immunity. Since the period of resistance to reinfection which he observed was of
short duration, he concluded that in practice, immunity in camels must be
considered as non existent. Development of resistance to T. evansi in the field also
occurs following infection and treatment as is evidenced by the history of the disease
in Mauritius (Adams, 1935). Following its initial introduction to the island in 1901,
T. evansi caused devastating epizootic outbreaks which decimated the local cattle
stock. But since 1921, when the disease was brought under control by a massive
treatment campaign, the infection in bovines has assumed a mild latent form
(Hoare, 1972). Experimentally, it has been demonstrated that rodents immunised
with T. evansi are fully protected against challenge with homologous strains or
serological variants but not against heterologous ones (Gill, 1965a, b, c).
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2A 4 Immunosuppression and African Trypanosomoses
Pathogenic trypanosomes induce a generalised immunosuppression of
humoral antibody responses as well as T cell-mediated immune responses both to
the parasite and non-parasite antigens. As a result, in the long term, the host's
immune responses to the parasite fail and it succumbs as a result either of
overwhelming parasite loads, especially in rodents, or of secondary infection.
Immunosuppression therefore has a three fold effect: (1) participates along with
antigenic variation in ensuring the survival and dissemination of the parasites in the
host, (2) predisposes hosts to secondary infections and (3) possibly compromises
effective immune responses to vaccine antigens.
The earliest evidence of tiypanosome-mediated immunosuppression are in
reports by Parkin and Hornby (1930) who observed that cattle infected with T.
congolense became incapable of thriving, lost condition and became susceptible to
intercurrent infections. This observation was supported by Fiennes (1954) who
reported enhanced susceptibility to bronchopneumonia in cattle suffering from
tiypanosomosis. More recently, conclusive support for the immunosuppressive
effects of trypanosome infections have been obtained from numerous experiments
carried out mainly in rodents, some of which are reviewed below.
2A 4.1 Immunosuppression in Infected Rodents
Experimental evidence that immunosuppression is a feature of
tiypanosomosis came from the observation that mice infected with T. brucei showed
reduced antibody responses to sheep red blood cells, SRBC (Goodwin, 1970;
Goodwin et al., 1972). Subsequent corroboration of this work came from
observations that trypanosome infections in mice were associated with profound
suppression in antibody responses in response to challenge with a variety of
antigens including T-dependent (SRBC) and T-independent (DNP-Ficoll) antigens as
measured by serum antibody levels and numbers of splenic plaque-forming cells
(PFC) (Longstaff, Freeman and Hudson, 1973; Murray et al., 1974a; 1974b; Hudson
et al, 1976; Eardley and Jayawardena, 1977; Jayawardena et al, 1978; Hudson
and Terry, 1979; Wellhausen and Mansfield, 1979). Furthermore, spleen cells from
T. brucei or T. congolense infected mice failed to respond in vitro to stimulation with
either the T cell mitogens concanavalin A (Con A) and phytohaemagglutinin (PHA) or
the B cell mitogen bacterial lipopolysaccharide (LPS). In addition, they suppressed
the ability of normal mouse spleen cells to respond to the same mitogens (Albright,
Albright and Dusanic, 1977; Jayawardena and Waksman, 1977; Corsini et al, 1977;
Pearson etal., 1978; 1979; Roelants etal., 1979a; Mansfield etal, 1981).
Throughout the course of infection, variant-specific antibodies continue to
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be produced against successive VATS but there is evidence that the degree of
antibody response to the parasite itself can also be depressed (Hudson and Terry,
1979). Mice infected with T. brucei exhibited depressed antibody responses as
compared to uninfected controls, following inoculation of irradiated trypanosomes
and the degree of the depression was related to the virulence of the infecting
organisms (Sacks and Askonas, 1980). Furthermore, by examining the antibody
responses of chronically infected mice to organisms derived from each of the first
three waves of parasitaemia, it was shown that there was a progressive suppression
of both IgM and IgG antibody responses to the parasites, such that by the third
parasitaemic wave only low levels of IgM remained while there was no detectable IgG
(Sacks and Askonas, 1980).
The process of immune expulsion of intestinal nematodes such as
Nippostrongylus brasiliensis and Trichuris muris from both primarily infected and
hyperimmune hosts is suppressed by T. brucei infections in mice and rats (Urquhart
et al, 1973; Phillips et al., 1974). Rats infected with N. brasiliensis and then with T.
brucei after the phase of immune expulsion of the worms, lose the ability to expel a
challenge infection, but if the trypanosome infection is treated they can mount a full
secondary response. This suggests that although trypanosome infection blocks the
expression of a secondary immune response, immunological memory is preserved.
It has been shown however, that both B and T cell memory may be exhausted in T.
brucei infected mice, since transfer of sensitised spleen cells from such mice does
not enable an irradiated recipient to mount a secondary immune response {Askonas
et al, 1979).
Cell-mediated immune responses are also suppressed in trypanosome-
infected rodents. In chronically infected mice the T cell responses in the ear, induced
by oxazolone treatment are depressed as determined by measurements of ear
thickness (Urquhart et ai, 1973; Murray et al., 1974c; Ackerman and Seed, 1976)
and by incorporation of 125I-labelled iododeoxyuridine in cells in local draining
lymph nodes (Jennings et al., 1974. Furthermore, Mansfield and Wallace (1974)
demonstrated partial suppression of DTH skin reactions to purified protein
derivative (PPD) of tuberculin in rabbits infected for 6 weeks with T. congolense while
Allt et al. (1971) reported a reduction in the development of experimental allergic
neuritis in T. brucei infected rabbits. However, a contradictory result to this was
reported by Mackenzie, Sibley and White (1979). In addition, normal cell-mediated
immune responses have also been observed in T. brucei infection although in some
cases, suppression became evident only during the terminal stages of the infection
(Freeman etai, 1973).
2A 4.2 Mechanisms of Trypanosome-induced Immunosuppression in Rodents
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Immunosuppression in trypanosome-infected rodents is well established
but the mechanisms of its induction and its relation to the lymphoid organ changes
and altered cellularity are not clear. A number of mechanisms have been proposed
to account for the generalised immune dysfunction.
1. Polyclonal B cell activation
Polyclonal activation of B lymphocytes by a non-specific trypanosome
derived mitogen (Esuruoso, 1976; Assoku and Tizard, 1978; Askonas et al, 1979;
Clayton et al., 1979; Oka, 1986; Oka et al., 1984) leading to clonal exhaustion of B
cell potential and function (Freeman et al., 1973; Urquhart et al., 1973; Hudson et
al, 1976; Mansfield and Bagasra, 1978) is among the proposed mechanisms. This
theory finds support from the observed maximal production of plasma cells in, and
increased proliferation of, cultured spleen cells from T. brucei infected mice. In vitro
cell proliferation is accompanied by production of high levels of IgM and IgG which
starts immediately the cells are in culture but declines as the infection progresses,
suggesting exhaustion of B lymphocytes (Corsini et al., 1977). Furthermore, the
presence of high IgM levels (Seed et al, 1969; Hudson et al 1976) and heterophile
and autoantibodies (Houba et al, 1969; reviewed in Parratt and Herbert, 1979) in
the sera of trypanosome infected animals, accompanied by failure of trypanosomes
to absorb most of the IgM, have all been regarded as evidence that B lymphocytes
are being activated in a non-specific manner (Hudson et al., 1976; Terry et al,
1980).
2. Suppressor T cells and Macrophages
A second proposed mechanism is the generation of suppressor cells
namely, macrophages and suppressor T cells. Spleen cells from T. brucei- or T.
congolense-infected mice fail to respond in vitro to stimulation with either the T cell
mitogens Con A and PHA or the B cell mitogen LPS and, suppress the ability of
normal mouse spleen cells to respond to the same mitogens (Jayawardena and
Waksman, 1977; Corsini et al, 1977; Pearson et al, 1978; 1979; Roelants et al,
1979a; Mansfield et al., 1981; Alcina and Fresno, 1985; Borowy et al, 1990). In
addition, they actively suppress the PFC response of normal spleen cells to SRBC
and DNP-Ficoll (Eardley and Jayawardena, 1977; Jayawardena et al, 1978;
Wellhausen and Mansfield, 1979), fail to respond to allogeneic mixtures of cells
differing at major (H-2) and minor (Mis) lymphocyte stimulation loci and do not
stimulate allogeneic cells in mixed lymphocyte reaction (MLR) experiments (Askonas
et al., 1979; Pearson et al., 1978; Roelants et al., 1979a; 1979b; Grosskinsky and
Askonas, 1981). Since the removal of glass-adherent cells and treatment with anti-
Thy 1 serum and complement restored the responses, it was concluded that
immunosuppression is mediated by macrophages and suppressor T cells. It was
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hypothesised that suppressor T cells directly stimulated by tiypanosomes release
factors having affinity for macrophages which in turn are activated to become
suppressors for T and B cell responses (Eardley and Jayawardena, 1977; Roelants
and Pinder, 1984). Alcina and Fresno (1985) proposed an alternative hypothesis,
suggesting that suppression is a result of complex immunoregulatory circuit in
which macrophages, after interaction with parasites, are able to induce the release
of suppressor molecules that act preferentially on immune T cells, which in turn
inhibit the proliferation of helper T cells by either defective IL-2 production or
inhibition of IL-2 action or both. Although the nature of the suppressor molecules
was not known, evidence in support of Alcina and Fresno's proposed central role for
macrophages and the subsequent sequence of events culminating in T and B cell
dysfunction is mounting (see below).
3. The Role of Secretory Products of Macrophages and T Cells
Recent investigations have focussed on impairment of secretion of various
lymphokines by macrophages and T cells. Production of IL-2, a lymphokine which
plays a central role in T cell activation and proliferation, from Con A stimulated
splenocytes is suppressed in both susceptible (A/J) and resistant (C57BL/6J) inbred
mice infected with T. congolense (Mitchell, Pearson and Gauldie, 1986). This is in
agreement with work by Alcina and Fresno (1985) in which Con A-stimulated
splenocytes from T. brucei-infected BALB/C mice failed to produce detectable
amounts of IL-2. Similarly, the production of IL-2 by T cells was severely
suppressed in Con A-stimulated spleen and lymph node cells from T. brucei-infected
C3H/H3, CBA/Ca and (C57/BL/6xBALB/C)F] mice (Sileghem, Hamers and De
Baetselier, 1986; 1987b; Sileghem et al, 1987a). Furthermore, several groups
exploring the mechanisms of immunosuppression in the related human Chagas'
disease, caused by T. cruzi, have also demonstrated suppressed production of IL-2
by mitogen-stimulated spleen cells in infected rodents (Harel-Bellan et al, 1983;
1985; Reed, Inverso and Roters, 1984a; 1984b; Tarleton and Kuhn, 1984;
Choromanski and Kuhn, 1985; Tarleton, 1988a; 1988b). Recent reports have in
addition identified diminished interleukin-2 receptor (IL-2R) expression by
lymphocytes from mice infected with T. brucei (Sileghem et aL, 1987b; 1989a;
1989b; 1991) and T. cruzi (Rottenberg et al, 1989). IL-2R of lymphocytes is a
complex heterodimer which binds IL-2 with high affinity and is responsible for IL-2
internalisation as well as transduction of the signal required for activated
lymphocytes to progress through their division cycle (Kierszenbaum and Sztein,
1990). Furthermore, it has been shown that there is elevated secretion of another
cytokine, gamma interferon (IFN-y) in both T. brucei- and T. cruzt-infected mice
(Sileghem, Daiji and De Baetselier, 1991; Nabors and Tarleton, 1991) and that this
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elevation is responsible for the hyporesponsiveness of T cells (Daiji et ai, 1991a).
Based on these results, Sileghem etal (1989a; 1989b; 1991) and Daij'i etal (1991a;
1991b) argued that macrophages play the key role in T cell unresponsiveness and
the subsequent generalised immunosuppression seen in murine trypanosomosis.
They proposed that macrophages act through two different suppressive
mechanisms; firstly, a prostaglandin (PG)-dependent mechanism which blocks the
IL-2 secretion by T cells and secondly, a PG-independent mechanism which
interferes at the level of IL-2R expression on T cells. In the PG-dependent
mechanism, macrophages interact with a distinct tiypanosomal fragment (of 70 kD
MW) and become triggered to secrete PG. The secreted PG actively inhibits IL-2
secretion by CD4+ T cells. In the PG-independent mechanism, the trypanosome
triggered macrophages, by direct cell-cell contact, provide a costimulatoiy signal to T
cells which in turn become triggered by exogenous stimuli (mitogens or antigens) to
produce substantial amounts of IFN-y. The IFN-y produced by T cells and soluble
factors released by the trypanosome-activated macrophages act in concert to inhibit
IL-2R expression on CD4+ and CD8+ T cells. Furthermore/since IFN-y is a potent
macrophage activator, it may act through its macrophage activating property to fuel
the suppression by further PG release which in turn inhibits IL-2 secretion by CD4+
T cells.
4. Defective Antigen Handling and Presentation
Immunosuppression in rodent trypanosomosis is also thought to be
mediated through defective processing of antigens by APCs and their inadequate
presentation with MHC class II products (Mansfield and Bagasra, 1978). The
progressive loss of the antigen-presenting (la antigen-bearing) macrophage
subpopulation from the spleen, lymph nodes and peritoneal cavity of T. rhodesiense-
infected mice (Bagasra, Schell and Le Frock, 1981) and the reduced expression of
mannose, Fc-, and complement-receptors (Grosskinsky et al, 1983) may result in
an early reduction in antigen handling and presentation by macrophages during the
disease.
2A 4.3 Immunosuppression in infected livestock
Efforts to demonstrate immunosuppression in domestic livestock
experimentally infected with tiypanosomes have been concentrated mainly on cattle.
Available literature indicates that trypanosome-induced immunosuppression in
these animals may not be as severe as in rodents since the disruption of the
lymphoid architecture is less dramatic and parasitaemias seldom reach the
fulminating proportions characteristic of rodent infections (Morrison and Murray,
1979; Masake and Morrison, 1981). The results of attempts to evaluate the immune
46
competence of trypanosome-infected ruminants in regard to their ability to produce
antibodies to various bacterial and viral vaccine antigens have been inconsistent
and conflicting.
There is depressed secondary antibody response to polyvalent clostridial
vaccine in cattle infected with T. congolen.se (Holmes et aL, 1974). These authors
drew attention to the potential danger of tiypanosomal immunosuppression
hampering the success of vaccination programmes carried out in endemic areas.
Similarly, Scott et at. (1977) reported depression of serum antibody titres to the
same Clostridium oedematiens Type B component of a polyvalent clostridial vaccine
in cattle naturally and experimentally infected with T. congolense. However,
antitoxin antibody titres were above the required minimum protective level and they
concluded that whilst there was distinct evidence of tiypanosome-induced
immunosuppression to clostridial vaccines it was unlikely to interfere with regular
vaccination programmes. They did not challenge the infected/vaccinated animals
with the clostridial organisms in order to substantiate this conclusion. T. uivax
infection alone or a combination of T. congolense and T. uiuax infection, caused only
slight depression of primaiy and secondary antibody responses in cattle vaccinated
6 and 18 weeks after infection with contagious bovine pleuropneumonia (CBPP)
vaccine (Ilemobade et ai, 1982). In spite of the slight nature of the depressed
antibody response, 50 percent of the infected/vaccinated cattle contracted CBPP
following challenge with Mycoplasma mycoides. Cattle experimentally infected with
T. congolense or T. uivax also showed slight suppression of antibody responses to
Brucella abortus (SI9), Leptospira bijlexa and M. mycoides vaccine (Rurangirwa et
aL, 1978, 1979; 1980). In a later study (Rurangirwa et aL, 1983) profound
suppression of IgGj, IgG2 and IgM responses to B. abortus (S-19) vaccine was
observed in cattle chronically infected with T. congolense.
Results of studies with viral vaccine antigens have also been inconsistent.
For instance, whilst suppression of antibody response to louping ill virus vaccine
occurred in cattle infected with T. congolense or T. viuax (Whitelaw et al., 1979) there
was no evidence for suppression of antibody response in cattle infected with T.
brucei. Only slight suppression of antibody response to rinderpest live, attenuated
vaccine was observed in cattle infected with T. congolense and T. uiuax (Rurangirwa
et aL, 1980). This inconsistent demonstration of immuno- suppression in
tiypanosome-infected livestock may be related to the fact that most of the studies
have concentrated on the first few weeks of the infection and it is also possible that
infections of longer duration are more likely to result in functionally significant
immunosuppression as demonstrated by Rurangirwa etal. (1983).
Studies on trypanosome-induced suppression of cellular immune
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responses are equally limited and conflicting. Using cell reactivity in mixed-
lymphocyte cultures (MLC) and mitogen-induced lymphocyte transformation in vitro
to study T cell responses in T. vivax-infected goats. Van Dam et al. (1981) claimed
that T. vivax infection in goats was associated with severe (50-100 percent)
suppression of mitogen-induced lymphocyte function. This suppression became
apparent from day 20 after the infection. Similarly, the reactivity of lymphocytes
from infected goats in MLC was diminished and remained so for up to 2 weeks after
Berenil treatment when restoration of functional capacity appeared. In contrast,
Sollod and Frank (1979), Masake and Morrison (1981) and Masake et al. (1981)
failed to demonstrate significant suppression of the in vitro responses to mitogens of
leucocytes from cattle infected with T. congolense or T. vivax . Furthermore, there
was no significant suppression of the responses in mixed lymphocyte reaction (MLR)
of PBL, lymph node and spleen cells of cattle infected with T. congolense (Morrison et
al, 1985).
Hie suppression of specific antibody or cellular responses to the
trypanosomes themselves has also been investigated. The antibody response of
cattle was examined following simultaneous or sequential challenge with two clones
of T. brucei. It was reported that the response to one of the clones was partially
depressed in animals inoculated with both clones either simultaneously or 2 days
apart (Nantulya et al, 1982). Similarly, Morrison et al. (1985) examined the
response of cattle infected with T. congolense to fixed numbers of an irradiated clone
of T. brucei which was inoculated either intravenously or by the subcutaneous route.
It was found that 60 and 40 percent respectively of cattle inoculated with the
irradiated T. brucei showed marked suppression in antibody response as measured
by the Farr assay with purified VSG. The degree of suppression depended on the
severity of the T. congolense infection. In studying the cellular responses to specific
trypanosomal antigen it was demonstrated that PBL from infected and treated cattle,
proliferated in vitro in response to stimulation with homologous, ultrasonicated
trypanosomal antigen (Emeiy, Wells and Tenywa, 1980). However, this response
was completely suppressed in animals with active infections. On the other hand, in
cattle cyclically infected with T. congolense, PBL collected between days 3 and 7 post
infection (i.e. before chancre development) showed a strong proliferative response to
ultrasonicated trypanosomal antigen but thereafter, the response was suppressed
reappearing only after the animals had been treated (Morrison et al.. 1985). Hence,
while T cell responses are suppressed during infection in large animals,
immunological memory is not affected.
2A 4.4 Mechanisms of Trypanosome-induced Immunosuppression in Large
48
Animals
The mechanisms of trypanosome-mediated immunosuppression in
domestic livestock is ill-understood. The subject has not been studied on the same
scale as in rodents probably as a result of the expense of the acquisition and
management of large animals as experimental models. It is possible that some of
the mechanisms suggested in rodent tiypanosomosis such as polyclonal B cell
activation, generation of suppressor T cells and macrophages may operate in
tiypanosome-infected livestock. Hypocomplementaemia and increased immuno¬
globulin catabolism occur in cattle infected with T. congolense which could be
responsible for the depressed antibody levels in infected animals (Nielsen et ai,
1978a; 1978b). In vitro proliferative responses of PBLs from animals harbouring
active infection is suppressed following stimulation with parasite antigens or
mitogens. This suggests that, as in infected rodents, T and B cell responses are also
depressed during infection. It is doubtful however, whether polyclonal B cell
activation could account for the loss of B cell potential and responsiveness in
ruminants. Although hypergammaglobulinaemia involving mainly IgM is a
consistent feature of livestock trypanosomoses (Clarkson et aL, 1975; Luckins and
Mehlitz, 1976; Kobayashi and Tizard, 1976; Nielsen et ai, 1978b; Masake and
Morrison, 1981), increase in the levels of heterophile antibodies has not been
reported. The mechanisms of trypanosome-mediated immunosuppression in large
animals may not parallel those operating in rodents, as illustrated in the case of T.
cruzi infections in rodents and in man. T. cruzi induces severe immunosuppression
in both naturally infected human patients and in experimentally infected rodents
(Clinton et ai, 1975; Reed, Larson and Speer, 1977; Teixeira et ai, 1978;
Kierszenbaum, 1981; Voltarelli et ai, 1987), but it has been shown that the
mechanisms of the induction of the suppression are not entirely similar in both
cases. For instance, parallel studies conducted with normal murine splenocytes and
human peripheral blood mononuclear cells co-cultured with T. cruzi
tiypomastigotes, revealed that the capacity of mouse cells, but not the human cells,
to secrete IL-2 in response to mitogen stimulation is suppressed (Beltz, Sztein and
Kierszenbaum, 1988). Furthermore, only mouse lymphocyte proliferative
responsiveness is restored by the introduction of exogenous IL-2 (Beltz et ai, 1988).
Production of IFN-y by mitogen-stimulated lymphocytes is suppressed by co-culture
of the mouse, but not human, lymphocytes with T. cruzi (Beltz, Sonnenfeld and
Kierszenbaum, 1989). Unlike the mouse model system, T. cruzi induced
suppression of human PBMC occurs in the face of normal IL-2 and IFN-y
production, suggesting a role for TH2-like cells in the suppression of human PBMC
responses (Beltz and Kierszenbaum, 1987; Beltz et ai, 1989). T. cruzi selectively
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exerts its suppressive effects on human lymphocytes through the inhibition of IL-2R
and transferrin receptor (TfR) expression on CD4+ and CD8+ T cells and through
reductions in the numbers of cells expressing CD3, CD4 and CD8 molecules which
play key roles in lymphocyte activation (Beltz et al., 1988; 1990; Kierszenbaum and
Sztein, 1990; Sztein, Cuna and Kierszenbaum, 1990).
Similar differences may exist in the mechanisms of immunosuppression
seen in infected rodents and large animal hosts. There is virtually no information on
the role of suppressor T cells and macrophages in the immunopathology of
trypanosome infections in domestic livestock. However, there is evidence that in
cattle and sheep infected with T. congolense, major alterations occur in various
lymphocyte surface molecules which play major roles in effective immunity and that
aberrations such as large increase in CD5+B cells is a feature (Ellis et al ., 1987;
Mwangi, Hopkins and Luckins, 1990; 1991; Mwangi, 1991; Williams et al., 1991).
These changes in the lymphocyte subsets, some of which correlate with resistance
and self-cure (Williams et aL, 1991), may underlie the immunosuppression that
occurs in livestock trypanosomosis. However, their further and extended analysis
over time and in relation to mitogenic and specific antigenic responses is still
required before their role in the immunosuppressive effects of trypanosomes can be
fully determined.
SECTION B
Immunobiology of the Sheep Lymphoid System
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2B 1 Lymphocyte migration in sheep
Although lymphoid organs are dispersed all over the body, they are
connected by two vascular networks: the blood vessels and the lymphatic ducts,
which enables the lymphoid organs to function as a single system. The major
cellular constituent of this system namely, lymphocytes, are mobile, travelling from
blood to lymph and then back to the blood (Gowans, 1957; Gowans and Knight,
1964). This orderly movement of cells between the various lymphoid compartments
ensures a coordinated expression of immunological functions by the system.
Lymphocytes are the major cellular participants in immune responses and it
appears that the reason for their recirculation is purely immunological. This is
because recirculation ensures that: 1) the efficiency of regional immune responses is
optimised by allowing antigen-induced selection of precursor cells from a larger pool
than is present in regional lymph nodes alone (Gowans and Steer, 1980); 2) enables
systemic immunity to be induced by local entry of antigen due to the dissemination
of effector and memory cells (Smith et al, 1970); 3) facilitates the collaboration of T
and B lymphocytes in immune responses by enabling antigen-sensitive cells of each
type to come together (Ford, 1975); 4) achieves control of immune responses by the
recruitment and transportation of regulatory cells (Gowans, 1980) and finally, 5)
gives antigen-sensitive cells an opportunity to dissociate themselves from a
particular environment from time to time so that not all of them are driven to the
stage of terminal differentiation (Morris, 1980). Since the ovine placenta is
syndesmochorial in nature, the ovine foetal immune system develops in an
environment devoid of extrinsic antigens, primed lymphocytes and circulating
antibodies. However, lymphocyte recirculation still takes place actively in ovine
embryos (Pearson et al., 1976). Thus, although there are immunological reasons for
lymphocyte recirculation, the capacity to do so also arises as a natural physiological
process independent of prior stimulation with external antigens.
Large numbers of lymphocytes continually leave the circulation through
specialised post-capillaiy venules in the cortex of the lymph node and enter the
efferent lymph (Gowans and Knight, 1964; Hall and Morris, 1965). This migration of
lymphocytes between the blood and lymph is non-random (Scollay, Hopkins and
Hall, 1976; Cahill et al., 1977; Issekutz, Chin and Hay, 1982). Their exit from the
blood is controlled by specific molecular interactions between lymphocytes and
endothelial cells, and tissue-specific migration-related receptors directing
lymphocytes to gut and peripheral lymph nodes (Gallatin, Weissman and Butcher,
1983; Woodruff, Clarke and Chin, 1987; Streeter et al., 1988).
The recirculation of lymphocytes, especially the examination of cells
migrating in afferent and efferent lymph, has been extensively studied in sheep
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(Smith, Mcintosh and Morris, 1970; Morris and Courtice, 1977; Mackay et aL,
1988a; Washington, Kimpton and Cahill, 1988). There is no doubt that the
recirculation of cells provides the means whereby large numbers of lymphocytes
with different antigen specificities may encounter antigen, allowing specific antigen-
reactive cells to be selected and to accumulate at sites of antigen deposition. There
is now a wide body of knowledge on immune and inflammatoiy responses to
introduced antigens or pyrogens and the modulatory effects of antigens upon the
migratory pathways of lymphocyte subpopulations between the vascular and
lymphoid compartments (Reviewed by Hall and Cahill, 1982). Cannulation of
afferent and efferent lymphatic ducts of lymph nodes have enabled the study of the
cell kinetics in the immune response to percutaneous or intralymphatic infusions
(Hall and Morris, 1962; 1965; Hay, Cahill and Trnka, 1974) and in the responses to
grafted tissues and organs (Hall, 1967; Pederson and Morris, 1970). The
development of hybridoma technology and mAbs to surface antigens of sheep
lymphocytes and other leucocytes has allowed the extension of these studies of
lymphocyte migration in sheep into precise definition of the qualitative and
quantitative cellular kinetics of lymphocyte phenotypes in the immune response and
their functional roles in immunity and pathogenesis of disease (Mackay et aL, 1985;
Puri, Mackay and Brandon, 1985; Hopkins et al., 1986; 1989; Mackay et aL, 1986;
1987; 1988a; Kimpton, Washington and Cahill, 1989).
2B 1.1 Cell Migration From Areas of Antigen Deposition in the Skin
The skin contains small numbers of lymphocyte and macrophages which
migrate into the draining lymph nodes via the dermal lymphatic network which
anastomoses to form larger afferent collecting lymphatics. These lymphatics have
few open junctions in addition to oneway valves and smooth muscles which by
spontaneous contractions propel lymph towards the lymph node. The ablation of
peripheral lymph nodes is followed by anastomosis of the afferent ducts with the
efferent duct (Trevella and Morris, 1980) which has allowed the study of cells
migrating in cutaneous lymph by cannulating the resulting pseudoafferent duct
(Hopkins et aL, 1985). Most of the cells in lymph draining subcutaneous tissues in
sheep are mononuclear cells in which lymphocytes predominate. Also present is a
small proportion of cells of the monocyte/macrophage lineage (Miller and Adams,
1977) and microphage-like cells having cytoplasmic veils (Morris, 1972) which are in
close association with lymphocytes. Following the injection of foreign antigen into
the skin, there is alteration in the composition of the lymph draining the area such
that it contains granulocytes, erythrocytes and antigen-antibody complexes (Hall
and Morris, 1963; Hay and Cahill, 1982; Hein et aL, 1987). In addition, the
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lymphocyte output increases as has been shown in afferent lymph draining
granulomatous and DTH lesions (Smith et al, 1970; Hay, Lachman and Tmka,
1973) and in sheep infected with T. congolense (Mwangi, 1991). The neutrophil
output is also increased and this is a characteristic feature of acute inflammatory
reactions elicited by skin contact with DNFB (Hall and Smith, 1971). Alterations in
the cellular composition of lymph draining areas of antigenic stimulation in the skin
are also accompanied by dramatic changes in the expression and output of various
lymphocyte phenotypes. For instance, following in vivo secondary antigenic
stimulation using OVA, PPD or sperm whale myoglobin, in the draining area of the
afferent lymphatic, the proportion of MHC class II-positive cells increase nearly
three-fold (Hopkins et al., 1989). Following intradermal infection of sheep with
cultured metacyclics of T. congolense, the proportions of CD5+ and CD4+ cells
markedly increase after the onset of parasitosis but later decline as the infection
progressed (Mwangi, 1991).
2B 1.2 Cell Migration and Localisation in Antigen-stimulated Lymph nodes
Lymph nodes are encapsulated secondary lymphoid tissues which act as
filters for foreign materials which enter the peripheral lymphatics and provide a
favourable environment for the interaction of different cell types in the generation of
immune responses to lymph-born antigens. Following antigen stimulation of the
skin, lymphoproliferation and increased recruitment of cells from blood and lymph
occur, resulting in the gross enlargement of the lymph node. T-dependent antigens
induce active T cell proliferation in the paracortical areas while stimulation by T-
independent antigens results in a greater proliferation of B cells in the cortex.
However, due to the heterogeneity of most antigens, the response seen is usually
that of generalised hyperplasia of both T and B cell areas. Germinal centres and
secondary follicles contain actively proliferating B cells while secondary follicles
contain dendritic cells, macrophages and few T cells (Mwangi et at, 1991). Together
with the specialised macrophages of the marginal sinus, these cells play a role in B
cell responses and the development of B memory cells.
2B 1.3 Cell Constituents of the Efferent Lymph
Lymphocytes are the predominant cellular constituents of efferent lymph
and large numbers exit the nodes. From a one-gram popliteal lymph node of sheep
that contains approximately 109 lymphocytes, about 3 x 107 of them leave via
efferent lymph every hour, whereas only less than 10 percent of that number enter
the node via afferent ducts. Local irradiation of a single lymph node does not result
in the obliteration of the cellular output, suggesting that the majority of efferent
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lymph lymphocytes are not generated within the node but are derived from the blood
perfusing the node (Hall and Morris, 1964). This finds support in studies which
showed unequivocally that during continuous infusion of 3H-thymidine(3H-TdR) into
a sheep popliteal lymphnode through an indwelling catheter in an afferent
lymphatic, less than 4 percent of the cells found in efferent lymph could be labelled
by 3H-TdR infusion throughout the whole course of the experiment. Clearly, this is
an indication that the majority of efferent lymph lymphocytes were not derived from
the node but were blood-borne (Hall and Morris, 1965).
Studies on the response of a single lymph node to antigenic stimulation
revealed that dramatic changes occur in the cell content of efferent lymph. In the
first 24 hours after antigenic challenge, cell traffic is greatly reduced (Hall and
Morris, 1965). Subsequently, cells are recruited from the blood into the node where
they undergo a process of selection, proliferation and differentiation into antibody
synthesising cells. At 72 to 96 hours after challenge, the cell output increases to a
maximum of 5-10 times above prestimulation levels and large blast cells and
antibody forming cells appear (Fahy et al, 1980). The cells leaving the node
disseminate the immune response systemically and widespread immunological
memory is established (Fahy et al, 1980).
2B 2 Lymphocyte Molecules in Sheep Identified by Specific Monoclonal
Antibodies
Monoclonal antibodies have revolutionised the techniques of examining
the immune system making it possible to identify and isolate individual components
or molecules from a complex mixture of antigens and to study their properties and
functions. Until recently, extensive panels of mAbs existed only for the leucocyte
molecules of humans and rodents, but a number of groups have now produced
mAbs which define the leucocyte molecules of sheep. The review below summarises
aspects of the knowledge of the major leucocyte subsets of sheep defined by these
mAbs.
CD5 (SBU-T1)
The CD5 molecule (formerly referred to as T1 or Leu-1 in man, MRC OX-
19 in rat and Ly-1 in mouse) consists of a single polypeptide chain of 67 kD in all
three species, as well as in sheep (Mackay et al., 1985; Beya and Miyasaka, 1986).
The tissue distribution of sheep CD5 is similar to that reported for other species.
The molecule is displayed on all T cells and thymocytes, and higher levels are
expressed on medullary than on most cortical thymocytes (Mackay et al, 1985).
A percentage of normal B cells in human and mouse has been shown to
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express the CD5 molecule. In mouse, these CD5+B cells have long-term survival in
vitro, secrete IgM autoantibody, have high IgM/low IgG surface expression and are
present in high numbers in foetal spleen (Hardy and Hayakawa, 1986). In both man
and mouse, the level of expression of CD5 on CD5+B cells is 5-10-fold less than on T
cells (Godal and Ault, 1986). In sheep CD5+B lymphocytes are most numerous in
adult spleen in which approximately 20 percent of B cells weakly express the CD5
molecule. On the other hand, CD5+B cells in sheep are not detectable within the
lymph nodes or efferent lymph, indicating that these cells may be non-recirculating
(Mackay, 1988).
The precise function of CD5 has not been defined but CD5-specific mAbs
augment the proliferation of T cells in vitro in response to various mitogens or
alloantigens (Dallman, Thomas and Green, 1984) and, Mackay (1988) claimed to
have observed similar results for sheep CD5. Although the ligand for CD5 has not
been determined, sequence analysis of human CD5 gene reveals structural features
similar to receptor molecules such as the insulin receptor, IL-2R and TfR (Jones et
al., 1986). Since mammalian leucocyte molecules are highly conserved through
evolution with respect to structure, function and, in many cases, tissue distribution
(Ledbetter et al, 1981; Dallman et al., 1984; Mackay and Mackay, 1989) it is
possible that some of these receptor molecules may also occur in the sheep CD5
gene structure. CD5 (SBU-T1) has been used as a 'pan T cell' marker in sheep and
until CD3 (T3)-specific mAb is produced, CD5 (SBU-T1) will probably remain the
best pan T cell marker for sheep (Mackay et al, 1987). CD5 in sheep is identified by
the mAb 25-91 (Mackay et al, 1985).
CD4 (SBU-T4)
In man and mouse, the CD4 molecule is a 55-56 kD single chain
polypeptide having a characteristic cellular distribution, being expressed by the
majority of CD8" T cells, cortical thymocytes, and cells of the macrophage and
langerhans cell lineage(s) (Mackay, 1988). It marks a subset of T cells which
recognise antigens in association with MHC Class II molecules and which are
usually responsible for helper/inducer activity (Reinherz and Schlossman, 1980;
Mason et al, 1983). However, several studies have shown that the CD4+ T cell
subset possesses a functional heterogeneity and can, on that basis and on the basis
of lymphokine secretion patterns, be subdivided into TH1 and TH2 subsets
(Janeway, 1975; Marrack and Kappler, 1975; Tada et al, 1978; Swierkosz et al,
1979; Imperiale et al, 1982; Kim et al, 1985; Tite et al, 1985; Mossman et al,
1986; Cherwinski et al, 1987; Francien et al, 1988). The TH1 subset provides in
some cases helper activity for polyclonal B cell differentiation, has cytotoxic
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capacity, suppresses some antibody responses, mediates macrophage activation
and, produces IL-2, IFN-y and lymphotoxin (LT). The TI{2 subset is a potent B cell
activator, gives antigen-specific help and is marked by the production of IL-4, IL-5,
IL-6 and IL-10, (Kim el aL, 1985; Tite et al., 1985; Mossman et aL, 1986; Killar et
aL, 1987; Boom, Liano and Abbas, 1988; Coffman et aL, 1988).
The CD4 molecule in sheep is similar to those described in human, mouse
and rat in its molecular nature, function and distribution (Maddox et aL, 1985a;
Baldwin et al., 1986; Lalonde et al., 1986). It comprises 70-80 percent of
thymocytes and a subpopulation of peripheral T cells (60 percent) whose in vitro
functional properties are similar to those ascribed to CD4+ cells of man and rodents
(Baldwin et aL, 1986; Lalonde etai, 1986). In sheep, the CD4 molecule is identified
by two mAbs, 44.38 and 44.97, which do not crossreact with other species (Maddox
etal, 1985a; Mackay etai, 1986).
CD8 (SBU-T8)
The molecular nature and tissue distribution of sheep CD8 resembles that
of other species (Maddox et aL, 1985a; Ezaki et al, 1987). It exists as a 36 kD
molecule on peripheral lymphocytes but when isolated from thymocytes exists in
two polypeptide forms of 33 and 36 kD respectively (Maddox et al., 1985a). CD8 is
present on 6-14 percent of peripheral blood lymphocytes, 12-23 percent of efferent
lymphocyte, on most cortical thymocytes and on CD4" medullary thymocytes
(Maddox et al., 1985a). In human and rodent, CD8 marks T cells which recognise
antigen in association with MHC Class I molecule (Swain, 1983) and which usually
exhibit cytotoxic (or suppressor function) and produce large amounts of IFN-y (Scott
and Kaufmann, 1991). The function of sheep CD8+ cells in vitro resembles that
described for CD8+ cells in other species in that anti-CD8 mAbs are able to block
cytotoxic T lymphocyte function (Ezaki et al., 1987). In sheep, CD8 is recognised by
three mAbs, 24.96 and 38.65 (Maddox el al., 1985a; Mackay et aL, 1986) and, S-T8
(Ezaki etal, 1985; 1987).
y§-T cell (SBU-T19)
In man and mouse most antigen-specific peripheral T lymphocytes
express the T cell differentiation antigens CD4 and CD8, and a T cell receptor (TcR)
composed of a CD3-associated disulfide-linked heterodimer, TcR-a/[3 (Allison et aL,
1984; Samelson et aL, 1985). A minor population of CD4"CD8"CD3+ (double
negative, DN) cells has also been identified in the thymus and peripheral organs of
these species (Reinherz and Schlossman, 1980; Fowlkes et al., 1985; Pardoll et aL,
1987). Immunoprecipitation studies of murine DN T cells have shown that they do
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not express cell surface TcR-a/P; rather they express the TcR-y/8 complex
(Nakanishi et al., 1987; Pardoll et al., 1987; Cron et al., 1988).
DN T cells are also present in the sheep and recently an antigen
designated T19, of high molecular weight (220 kD), has been identified on the
surface of most of the peripheral DN T cells (Mackay el al., 1986; Miyasaka et ai,
1988). This antigen is recognised by mAbs 19-19 (Mackay et al., 1986) and 197
(McClure et al., 1989). T19 defines a lymphocyte subset which is CD5+CD4~CD8"
but slg". T 19+ cells in the peripheral lymphoid organs are found almost exclusively
in the small lymphocyte population, exhibit the physical characteristics of normal
recirculating lymphocytes, and are responsive to T cell mitogens and not to B cell
mitogens (Mackay et al., 1986). The tissue distribution of T19+ cells reveals a
predominance in peripheral blood and afferent lymph where, depending on the age
of the animal, they may represent 6-30 percent of lymphocytes, with reduced
numbers in lymph node, efferent lymph and thymus (Mackay et al., 1986; Maddox
et al., 1987a; 1987b; 1987c; Mackay, 1988; McClure etal, 1989).
Although there is no specific mAb for CD3 of sheep, it has been
characterised using rabbit anti-human CD3 antiserum which also reacts with the
sheep CD3 molecule (Hein, W., unpublished, 1988). Using this antiserum it has
also been shown that in sheep, T19+ cells express the CD3 molecule (Hein and
Mackay, 1991). Since in human and mouse, CD3+CD4"CD8" cells express the yand
the 8 chains of the TcR, it is likely by analogy that the CD3+CD4~CD8"T19+
lymphocytes in sheep also express the y and 8 chains of the TcR. In fact. Northern
blot hybridisation using sheep a, (1, y and 8 probes showed that T19+ (197+) cells
express y and 8 message (Hein et at, 1989; Mackay, Beya and Matzinger, 1989;
Clevers etal., 1990).
In human and mouse, functional studies of y8 T cells isolated from
peripheral T cell populations and activated with antigen-independent stimuli such
as mitogens or mAbs, have shown that they develop non-MHC-restricted cytolytic
activity (Brenner et al., 1987; Borst et at, 1987). Thus, it has been proposed that y8
T cells in epithelial regions function in disease surveillance and could eliminate in a
cytotoxic fashion, transformed epithelial cells and those infected by pathogens from
the environment (Janeway etal., 1988; Goodman and Lefrancois, 1988; Brandtzaeg
et al., 1989). Furthermore, the abundance of y8 T cells in epithelia of skin may
provide a unique role for them in the recognition of certain infectious agents
presented in the context of modified Class I antigens, since it was demonstrated that
mouse alloreactive y8 T cell lines and clones were both cytolytic and released
lymphokines after recognition of a non-classical H-2 antigen encoded in the TL
region of the MHC (Bluestone et at, 1988). In addition, y8 TcR+ intestinal intra-
57
epithelial lymphocytes (IEL) spontaneously produced IFN-y and IL-5 and possessed
large quantities of cytokine-specific mRNA, an indication that they were
programmed for cytokine production (Taguchi etal., 1991).
Results from functional studies of ruminant y8 T cells are limited and
inconclusive. Sheep y5 T cells generally show poor proliferative responses when
stimulated in vitro with T cell mitogens but, in allogeneic mixed lymphocyte cultures,
they can proliferate vigorously and may even overgrow the a/p population (McClure
and Hein, 1989; Hein and Mackay, 1991). In some assays, sheep y8 T cells exhibit
cytotoxic activity against allogeneic cells, although the MHC restriction pattern of
the response was inconsistent (Mackay et al, 1988b). It has been speculated that in
sheep, y5 T cells may have an immunoregulatory function in peripheral immune
responses to antigen, exercised via their contribution to the various effector
molecules. This derives support from the fact that in vitro mitogenic stimulation of
T19 enriched cells resulted in a substantial decrease in the expression of the antigen
and was accompanied by the appearance of CD4+ and/or CD8+ cells (McClure and
Hein, 1989). It is too early to assess the role of y5 T cells in ruminants during the
pathogenesis of disease. However, y5 T cells infiltrate lesions in sheep skin caused
by infection with orf virus (Hein and Mackay, 1991). In addition, significant
numbers of y5 T cells have also been observed within liver leucocyte foci in sheep
challenged with Taenia hydatigena and interestingly, appreciable numbers of the
cells were also present in well developed germinal centres in the draining hepatic
lymphnode (Meeusen et al, 1990). These observations clearly suggest that in some
circumstances y5 T cells are selectively recruited to sites of active inflammation.
CD45 (SBU-LCA) Leucocyte Common Antigen
The CD45 molecule of mammals (formerly LCA or T200) is expressed by
all leucocytes although different cell lineages or cells at various stages of
differentiation express different forms of the molecule (Mackay, 1988). In sheep, the
mAb 1-32 defines an antigen which, based on tissue distribution and MW, is an
analogue of the CD45 or LCA of human, mouse and rat. In sheep, the antigen is
present only on cells of the haemopoietic lineage and is expressed on the surface of
all lymphocytes of the thymus, spleen, lymph nodes, ileal Peyer's patches (IPP) and
peripheral blood, as well as being found on macrophages and granulocytes (Maddox
et al, 1985b). SDS-PAGE analysis of LCA isolated from lymphocytes reveals
molecular forms of 190 kD, 210 kD and 225 kD. However, different molecular forms
of ovine LCA were found on different lymphocyte populations, with B cells lacking
the 210 kD form found on T cells and thymocytes, and thymocytes lacking the
225 kD form found on B cells. One interesting aspect of ovine CD45 is the presence
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of the 190 kD molecule on B cells from IPP which contrasts with the 225 kD form on
peripheral B cell CD45 (Mackay et al, 1987). This finding most probably relates to
the unique nature of IPP as a primary B cell lymphoid organ (Reynolds and Morris,
1983) and indicates that the majority of B cells in IPP are 'immature'.
Since only one CD45 gene has been identified, the various molecular
species of LCA probably result from alternative splicing of mRNA (Saga et al., 1986;
Thomas and Lefrancois, 1988) and in fact, mAbs have been produced to the regions
of CD45 with restricted expression. Thus, the mAb B220 in the mouse reacts
mostly with B cells (Coffman and Weissman, 1981) and the epitope for this antibody
is probably located on that portion of CD45 expressed only by B cells. A similar
mAb, 20-96 has been produced against the P220 component of sheep CD45
displaying a restricted tissue distribution (Mackay et al, 1987). This antibody
reacts with all B cells and a subpopulation of CD4",CD8~,T19~ and slg" lymphocytes.
The function of CD45 is not clear but it is thought to be essential for the activation
of protein tyrosine kinase during lymphocyte triggering. It has been claimed to
participate in lysis by cytotoxic T cells and NK cells (Newman et al, 1983) as well as
in B cell differentiation (Yakura et al, 1983).
Major Histocompatibility (MHC) antigens (Ovine Leucocyte Antigens, OLA)
The MHC complex is a chromosomal region that contains loci coding for
molecules that are involved in self recognition. There are two major loci namely,
Class I and Class II. The Class I gene products or MHC Class I antigens (H-2 K,-D,
and -L in mouse; HLA-A, -B, and -C in human) are found on every nucleated cell in
varying amounts and function as targets for cytotoxic T lymphocytes. They are
classical alloantigens consisting of a polymorphic glycosylated polypeptide chain of
40-45 kD (heavy chain) in close noncovalent association with an oligomorphic non-
glycosylated light chain ((3-2 microglobulin) of approximately 13 kD (Male, Champion
and Cooke, 1987). The Class II gene products or MHC Class II antigens; I-A, I-E in
mouse; HLA-DR.-DC and -SB in human (Klein, 1978; Schwartz and Cullen, 1978;
Shackelford et al, 1982; Kaufman et al, 1984) are normally found as heterodimeric
cell surface glycoproteins consisting of a heavy (a) chain of 33-38 kD and a light ((3)
chain of 25-28 kD (Ferrone, Allison and Pellegrino, 1978; Schwartz and Cullen,
1978) and are expressed mainly on B cells, activated T cells and on cells of the
monocyte/macrophage lineage (Hammerling et al., 1975; David et al, 1976). The
MHC Class II molecules are recognised by the helper/inducer T lymphocyte
subpopulations.
In sheep, both the Class I and Class II MHC antigens have been
characterised using mAbs. Three mAbs, SBU-I 41-17; SBU-I 41-19 and SBU-I 41-
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28 have been generated against MHC Class I antigens which identify all peripheral
lymphocytes, but only 20-40 percent of thymocytes (Gogolin-Ewens et al., 1985).
They all precipitate a 44 kD heavy chain that is noncovalently linked with a 12 kD
light chain. Similarly, mAbs SBU-II 28-1, 38-27 and 38-64 (Puri et al, 1985) and
SW73.2 (Hopkins et al, 1986) believed to react with sheep MHC Class II antigens
have been produced. The antigens immunoprecipitated with these mAbs all gave
typical two-chain patterns of 30-32 kD/24-26 kD (Puri et al, 1985) and 33-35/28-
30 kD (Hopkins et al., 1986) by SDS-PAGE and could be detected on majority of B
cells, a small proportion of slg" cells in the blood, macrophages in afferent lymph
and reticular epithelial cells in the thymic cortex and medulla. The MHC Class II
molecules have proven to be useful markers for assessing the state of activation of T
cells in different lymphoid compartments and after antigenic stimulation and, are
also involved in antigenic recognition by CD4+ T cells (Mackay et al., 1986; 1987).
CD1 (SBU-T6)
This thymic antigen, termed SBU-T6 in sheep, is similar to CD1 or T6 in
man and has been characterised in sheep by Mackay et al. (1985) using the mAb 20-
27. Its distribution in sheep differs slightly from that of T6 in human since SBU-T6
is detectable at low levels on peripheral blood B cells. However, its pattern of
expression on Langerhans cells and cortical thymocytes is conserved in all species.
SBU-T6 is a 46 kD polypeptide which associates with a 12 kD subunit presumably
representing sheep P-2 microglobulin. In addition to staining cortical thymocytes
and Langerhans cells, monoclonal anti-SBU-T6 also reacts with dendritic (veiled)
cells in afferent lymph and with dendritic cells within the paracortical areas of the
lymph node (Mackay et al., 1987).
B Cell Antigens
B cells recognise antigens by their endogenously synthesised surface
immunoglobulin, which is the characteristic B cell marker. During differentiation, B
cells initially acquire slg of the IgM class, which acts as their antigen receptor. In
subsequent development they may change the class of their slg, but their antigen
specificity remains the same. Surface Ig is present on all B cells but is not
expressed when they terminally differentiate into plasma cells. Detection of slg in
sheep has depended on the use of heteroantisera (Beh et al, 1979; Husband et al,
1979; Gerber et al, 1985). However, mAbs have been produced which discriminate
B cells from T cells in sheep (Miyasaka et al., 1985). The mAb VPM 30 is an IgM
monoclonal specific for sheep B cells (J Hopkins, personal communication).
CHAPTER THREE
General Materials and Methods
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3.1 Experimental Animals
Finnish Landrace (Finns) or Suffolk breeds of sheep aged between six to
18 months were purchased from Moredun Research Institute, Edinburgh. Those
used for peripheral blood studies were housed in an air-conditioned, fly-proof urban
isolation unit whereas sheep used for efferent lymphatic cannulation studies were
kept in metabolism cages in the isolation unit at the Centre for Tropical Veterinary
Medicine, Edinburgh. All the animals were dewormed with 5 mg kg1 dose of
Fenbendazole (Panacur™; Hoechst, Frankfurt, Germany) before use in experiments.
They were fed ad libitum on hay and water with regulated supply of concentrates.
3.2 Trypanosomes
T. evansi TREU 2143 was used throughout the course of study. It was a
cloned derivative of T. evansi TREU 1558, originally isolated from a naturally
infected camel in Aroma, Kassala Province of Sudan in 1977 as T.
euansr/KASSALA/77/KAS/4. Appendix I details the cloning of TREU 2143.
3.2.1 Subpassage in mice
T. evansi TREU 2143 was cryopreserved in liquid nitrogen in sealed
capillary tubes. For use, two capillary tubes were rapidly thawed and their contents
suspended in 1 ml sterile phosphate buffered saline glucose (PSG), pH 8.0 (Appendix
11(1). Two mice treated three days previously with 300 mg kg-1 of cyclophosphamide
(CPA) were inoculated intraperitoneally with 200 pis of trypanosome suspension.
Three days later, 400 pis of blood were expressed from the tail vein of the mice and
further passaged in two CPA-treated mice.
3.2.2 Separation of T. evansi from Mouse Blood
The second set of infected mice were exsanguinated by sterile open
cardiac puncture under terminal anaesthesia using diethylether, 6-7 days p.i. when
they had developed fulminating parasitaemia. Trypanosomes were then separated
from the blood by anion exchange chromatography on a column of sterile
diethylaminoethyl cellulose, DEAE-52 (Whatman Chemical Separation Ltd, Kent,
England) as described by Lanham and Godfrey (1970). This technique is detailed in
Appendix 11(2) and III(l).
3.2.3 Establishment of Infection in Sheep
The neck of each animal was clipped and sterilised by scrubbing with
cotton wool soaked in 70 percent alcohol. Sheep were infected by inoculation into
the external jugular vein of 2 x 106 T. evansi TREU 2143 in 200 pis of sterile PSG.
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3.3 Clinical and Parasitological Parameters
3.3.1 Body Temperature
The body temperature of sheep used in the peripheral blood experiments
was monitored daily using a digital electronic thermometer.
3.3.2 Packed Cell Volume (PCV)
Routine haematology and assessment of parasitaemia were performed on
2 ml blood taken by jugular venipuncture into 5 ml EDTA coated plastic vials.
Blood for PCV was drawn into microcapillaiy tubes up to two-thirds of their
capacity, which were then heat-sealed at one end. The capillaries were then
centrifuged at 12,000 rpm in a microhaematocrit centrifuge (Biofuge, Heraeus
Sepatech) and the PCV determined using a microheamatocrit reader (Hawksley).
3.3.3 Detection of Trypanosomes in Blood and Lymph
Blood parasitaemia was monitored by the examination of unstained wet
blood films on a clean slide covered with 22 x 22 mm2 coverslip. A systematic
examination was made using a phase contrast microscope at x400 magnification for
200 fields. Parasitaemia was represented as numbers of trypanosomes per 200
fields. Where no parasites were detected by this technique, the haematocrit
centrifugation technique (HCT) for parasite detection as described by Woo (1970)
was done and examined under xlOO magnification.
In lymph, trypanosomes were concentrated by centrifugation at
2260 r.p.m. for 20 minutes at 4°C and detected by examining the resuspended
pellet.
3.3.4 Total and Differential Leucocyte Counts
Total leucocyte count (TWBC) of blood was determined using a Coulter
cell counter (Coulter Electronics Ltd, Harpenden, U.K.). Differential counts were
made using Giemsa stained thin blood smears and were expressed as percentages of
1000 leucocytes counted. Lymph cell counts were made in a System 9000
automated cell counter (Serono, Baker Diagnostics, Allentown, Pennsylvania, U.S.A.)
which also discriminated small lymphocytes from blast cells. Differential cell counts
were determed using Giemsa stained smears.
3.4 Separation of Peripheral Blood Leucocytes
Peripheral blood leucocytes were separated either by density gradient
centrifugation of defibrinated blood over lymphoprep (Boyum, 1968; Ling and
MacLennan, 1981) or by hypotonic lysis of erythrocytes using tris-ammonium
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chloride (Mishell and Shigi, 1980). Density gradient centrifugation yields a relatively
pure peripheral blood mononuclear cells since it separates them from erythrocytes,
granulocytes and platelets. Separation by hypotonic lysis on the other hand is
simpler and quicker but yields a mixed population of all other WBC elements. These
different populations can, however, be analysed separately in flow cytometry by 'live
gating' using the different physical parameters of the cells. Detailed protocols of the
density gradient centrifugation and hypotonic tris-ammonium chloride lysing
techniques used are given in Appendices 111(2) and 111(3) respectively.
3.4.1 Preparation of Cytospin Smears
Cytosmears were made using a cytocentrifuge (Shandon Southern
Instruments Ltd, Cheshire, U.K.). 80 pis of cell suspension at 105 cell ml-1 was
centrifuged at 800 r.p.m. for 5 minutes. Smears were air dried, fixed for 2 minutes
in technical methanol (95 percent, BDH) and stained in 10 percent Giemsa.
3.5 Phenotypic Analysis of Peripheral Blood Leucocytes and Efferent
Lymphocytes
3.5.1 Monoclonal Antibodies and Immunoconjugates
A panel of 11 mAbs were used to analyse the dynamics of various
leucocyte phenotypes in sheep. Nine of the mAbs were obtained from the Sheep
Biology Unit (SBU), School of Veterinary Science, University of Melbourne, Australia,
as lyophilised ascitic fluid, reconstituted in 5 mis of sterile distilled water and stored
in 200 pi aliquots at -20°C until used. Two mAbs were provided by Dr J Hopkins of
the Department of Veterinary Pathology, University of Edinburgh, as tissue culture
supernatants and were also stored at -20°C in 1 ml aliquots until used. In cases of
mAbs which identify antigens analogous to those described in other species such as
human and mouse, the cluster of differentiation (CD) nomenclature (Bernard et al,
1984) has been adopted and applied to them. Table 3.1a lists the mAbs used and
some of their biological characteristics.
The immunoconjugates used are listed in Table 3.1b. For single colour
flow cytometry, fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse
immunoglobulin (GAM/Ig/FITC) and goat anti-rabbit immunoglobulin
(GAR/Ig/FITC) [Nordic immunochemicals] were used as second antibodies. For two
colour flow cytometry, biotinylated anti-cell (SBU) antibodies, including biotinylated
VPM30 (anti-sheep B cell), for red fluorescence, and non-biotinylated anti-sheep
mAbs for green fluorescence were used as first antibodies. Red fluorescence was
visualised with R-phycoerthrin-streptavidin (PE-SA) complex (Amersham, U.K.) while
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21-91 (SBU-T1) IgGi CD5 T cells and a subpopulation
of B cells






CD8 MHC Class I restricted T
cells
19-19 (SBU-T19) IgGj T-19 y5 T cells
20-27 (SBU-T6) IgGi CD1 Cortical thymocytes,
dendritic cells and some
B cells in peripheral blood




p220) IgGi CD45R B cells and some T cells
VPM 30 IgM B cell antigen All B cells
41-19 (SBU-I) IgGi MHC Class I All somatic cells
1-28 (SBU-LCA) IgG24 CD45 All leucocytes











Sheep anti-mouse Ig Fluorescein isothiocyanate (FITC) anti-IgGj
Sheep anti-mouse Ig Fluorescein isothiocyanate (FITC) anti-IgG2a
Sheep anti-mouse Ig Fluorescein isothiocyanate (FITC) anti-IgM(Fc)
Goat anti-mouse Ig Fluorescein isothiocyanate (FITC) anti-Ig









FIGURE 3.1 Flow cytometry display of PBLs for 'live gating' of lymphocytes using
forward and side angle light scatter (FSC and SSC).
(a) Dot plot display (ungated) of a negative control sample
showing the distribution of the various blood elements based
on their physical characteristics.
(b) Exclusion of dead cells, rbcs, granulocytes and monocytes by
'live gating' the lymphocytes.
(c) Frequency histogram display of the 'live gated lymphocytes.
(d) Contour profile of the negative control sample of a 2-colour
staining adjusted for optimal FITC and RPE voltage levels.
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green fluorescence was visualised with isotype specific FITC-sheep anti-mouse Ig
(ShAM/Ig/FITC) conjugates (The Binding Site.U.K.)
3.5.2 Flow Cytofluorimetry and Analysis of Cytometric Data
Flow cytometry is an analytical technique which in a population of
continuously flowing fluorochrome labelled cells permits accurate quantitation of
various parameters of individual cells, such as the distribution of fluorescence
intensities and their sizes. Data on these parameters can be stored and analysed in
a computer. In this work, flow cytometric acquisition of fluorochrome labelled cell
data was carried out using a fluorescence-activated cell analyser, FACSCAN (Becton
Dickinson, Mountain View, CA, U.S.A.). The Consort 30 programme was used in the
acquisition, storage and analysis of both the single and two colour flow cytometric
parameters of the labelled sheep peripheral blood and efferent lymph lymphocytes.
In each case data was derived by analysing 10,000 cells (or events) per sample.
For single-colour parameters, the cytometer configurations were
calibrated and set using negative control cells stained with normal mouse serum
(NMS) and the appropriate immunoconjugates. FITC fluorescence (520 nM)
emission was detected with the photomultiplier tube voltage set at 555 mV. Forward
(FSC) and side or 90 degree (SSC) scatter amplifications were linear and set at E00
and 326 respectively, while FITC amplification was logarithmic (all 256 channels).
Using dot plot (Figure 3.1a), lymphocytes were 'live-gated' for acquisition and
analysis while cell debris, dead cells, red blood cells (RBCs), granulocytes and
monocytes were excluded on the basis of forward and side angle light scatter (Figure
3.1b). Forward-angle light scatter, 90-degree light scatter and fluorescent data were
plotted as frequency histograms with the log fluorescent intensity presented on the
x-axis and the frequency of cell numbers presented on the y-axis (Figure 3. lc).
For two-colour parameters, the cytometer configurations were calibrated
and set using the negative control cells stained with appropriate concentrations of
NMS-biotin and negative mAb, and then visualised with PE-SA and the FITC
conjugated anti-immunoglobulin. The FSC and SSC configurations were the same
as above. By using dot plot of FSC vs SSC, the lymphocyte cluster was 'live-gated'
while the unwanted clusters were excluded (Figure 3.1b). Using the
autofluorescence (in the FL1 vs FL2 parameter option) of the unstained negative
control lymphocytes inside the monitor gate, the optimum FITC and RPE voltage
levels were adjusted to the lower left corner of the box (Figure 3. Id). These optimal
PMT voltages were found to be 625 mV and 574 mV for FITC and RPE respectively,
and both FL1 (FITC) and FL2 (RPE) were in the logarithmic amplification. To
compensate for the unwanted spectral overlap of emitted light from the FITC and
IB0 IB1 IB2 IB3 IB4
FL1
FIGURE 3.1 (e) Two-colour immunofluorescence contour display of PBLs
stained for CD4+ (FL2) and CD8+ (FL1) cells. Quadrant 1 =
CD4+ cells; 2 = CD4+CD8+ cells (none in this case); 3 =■
negative cells, i.e. CD4~CD8~; 4 = CD8+ cells.
(0 Frequency histogram of the CD4+ cells: ( ) = negative
control sample; (— ) = stained cells; The first peak
represents the CD4" cells while the second peak (right of
marker) is the CD4+ cells.
(g) Frequency histogram of the CD8+ cells: ( ) = negative
control; ( -) = stained cells: First peak = CD8"; second
peak = CD8+ cells.
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RPE dyes used, the FLl-% FL2 PMT voltage was set at 9 mV to remove PE signal
from the FL1 region, while the FL2-% FL1 PMT voltage was set at 30 mV to remove
FITC signal from the FL2 region. All parameters for two-colour immunofluorescence
were acquired in the LIST DATA structure which allows for the presentation of data
in frequency histograms as in uncorrelated single-colour parameter, as well as
allowing the generation of various combinations of dual parameter correlations such
as FSC vs SSC dot plot and FL1 vs FL2 contour plot. Contour plot (graph) maps
events in a 64 x 64 channel area defined by the selected parameters, with contour
lines representing the cell density distribution over this area. The result
corresponds to a geographical topographic map, which distinguishes between
altitude differences of a terrain, i.e. mountains (increasing cell densities or peaks)
and valleys (areas of low cell densities). For statistical data analysis, the contour
graphs in this study were set into calculation regions defined by setting quadrant
markers or windows. Figure 3.1e represents a CD8 FITC/CD4 PE system in which
quadrant 1 represents CD4 (PE) positives only, quadrant 2 represents CD4/CD8
(FITC/PE) dual positives (in this experiment there are no dual positives), quadrant 3
represents the negative population for both antibodies while quadrant 4 is the CD8
(FITC) positives only. Figures 3. If and 3. lg represent frequency histograms
generated for CD4+ and CD8+ cells respectively from the sample parameter.
3.5.3 Protocols for Indirect Immunofluorescence Staining
3.5.3.1 Single Colour Flow Cytometry
Slight modifications of the methods of Mackay et al. (1988a) and Hudson
and Hay (1989) were adopted in this study. Briefly, 5 x 105 ovine peripheral blood
or efferent lymphocytes in ice cold immunofluorescence buffer [IFB] (Appendix 11(3))
were dispensed in 50 pi aliquots into round-bottomed mini-test tubes (Sterilin).
Each was treated with 25 pis of appropriately diluted mAbs, mixed by gentle tapping
and incubated on ice (4°C) for 30 minutes. The cells were then washed twice in
800 pis of IFB by centrifugation, resuspended in 50 pis of IFB and labelled with
25 pis of an optimal dilution of the appropriate antibody conjugate or PE-SA
complex. They were incubated again in the dark for 30 minutes at 4°C, washed
twice (for FITC stained cells) or once (for PE stained cells) as before and resuspended
in 200 pis of IFB. Cells were usually analysed on the same day, but if this was not
possible, the cells were fixed by resuspension in equal volumes (100 pis each) of IFB
and freshly made one percent paraformaldehyde fixative (Appendix 11(4)), wrapped in
tinfoil, stored at 4°C and analysed the following day. The control samples were
treated in exactly the same way except that instead of a mAb they were reacted with
NMS or biotinylated NMS (BNMS).
FL 1 FL1
FL1 FL1
FIGURE 3.2 Contour profiles of cells stained with SBU-T4, SBU-T8, SBU-T19 and
VPM 30 after the antibodies were biotinylated.
(a) CD4+ cells (quadrant 1)
(b) CD8+ cells (quadrant 1)
(c) T19+ cells (quadrant 1)
(d) VPM 30+ cells (quadrant 1)
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3.5.3.2 Two-colour Flow Cytometry
For this technique, a modification of the method of Loken, Parks and
Herzenberg (1977) was adopted. Cells were dispensed as above and treated
simultaneously with 25 pis each of the non-biotinylated and biotinylated mAbs as
appropriate. They were incubated as above and washed three times in IFB. 25 pis
each of the appropriately diluted PE-SA and isotype specific FITC-conjugated second
antibodies were again simultaneously added for visualisation of the red and green
fluorescence respectively. They were then incubated at 4°C in the dark for 30
minutes, washed once and analysed. Negative controls were stained with BNMS and
an anti-metacyclic T. congolense mAb as the first antibody.
3.5.4 Blotlnylatlon of Monoclonal Antibodies
SBU-T4, SBU-T8, SBU-T19 and VPM 30 were biotinylated for use in two-
colour flow cytometry according to the method of Hudson and Hay (1989). Briefly, Ig
isotypes from 1 ml ascitic fluid or 5 mis tissue culture supernate (VPM 30) were
precipitated by treatment with ammonium sulphate at 45 percent saturation (v/v).
The precipitates were centrifuged at 1000 g for 15 minutes at 4°C, redissolved in
1 ml of 0.1 M bicarbonate buffer, pH 8.4 (Appendix 11(6)) and dialysed extensively in
bicarbonate buffer. The protein concentration was determined and adjusted to 1 mg
ml"* in buffer. Immunoglobulins were biotinylated by the addition of biotin-amido
caproate N-hydroxysuccinimide ester (Sigma) in dimethyl sulphoxide (DMSO) at
2 mg ml-1 at a biotin: protein ratio of 75 pg:l mg. They were mixed together and
rotated at room temperature for 4 hours. The biotinylated antibodies were then
dialysed against three changes of 0.1 M Tris-Hcl buffer, pH 8.4 (Appendix 11(9) for 72
hours at 4°C. Figure 3.2 illustrates contour profiles of peripheral blood leucocytes
stained with the biotinylated antibodies.
3.5.5 Optimisation of mAb and Conjugate Dilutions
All rriAbs and conjugates were titrated for optimal working dilutions
except for S-T8 (T8 basal) and VPM 30 which were used as undiluted tissue culture
supernates. The biotinylated SBU-T4, SBU-T8, SBU-T19 and VPM 30 as well as the
F(ab)2RAS serum were titrated at doubling dilutions from 1:25 to 1:400 whereas
SBU-T6 and SBU-T19 were titrated from 1:125 to 1:1000. All other mAbs, NMS and
the anti-metacyclic T. congolense mAb were tested at doubling dilutions from 1:250
to 1:2000. Sheep peripheral blood leucocytes were stained for flow cytometiy with
these dilutions. Red and green fluorescence were visualised by PE-SA and FITC
conjugates at arbitrary dilutions of 1:200 and 1:80 respectively. The optimal
working dilution of each of the antibodies chosen was that which gave the strongest
FIGURE 3.3 Optimisation of working dilutions of monoclonal antibodies by
titration.











In each case the dilution which gave the best definition between the
negative and positive population was chosen. In this case 1:500 for
SBU-T1 and 1:50 for VPM 30.
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fluorescence based on the mode and mean channel fluorescence intensities and, a
clear distinction (within normal range) between the positive and negative
populations.
The optimal working dilutions of the various conjugates and the PE-SA
complex were determined by testing different dilutions against the optimal dilutions
of the mAbs, and the dilution giving strong specific fluorescence with low
background staining of the negative control cells was chosen. Figures 3.3a,b
represent FACSCAN frequency histograms and contour profiles of SBU-T1 and
biotinylated VPM 30 at various dilutions. The profiles of the rest of the mAbs and
conjugates are not shown because they were destroyed in an arson attack at the
Centre for Tropical Veterinary Medicine (CTVM) in November 1991. Table 3.2 lists
the working dilutions chosen for each of the mAbs and conjugates.
3.5.6 Comparison of Cell Separation Techniques
To assess which cell separation technique would give the best result in
the study, separation by density gradient centrifugation and hypotonic lysis were
compared. Leucocytes isolated by each method were stained for CD5, CD4, CD8, y5
T cell and B cells using appropriate mAbs and then analysed by flow cytometry. The
analysis revealed that a significant proportion of lymphocyte subsets was lost when
separated by density gradient centrifugation over lymphoprep in comparison to
those separated by hypotonic red blood cell lysis using tris-NH4Cl (Figure 3.4). As a
result, hypotonic lysis was adopted and used in all cell separation for
immunocytofluorimetric studies.
3.6 Surgical Cannulation of the Efferent Lymphatic Duct of the
Prefemoral Lymph Node
The prefemoral (subiliac) lymph node is a superficial node located
laterally on the cranial border of the tensor fasciae latae, half the distance between
the coxal tuber and the patella. It is laterally bounded by the deep surface of the
cutaneous muscle (panniculus carvanosus). The node drains the skin and subcutis
of the pelvic and cranial part of the thigh area as well as the skin and subcutis
caudal to the transverse line drawn through the seventh or eighth rib, except for the
caudoventral regions of the abdomen (Grau, 1933; cited in Sisson and Grossman,
1975; Figure 3.5a). The ducts accompany the circumflex iliac blood vessels on the
deep surface of the tensor fasciae latae and then enter the abdominal cavity where
they drain into the lateral or medial iliac lymph nodes or join the lumbar lymphatic
ducts directly (Figure 3.5b).
FIGURE 3.4 Comparison of cell separation techniques. PBLs were separated by
either hypotonic lysis of RBCs using Tris-ammonium chloride or by
density gradient centrifugation over lymphoprcp and stained for flow
cytometry using SBU-T1. SBU-T4, SBU-T8. SBU-T19 and VPM 30 in
order to assess the proportion of CD5+, CD4+, CD8+, y5 and B cells
stained by each antibody in the cell populations.
a(—) = cells separated by Tris-NH4C1 lysis
b( ) = cells separated by lymphoprep
c(... .) = Negative control
l. CD5+ cells
(a) Lysis = 68.8 percent positive
(b) Lymphoprep = 51.8 percent positive
2. CD4+ cells
(a) Lysis = 47.8 percent positive
(b) Lymphoprep = 25.9 percent positive
3. CD8+ cells
(a) Lysis = 15.3 percent positive
(b) Lymphoprep = 13.0 percent positive
4. y5+ T cells
(a) Lysis = 10.1 percent positive
(b) Lymphoprep = 8.8 percent positive
5. B cells
(a) Lysis = 42.8 percent positive
(b) Lymphoprep = 57.1 percent positive
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Table 3.2 Optimal working dilutions for monoclonal













Anti-metacyclic mAb 1 1000
F(ab')2RAS Ig 1 50
SBU-T4 biotin 1 50
SBU-T8 biotin 1 50
SBU-T19 biotin 1 50
VPM 30 biotin 1 50
GAR/Ig/FITC 1:80





E 3.5 (a) Diagram showing Ihe areas drained by afferent lymphatics of
prcfcmoral lymph node (adapted from Sisson and Grossman's. The
Anatomy of the Domestic Animals, Vol. 1, Editors R- Getty, W.B.
Saunders Company, Philadelphia, London, Toronto, 1975).
(b) Schematic diagram showing lymph flow from areas drained by
prcfcmoral node in sheep and indicating the rcanastomosis of afferent
lymphatics after lymphadenectomy. S, Skin; AF, Afferent lymphatic
duct; AN, Accessory lymph node; PN, Prefcmorai lymph node; X,
Position of ablated lymph node; EF, Efferent lymphatic duct; PA,
Pseudo-afferent lymphatic duct; LIN, Lateral iliac lymph node; MIN,
Medial iliac lymph node, LT, Lymphatic trunk; CC, Cystoma chyli;
H, Heart; JV, Jugular vein; BC Blood Circulation (adapted from
Sissons, Grossman, 1975 and Akol, 1985).
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3.6.1 Presurgical Procedures and Anaesthesia
Animals were starved overnight prior to surgery. Induction of
anaesthesia was by intravenous Saffan™ (alphaxolone/alphadolone acetate;
Pitman-More, U.K.) at 2 mg kg-1 and was maintained using gaseous halothane
(Halothane BP, Dagenham, England) and 50:50 oxygen/nitrous oxide flow
introduced using cuffed endotracheal tube. A closed circuit anaesthetic machine,
Fluotec 3 (Boyles International 2, Harlow, England) fitted with a C02 absorber and
rebreathing bag, was used to deliver the halothane/02/C02 gases.
3.6.2 Surgical Procedure
Cannulation of the pefemoral efferent lymphatic was as described by Hall
and Morris (1965). Strict asceptic technique was used throughout. The duct was
cannulated using a Portex polypropylene cannula which was exteriorised via a stab
wound. The cannulation wound was closed with a continuous 2/0 catgut (Ethicon
Ltd, Edinburgh, Scotland) followed by Michell-clips. Immediately after the operation
the sheep were given 5 mis of Depomycin forte (procaine-penicillin/ dihydro-
streptomycin sulphate; Mycofarm, U.K.) at a site distal to the cannulation and as
well 1 ml (1000 I.U.) heparin subcutaneously within the prefemoral drainage area to
obviate immediate postsurgical clotting.
Lymph was collected into sterile, siliconised plastic bottles containing
1000 I.U. heparin daily at 10.00 am. The volume was determined using a
measuring cylinder in order to calculate the hourly flow rate. The cells were
enumerated using a System 9000 automated cell counter. The cell counts per ml
and the flow rates were used to calculate the total and hourly cell outputs. In all
cases, cannulations were allowed 5 days to stabilise before collecting lymph for
analysis.
3.6.3 Preparation of Efferent Lymphocytes
25 mis of lymph were centrifuged at 800 g for 15 minutes at 4°C to
separate cells from lymph fluid. The cell-free lymph was decanted and stored at
-20°C until used. The cell pellet was then resuspended in IFB and contaminating
erythrocytes lysed with tris-ammonium chloride where necessary.
3.7 Quantitation of Parasite Specific Serum Antibody
3.7.1 Serum Sample Preparation
Serum samples were prepared from jugular blood. 10 mis of blood were
collected in glass universal bottles, and allowed to clot in an inclined position in a
37°C incubation for 30 minutes. Alternatively the samples were left overnight at
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4°C. The formed serum was pipetted into plastic universal bottles and spun at
10,000 g for 20 minutes at 4°C. 5 mis of the supernatant were collected and stored
at -20°C until used.
3.7.2 Preparation of Trypanosomal Antigen
The antigen was prepared from purified T. evansi TREU 2143. Infected
blood was collected from mice with fulminating parasitaemia and parasites
separated on a column of DE-52 as described in Appendix III(l). The tiypanosomes
were resuspended in 2 mis of PBS and subjected to two cycles of freeze-thawing at
-70°C. The sample was then diluted 1/4 with ice-cold PBS, kept refrigerated in an
ice bath and subjected to four cycles of ultrasonication for 45 seconds at maximum
amplitude on an MSE 100 W Ultrasonic Disintegrator. The resulting suspension
was centrifuged at 10,000 g for 20 minutes to remove debris. The protein
concentration of the supernate was then determined photometrically, adjusted to
1 mg ml" *, aliquoted and frozen at -20°C as stock antigen.
3.7.3 MicroELISA Technique
T. euansi-specific antibody responses were assayed using the micro-scale
enzyme-linked immunosorbent assay (microELISA) as described by Luckins (1977)
and modified by Payne et al. (1988). Specific IgGl and IgM were detected in an
indirect (double sandwich) microELISA using mouse anti-sheep IgG 1 and IgM mAbs
(kind gifts from Dr K.J. Beh, C.S.I.R.O., Division of Animal Health, McMaster
Laboratory, Glebe, Australia) and horseradish peroxidase (HRP) conjugated goat
anti-mouse polyvalent immunoglobulins (SIGMA). Detailed protocol of the ELISA
technique used is given in Appendix 111(4). The mAbs and immunoconjugates used
in all ELISA systems are listed in Tables 3. la and b respectively.
3.7.4 Optimisation of Antigen, Reference Sera and Conjugate Dilutions
The optimal working dilutions of tiypanosomal antigen was determined
empirically in an ELISA. Doubling dilutions of the antigen from 1:25 to 1:1600 in
0.05 M carbonate/bicarbonate buffer, pH 9.6 (Appendix 11(6) were made. Four
replicates of each of the dilutions were tested against a 1:500 arbitrary dilution of
the negative and positive reference sera and 1:300 dilution of DASh/HRP/Ig (SAPU,
Scotland). The negative reference serum was obtained from 2-week old specific-
pathogen-free lambs (courtesy, Dr W. Donachie, Moredun Institute, Edinburgh)
while the positive reference serum was a 21 days p.i. sample from a Suffolk lamb
infected with 2x 106 T. evansi TREU 2143. The 1:100 dilution representing an
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FIGURE 3.6 I. Determination of optimal dilutions of tiypanosomal antigen.
positive and negative reference sera for trypanosome specific antibody
ELISA.
(a) Trypanosomal antigen titration
(b) Negative and positive reference sera titration
(c) Conjugate titration
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between the optical density values of the negative and positive reference sera (Figure
3.6a).
The reference sera were tested in dilutions of 1:50 to 1:51200 against the
optimal antigen dilution and an arbitrary conjugate dilution of 1:300. The 1:800
dilution gave the greatest difference between the two (Figure 3.6b) and was used
throughout the work. The conjugate was tested as dilutions of 1:125 to 1:32000
against the optimal antigen and reference sera dilutions with the 1:1000 chosen as
the optimal working dilution (Figure 3.6c).
3.8 Measurement of Immune Responses to Pasteurella Vaccine
3.8.1 Vaccination of Sheep
A monovalent Pasteurella haemolytica Al vaccine prepared from its
sodium salicylate capsular extract (SSE) and adsorbed onto aluminium hydroxide
gel (alhydrogel) (Gilmour et al, 1983; Fodor and Donachie, 1988) was used in the
study. Sheep were primed and boosted by subcutaneous inoculation of 2 mg doses
of the vaccine four weeks apart except in efferent lymphatic duct cannulation
experiments where they were administered 10-14 days apart. Prior to vaccination
the site was clipped and disinfected with 70 percent alcohol.
3.8.2 Assessment of Local Skin Reaction to Vaccine Administration
Local inflammatory reaction at the site of vaccine administration was
assessed by visual examination, touch and by the measurement of the skin
thickness using a pair of vernier calipers.
3.8.3 Quantitation of PasteurelZa-specific antibodies
Antibody responses to Pasteurella vaccination were assayed in both direct
and double sandwich microELISA techniques using mouse anti-sheep IgGj, IgG2
and IgM mAbs (Table 3.1a). The ELISA protocol is given in Appendix 111(4). The
conjugates are listed in Table 3.1b.
3.8.3.1 Pasteurella Antigen, Positive and Negative Serum
The Pasteurella haemolytica Al antigen as well as the negative and
positive reference sera used in the ELISA were gifts from Dr W. Donachie. The
antigen was supplied as a 10 mg ml"1 SSE suspension but was later adjusted to
2 mg ml*1, aliquoted and stored at -20°C until used. The positive reference serum
was obtained from SPF lambs vaccinated at 3 weeks of age and boosted 4 weeks
later with the Al SSE vaccine (Fodor and Donachie, 1988). The negative reference
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FIGURE 3.6 II. Determination of optimal working dilutions of Pasteurella antigen,
positive and negative reference sera, conjugates and mAbs for
Pasteurella-specific antibody ELISA.
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3.8.3.2 Test Serum and Lymph Preparation
Test serum was prepared as described in section 3.8.1 earlier. Lymph
was collected from cannulated sheep and cell-free lymph prepared as described in
Section 3.7.4. Before use, the serum was spun at 10,000 g for 20 minutes to
remove debris.
3.8.3.3 Optimising Pasteurella Antigen, Reference Sera, mAbs
and Conjugate Dilutions
The antigen, reference sera and conjugates were titrated in an ELISA as
described by Burrells et al. (1979) and Donachie et al. (1983). The antigen was
diluted 1:200 to 1:204800 and tested against arbitrary 1:100 and 1:500 dilutions of
the reference sera and conjugate respectively. There was no difference between the
values for 1:200 to 1:800 (Figure 3.6d) so the median point of 1:400 (5 pg ml"!
antigen concentration) was chosen as the optimal antigen dilution. The reference
sera were titrated against the conjugate and optimal antigen dilution. The 1:800
dilution (Figure 3.6e) gave the optimal response. Figures 3.6f and 3.6g-i show the
results of the titrations of the conjugates and the mAbs respectively. The 1:1000
dilution was optimal for the conjugates and the antibodies respectively.
3.9 In vitro Functional Assay of Sheep Peripheral Blood Leucocytes
The functional status of lymphocytes from sheep following infection with
T. evansi TREU 2143 and/or inoculation with Pasteurella haemolytica vaccine was
assayed in in vitro culture systems. Their proliferative responses upon stimulation
with mitogens or specific Pasteurella and trypanosomal antigens were used as the
index of functional activity. Furthermore, cell depletion experiments were conducted
in order to assess the role of the depleted cell population. The general protocol of
the in vitro culture system used is given in Appendix 111(5).
3.9.1 Mitogens and Antigens for Lymphoproliferative Assays
Two mitogens, concanavalin A (Con A) from Conavalia ensiformis (Jack
Bean) type V, and bacterial cell wall lipopolysaccharide (LPS) from E. coli 055:B5,
were purchased from Sigma Chemical Co., St Louis, Mo, U.S.A. and used in the
study. Pasteurella haemolytica Al and T. evansi TREU 2143 were used as the
specific antigens .
Con A is a lectin with mitogenic specificity for T lymphocytes. It was
reconstituted to a concentration of 250 pg ml"1 (w/v) using RPM1 1640 complete
culture medium (GIBCO Ltd, U.K., Appendix 11(7)). This was aliquotted and stored
at -20°C as stock mitogen. Prior to use, the stock was adjusted to a concentration
FIGURE 3.7 Test of the efficiency of CD8+ T cell depletion by monoclonal antl-CD8
(S-T81 treatment plus complement.
(a) Depleted and undepleled cell populations were subjected to
single colour Immunofluorescence staining using S-T8 and
then analysed by flow cytometry
1. Frequency histogram of the negative control
ti. Frequency histogram of CD8+ cells from the
undepleled cells
iff Frequency histogram of CD8+ cell from the depleted
population. More than 98 percent depletion of the
CD8+ cell population was consistently obtained.
(b) Depleted and undcpleted cells were also subjected to two-
colour flow cytometry using biollnviated SBU-T8 and SBU I
(MHC I).
1. Contour profile of the negauve control
ii. Contour profile of the undepleted cells
Quadrant 1 = CD8"*CL1" cells (none)
2 = CD8+CL1+ cells
3 = CD8"CL1" cells (none)
4 = CD8 CL* cells
ill. Contour profile of the depleted cells
Quadrant 1 = as above
2 = * " (none)
3
4 = " "
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of 50 pg ml"1 as the working stock. LPS is a hghly immunogenic constituent of the
cell wall of most gram negative bacteria. It has an adjuvant activity (Landy and
Baker, 1966; Skidmore et al., 1975) and also acts as a specific mitogen for B
lymphocytes (Andersson, Moller and Sjoberg, 1972; Hammarstrom et al, 1976;
Smith et al., 1979). It was supplied as a gamma-irradiated, lyophilised powder
which was reconstituted in culture medium, adjusted to a concentration of 250 gg
ml"l and stored at -20°C until required.
P. haemolytica antigen was obtained as described under subsection 3.8.2.
It was also adjusted with culture medium to a concentration of 250 pg ml-1 and
stored at -20°C. T. evansi was used as either live or ultrasonicated antigen. Live
tiypanosomes were obtained aseptically using anion-exchange chromatography as
described in Appendix III(l), and used as a stock adjusted to 107 ml1 with complete
culture medium. The ultrasonicated antigen prepared as described under
subsection 3.7.2 was adjusted with complete culture medium to 250 pg ml"1 and
sterilised again by ultrafiltration first through a 0.45 mm millipore then through a
0.22 mm Millipore filter.
3.9.2 Preparation of Cells for in vitro Functional Assays
3.9.2.1 Separation of Peripheral Blood Leucocytes
Sheep peripheral blood leucocytes were separated by density gradient
centrifugation over lymphoprep (Appendix 111(2). All washing processes were carried
out using tissue culture wash medium (Appendix 11(8) and, the cell concentrations
adjusted to 107 ml"1 using complete culture medium.
3.9.2.2 Depletion of CD8+ T Cells
CD8+ T cells were depleted by antibody-mediated complement lysis
(Tarleton, 1988b; Stefanovic et al, 1989). Two mis of purified PBLs adjusted to 107
cells ml"1 in complete culture medium were incubated with 2 mis of culture
supernatant fluid of the anti-CD8 mAb, S-T8 for 30 minutes at 4°C. The cells were
then washed three times in tissue culture wash medium, resuspended in 1 ml of
1:10 dilution of rabbit complement (Sigma Chemical Co. Ltd., Fancy Road, Poole,
Dorset, England) and incubated at 37°C for 1 hour. Treated cells were then washed
three times, counted and readjusted to 107 cells ml"1 in complete culture medium.
Nigrosan dye exclusion test of the treated cells consistently gave >98 percent viable
cell count. The efficiency of CD8+ T cell depletion was assessed in a single and two-
colour indirect immunofluorescence and flow cytometry using SBU-I, S-T8 and
biotinylated SBU-T8 mAbs. The results are shown in Figures 3.7a and b.
FIGURE 3.8 Testing the efficiency of monocyte depletion from PBLs.
Two sheep were primed and boosted with 2 mg doses of P.
haemolytica vaccine 4 weeks apart. 6 weeks after the booster
vaccination, PBLs separated from the jugular vein blood of the sheep
were depleted of monocytes as described in Section 3.9.2.3. Five
replicates each of 5 x 105 cells ml1 from the depleted and undepleted
cell population were subjected to specific stimulation with Pasteurella
antigen in an in vitro culture system. In both sheep, depleted cells
failed to respond to the antigen.
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3.9.2.3 Removal of Monocytes
Monocytes were removed from the cell population by incubating 5 x 107
PBLs suspended in 10 mis of culture medium for 1 hour at 37°C in a humid
atmosphere of 5 percent C02/95 percent air using a 25 ml Falcon tissue culture
flask (Scientific Supplies, Co., Vine Hill, London). The nonadherent cells were
removed by vigorous swirling with warm (37°C) culture medium and recultured
twice in fresh flasks under the same conditions and duration as above. The final
suspension of nonadherent cells were then washed twice in wash medium, counted
and readjusted to the working concentration of 107 cells ml"1. The efficiency of
removal of monocytes was tested by comparing the responses of depleted and
nondepleted cell populations to in vitro stimulation with P. haemolytica antigen.
These cells were obtained from sheep that had previously been primed and
subsequently boosted with 2 mg doses of P. haemolytica vaccine. Figure 3.8 shows
failure of the adherent cell depleted population to respond to specific antigen in vitro.
3.9.2.4 Depletion of CD8+ T Cells and Monocytes
CD8+ T cells and monocytes were removed by first subjecting 5 x 107 PBL
ml"1 to monocyte depletion, followed by antibody and complement mediated
cytotoxic killing of CD8+ T cells as described above. The resulting cell suspension
was washed, counted and readjusted to 107 cells ml"1 with complete culture
medium.
3.9.3 Optimisation of Culture System Conditions
3.9.3.1 Cell Concentration
Six different cell concentrations were used to determine the number of
cells which gave optimal proliferative responses to previously optimised
concentrations of Con A, LPS, and P. ag. The cells were dispensed into 96-well flat-
bottomed NUNC microculture plates (Flow Laboratories, Rickmansworth, Herts,U.K.)
in triplicate in volumes of 2.5, 5, 10, 20, 40 and 80 pis, to give final cell
concentrations of 2.5 x 104, 5x 104, 105, 2x 105, 4x 105 and 8x 105 per well
respectively. From stock solutions of 50 pg ml"1 Con A and 250 pg ml"1 LPS and
Pasteurella antigen (P. ag.), respective volumes of 10 pis, 60 pis and 40 pis were
added to the cells. Complete culture medium was then added so that each well
contained a total volume of 200 pis. The cultures were incubated at 37°C for 72
hours in a humified atmosphere of 5 percent C02/95 percent air. Cells were then
pulsed with 0.5 pCi of [methyl-3H] thymidine (specific activity 5Ci mMol"1;
Amersham, Amersham International pic, Buckinghamshire, England) during the last
5 hours of culture. The cells were harvested onto glass fibre filter paper discs
FIGURE 3.9 Optimisation of culture system variables for in vitro lymphocyte
transformation assays.
(a) Titration for determining optimal cell concentration
(b) Titration for determining optimal Con A concentration
(c) Titration for determining optimal LPS and Pasteurella antigen
concentrations.
(d) Time curve (optimal duration of culture)
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(Whatman, U.K.) using a semi-automated cell harvester, multi MASH II (Dynatech).
The filter strips were dried for 30 minutes at 65°C and the discs placed in
disposable plastic scintillation vials (Sterilin Ltd, Middlesex). 2 mis of scintillation
fluid were dispensed into each vial, the vials were then capped and thymidine
incorporation was determined by counting in a beta liquid scintillation spectrometer
(Packard 2000).
The optimum cell concentration is regarded as that which gives the
highest cell count per minute (CPM) of the treated cells and the lowest CPM of the
untreated cell, which is usually reflected in higher stimulation index. For both Con
A and LPS as well as P. ag the cell number which gave maximum CPM with low
background and blastogenesis was 105 cells well"1 (Figure 3.9a). This represents a
final cell concentration of 5 x 105 cells ml"1 and was used throughout the assay.
3.9.3.2 Mitogen and Pasteurella Antigen Concentrations
Triplicate cultures were set up as above using an arbitrary cell
concentration of 2 x 105 in 20 pi volumes. A range of concentrations of Con A, LPS
and P. ag were titrated against the cell. A triplicate control consisting of cell culture
without mitogen or antigen added was also set up. Figure 3.9b and c shows that the
optimal concentration as determined by CPM and SI for Con A was 0.5 pg well"1,
representing a final concentration of 2.5 pg ml1; for LPS was 15 pg well"1 or 75 pg
ml-1 final dilution and, for P. ag was 10 pg well1 representing a final concentration
of 50 pg ml"1.
3.9.3.3 Time Curve
The time of optimal blastogenesis in an equilibrated system was
determined by setting up cultures for Con A, LPS and P. ag in quadruplicate. Six
plates were used per mitogen or antigen and one each harvested and counted daily
as already described. From Figure 3.9d the 72 hour (3 days) culture gave the best
CPM and SI for all the systems, hence 72 hours was chosen as the optimal culture
duration.
3.9.3.4 Trypanosome Concentration and Survival
To determine the optimal survival time of trypanosomes in culture
without daily changes of culture medium, a range of parasite concentrations from
1.25 x 105 ml-1 to 8 x 106 ml"1 were set up in culture and counted daily. Each
concentration was used to set up cultures in 12 wells in a total culture medium
volume of 200 pis. Two wells of each dilution were washed out with 1 ml of culture
medium daily and counted. Table 3.3 shows that parasite survival time was
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maximal at a concentration of 5 x 105 ml1.
Table 3.3 Parasite concentrations and numbers surviving daily over 6 days
of culture without daily change of culture medium
Parasite numbers (xlO5 ml1)
Days 0
1.25 1.3 1.25 1.00 0.50 0.02 0.001
2.50 2.55 2.50 1.75 0.75 0.02 0.001
5.00 5.15 5.18 4.50 1.20 0.04 0.001
10.0 8.20 6.00 2.90 0.80 0.002 0
20.0 12.50 5.51 2.10 0.40 0.002 0
40.0 14.45 3.10 0.55 0.10 0 0
80.0 20.15 2.00 1.01 0.001 0 0
3.9.4 Test Culture Systems
The above optimised in vilro system was used to study the proliferative
responses of PBLs from sheep infected with T. evansi and also vaccinated against
Pasteurella or had been infected and treated with a trypanocidal drug. Cells were
also taken from non-infected, Pasteurella vaccinated sheep. In addition, cells from
these categories of sheep were taken and selectively depleted of CD8+ cells and
monocytes as already described and used in the culture system. The purified cells
were then used to set up cultures in triplicates as described in Appendix 111(5) as
follows:
For animals with active infection and/or vaccinated against Pasteurella
1. Medium alone (200 pis)
2. Cells + medium
3. Cells + Con A
4. Cells + Con A + Trypanosomal antigen (T. ag)
5. Cells + LPS
6. Cells + LPS + T. ag.
(200 pis)
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7. Cells + P. ag
8. Cells + P. ag + T. ag
9. Cells + T. ag.
10. Con A or LPS + T. ag.
For cell depletion cultures
1. Cells + medium
2. Cells depleted of monocytes + Con A or LPS
3. Cells depleted of CD8+ cells + Con A or LPS or P. ag or T. ag
4. Cells depleted of CD8+ cells and monocytes + Con A or LPS
5. Non depleted cells + Con A or LPS or P. ag or T. ag
The results were presented either as counts per minute (CPM) or as
stimulation indices (SI).
CHAPTER FOUR




The examination of peripheral blood leucocyte subset demographics along
with parasite-specific antibody responses is an approach which might lead to a
better understanding of the complex immunological events involved in determining
trypanotolerance or trypanosusceptibility. This is because lymphocytes,
continuously enter and exit lymphoid and nonlymphoid organs using the blood as a
traffic route, with a mean transit time of approximately 30 hours (Westermann and
Pabst, 1990). This means that roughly 5x 10'1 lymphocytes travel through the
blood each day (Matsuda, Uchida and Kariyone, 1985; Pabst, 1988). Since this
number is about the same as the entire lymphocytes within the system
(Westermann and Pabst, 1990), the study of the dynamics and alterations in their
phenotypes in the blood could provide useful information on the immunological
status of the lymphoid system in general and on how they affect humoral responses
during disease.
T. congolcnsc infections in cattle and sheep are associated with dramatic
changes in the dynamics of expression of various lymphocyte subsets in the
periperhal blood (Ellis et al., 1987; Mwangi, 1991; Williams et al., 1991) as well as in
the skin, afferent and efferent lymph and lymph node draining the site of infection
with metacyclic forms of T. congolense (Mwangi et al., 1990; 1991). Some of these
lymphocyte subsets, such as CD4+ and CD8+ T cells, synthesise cytokines which in
normal immunological responses enhance the proliferation and differentiation of B
cells into specific antibody producing plasma cells (Kierszenbaum and Sztein, 1990;
Pentreath, 1991). It is likely therefore, that alterations in the various T cell subsets
resulting in an altered balance in lymphokine production (Sileghem et al., 1989a)
may underlie immunological aberrations in B cell function and failure to produce
sterilising specific antibody isotypes during tiypanosome infections.
The following experiments determine the dynamics of expression of
various lymphocyte phenotypes in the peripheral blood during the course of
trypanosome infection in sheep infected with a clone of T. euansi together with
changes in routine haematology, clinical parameters and parasite specific antibody
responses.
4.2 Materials and Methods
4.2.1 Experimental Animals and Trypanosome Infection
Eight yearling Finnish Landrace sheep of either sex were used in this
study. Each sheep was infected by i.v. inoculation of 2 x 106 bloodstream
trypomastigotes of T. evansiTREU 2143.
4.2.2 Experimental Design











736 (female) Day -13 to Day 0 By By microELISA
744 (female) weekly indirect
767 (male) immuno¬
944 (female) Day 1 to Day 61 fluorescence
945 (male) twice weekly and flow
948 (female) cytometiy
950 (male) Day 62 to Day 99
764 (female) weekly
4.2.3 Clinical and Parasitological Parameters
The routine clinical parameters: body temperature, PCV, eiythrocyte
counts, total and differential leucocyte counts, and monitoring of parasitaemia were
carried out as described in Section 3.3. The absolute numbers of the lymphocytes,
neutrophils, monocytes and eosinophils were based on the product of the total
leucocyte counts and their percentages out of 2000 cells counted in Giemsa stained
thin blood film preparations.
4.2.4 Analysis of Lymphocyte Subsets
This was done by single colour indirect immunofluorescence staining of
purified PBLs using a panel of 9 mAbs and a polyclonal F[ab'] rabbit anti-sheep
(RAS) Ig followed by flow cytometry. The protocols for PBL isolation and staining
have been detailed in Sections 3.4 and 3.5.3 respectively. Similarly, the
characteristics of the mAbs and conjugates used have been itemised in Tables 3.1a
and 3.1b. The results are presented as proportions of 10,000 cells analysed by flow
cytometry and their absolute numbers per ml of peripheral blood computed on the
basis of their proportions and the absolute numbers of the lymphocytes.
4.2.5 Assay of Parasite-Specific Antibody Responses
The IgGj and IgM responses during the course of T. eixinsi TREU 2143
infection in sheep were assayed in a microELISA technique as described in Section
3.8.4. Results were quantified photometrically using a microELISA minireader
(Dynatech) at a wavelength of 450 nm and recorded as optical densities (O.D.).
4.3 Results
Two sheep, 950 and 764, selfcured at days 50 and 54 p.i. respectively and
also showed similar trends in their responses. On this basis, some data are
presented to show the responses of two groups. Group A comprises sheep, 736,
4 1.00
a
FIGURE 4.1 Mean changes in temperature, erythrocyte counts and packed cell
volumes (PCV) in T. evansi infected sheep. Sheep in group B
underwent selfcure on days 50 and 54 p.i. respectively
(a) Mean temperatures + S.D.
(b) Mean erythrocyte counts + S.D.
(c) Mean PCV ± S.D.
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744, 767, 944, 945 and 948 which remained parasitaemic until treated and showed
similar trends in their responses, while group B is made up of sheep 950 and 764
which required no drug therapy. The group A sheep were treated by i.v. injection of
10 mg kg-1 NaganolR (Suramin, Bayer) on day 62 p.i, which failed to clear the
parasites and was thus followed on day 74 p.i. by deep i.m. injection of AntiycideR
(Quinapyramine sulphate, B. Vet. C) at 5 mg kg1 body weight. Confirmation of
selfcure by group B and eventual drug cure in group A was based on the failure of
mice subinoculated with blood samples to develop infection after 30 days of
observation. The pooled data for all eight sheep are compared with values for day
seven before infection by Student's paired t-test (Appendix v).
4.3.1 Clinical Assessment and Analysis of Routine Haematology
Infection was chronic in nature and characterised by low and frequently
ciyptic parasitaemias detected mostly by the microhaematocrit centrifugation
technique. On only one occasion each in sheep 944, 948 and 950 on day 8, 13 and
18 p.i. respectively, was parasitaemia detected by the wet blood smear method.
Despite this however, parasitaemia remained detectable in both groups by HCT until
either selfcure or drug therapy. The onset of parasitaemia ranged from 8-15 days
p.i. (Table 4.2). There were varying increases in the mean body temperature which
fluctuated throughout the course of the infection but showed significant increases
for the six sheep which remained parasitaemic (p < 0.001) by day 15 p.i. when
compared with values 7 days prior to infection (Figure 4.1a). During the first four
weeks of infection, the mean erythrocyte count of the six sheep showed a significant
decrease (p < 0.01) from a preinfection mean of 11.2 x 106 ml"1 to 8.8 x 106 ml-1 by
day 19 p.i. (Figure 4.1b). After day 29 p.i., although the erythrocyte counts
remained below preinfection values until after drug treatment, they did not differ
significantly (p > 0.05) from preinfection values. The mean PCV values for the six
sheep also decreased significantly (p < 0.001) from a preinfection value of 31 percent
to 22 percent by day 12 p.i. in the six sheep which were persistently infected,
remaining throughout the course of the infection at or below 26 percent (Figure
4.1c). It is noteworthy however that in the two sheep which selfcured, apart from a
decrease in erythrocyte count from a preinfection mean of 11.2 x 106 ml"1 to
9.6 x 106 ml-1 and 9.4 x 106 ml"1 on days 15 and 19 p.i. respectively, the mean
erythrocyte counts remained within preinfection levels and in fact showed marked
increases between days 22-40 p.i. (Figure 4.1b). Following selfcure, the mean
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FIGURE 4.2 Changes in total and differential leucocyte counts in T. evansi
infected sheep
Group B sheep selfcured on days 50 and 54 post infection.
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erythrocyte counts of the group again rose above preinfection levels between days 61
to 78 p.i. There was no obvious change in mean PCV values (Figure 4.1c).
Table 4.2 Days and methods of detection of first parasitaemia in sheep
infected intravenously with T. evansi TREU 2143. HCT =
microhaematocrit centrifugation technique; WM = Wet blood mount;









736 Day 12 HCT No
744 " 9 HCT No
767 " 11 HCT No
944
" 9 WM No
945 " 10 HCT No
948 " 9 HCT No
764 " 15 HCT Yes/54
950 « 14 HCT Yes/50
A transient initial decrease in the mean TWBC count of group B was
followed by significant increases (p < 0.05) from preinfection levels by day 22 p.i.
(Figure 4.2a). This rise was paralleled by a significant (p < 0.001) steady rise in the
mean proportion (Figure 4.2b) and numbers (Table 4.3) of the lymphocytes and a
steady decrease in the mean proportions and numbers of neutrophils (Figure 4.2c;
Table 4.3). Eosinophil levels decreased significantly (p <0.001) by day 8 p.i. and
remained below preinfection levels throughout the course of the infection while there
was an initial insignificant (p > 0.05) rise in the mean proportion of the monocytes
between day one and 12 p.i. (Figure 4.2d and 4.2e respectively). Thereafter, the
proportions remained within preinfection levels throughout infection.
It is also noteworthy that in the two animals which selfcured, although the
initial decrease in mean TWBC counts between days one and 15 p.i. was greater, the
counts thereafter remained slightly below preinfection levels until day 43 p.i. when
they rose. Irrespective of this, there was an apparent pattern of triphasic
proportional lymphocytosis (Figure 4.2b) which was paralleled by phases of
neutropaenia (Figure 4.2c). In absolute terms however, these phases did not
represent overt increases or decreases in the number of lymphocytes and
neutrophils (Table 4.3). As in group A, there was a steady decrease in the mean
proportions of the eosinophils from day one p.i. and although there were occasional
slight increases, the level remained below the preinfection means (Figure 4.2d). In
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Table 4.3 Mean absolute numbers (x 106 ml-1) of differential leucocyte counts
in sheep infected with T. evansi TREU 2143. Group B selfcured.
Lymphocytes Neutrophils Eosinophils Monocytes
Day Group A Group B Group A Group B Group A Group B Group A Group B
-13 4.8 4.0 2.7 2.7 0.30 0.30 0.25 0.25
- 6 5.0 4.3 2.7 2.7 0.35 0.35 0.25 0.25
1 4.7 4.2 2.1 3.1 0.10 0.40 0.30 0.30
5 4.8 3.2 2.0 2.4 0.04 0.20 0.30 0.10
8 5.1 3.5 2.0 1.7 0.10 0.20 0.40 0.20
12 5.3 3.2 2.0 1.4 0.04 0.02 0.20 0.10
15 6.7 3.2 1.9 1.1 0.04 0.04 0.30 0.10
19 6.6 3.8 1.5 1.0 0.05 0.10 0.20 0.20
22 9.3 4.9 2.2 2.5 0.06 0.10 0.30 0.20
26 9.2 4.5 2.2 1.2 0.06 0.10 0.30 0.10
29 8.8 4.5 1.7 1.2 0.05 0.10 0.20 0.20
33 9.9 4.6 1.8 1.0 0.02 0.03 0.20 0.10
36 8.4 4.1 1.4 1.7 0.10 0.10 0.20 0.10
40 9.7 3.5 1.4 1.6 0.07 0.10 0.20 0.10
43 10.4 4.7 2.0 2.5 0.13 0.10 0.40 0.40
47 10.3 4.5 2.0 2.0 0.14 0.03 0.30 0.20
50 10.4 4.8 2.1 1.8 0.05 0.10 0.30 0.10
54 11.1 6.5 2.3 2.4 0.07 0.05 0.40 0.20
57 10.1 4.8 1.7 1.4 0.12 0.10 0.30 0.10
61 10.2 4.8 1.7 1.5 0.20 0.10 0.20 0.10
69 9.6 4.2 1.6 1.5 0.06 0.10 0.30 0.20
78 9.6 5.2 1.6 2.7 0.20 0.04 0.30 0.20
85 8.3 4.8 2.4 2.1 0.40 0.10 0.30 0.20
92 8.0 3.9 2.3 2.6 0.30 0.10 0.30 0.20
99 6.3 4.4 2.3 2.8 0.10 0.20 0.20 0.20
FIGURE 4.4 Sequential changes in the mean proportions of T cell phenotypes in
PBLs of T. evansi infected sheep (Mean + S.D.)
(a) CD5+ T cells
(b) CD4+ T cells
(c) CD8+ T cells
(d) 78 T cells
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contrast to group A, the mean proportions of the monocytes decreased below
preinfection levels (Figure 4.2e).
4.3.2 Analysis of Lymphocyte Phenotypes
Infection with T. evansi TREU 2143 produced marked alterations in the
various lymphocyte phenotypes. Representative FACS frequency histograms
illustrating these changes in one animal which selfcured and one which remained
infected until treated with a trypanocidal drug are shown in Figure 4.3.
4.3.2.1 Changes in T Cell Phenotypes
Graphical representations of the sequential changes in the various T cell
phenotypes in the two groups are shown in Figure 4.4. In group A infection was
followed by an initially significant decrease (p < 0.05)in the mean proportions of
CD5+, CD4+ and CD8+ cells by day 5 p.i. when compared with preinfection values,
with slight recoveries which ranged variously between day 8 and 19 p.i. (Figures
4.4a, b and c respectively). Similarly, there was a significant steady decrease
(p < 0.001; days 5, 15, 22, 40) in the mean proportion of 78 T cells decreased steadily
(Figure 4.4d). By day 22 p.i., the mean proportions of all T cell phenotypes in group
A had shown significant (p < 0.001) decreases from preinfection levels, remaining so
until after drug therapy. There was no significant change over time in the mean
CD4:CD8 ratio in this group (Table 4.4a) despite the decreases in their proportions.
This is because of a similar trend in the rate of decrease in the proportions and
numbers of these cell phenotypes. The decrease in the mean proportion of CD5+
cells, unlike that of other T cell subsets did not result in concurrent decrease in the
mean numbers (Table 4.4b).
It is of interest to note that the mean proportions of CD5+, CD4+ and
CD8+ phenotypes of the two sheep which selfcured showed initial increases between
days 8 to 19 and that thereafter those of CD5+ and CD4+ cells remained slightly
below preinfection levels and until selfcure when they steadily increased to well
above preinfection levels (Figures 4.4a,.b; 4.3a, b). In contrast, the mean
proportions of CD8+ cells in these two sheep following the initial slight increase,
decreased well below preinfection values and remained so throughout the course of
the infection (Figure 4.3c; 4.4c). Thus the CD4:CD8 ratio in the two animals showed
a marked increase from days 22 to 78 (Table 4.4a) as a result of the greater decrease
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FIGURE 4.3 (a) FACS frequency histograms showing redutions in CD5"1 T cells
in the peripheral blood of sheep infected with T. euam i TREU
2143. Profiles in column A are those of sheep 95C which
selfcured while those in column B are those of sheep 945
which remained parasitaemic until treated. Note the aiarked
reduction in sheep 945 and the minimal reduction in sheep
950. Day 78 is the same as two weeks after treatment for
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FIGURE 4.3 (b) FACS frequency histograms showing changes in PEL CD4+ T
cells in sheep infected with T evansi TREU 2143. Profiles in
column A = sheep 950 (selfcured); column B = sheep 945
(parasitaemic until treated). Decreases were more marked in
945 than 950.
FIGURE 4.3 (c) FACS frequency histograms of changes in peripheral blood
CD8+ T cells in sheep infected with T. evaixsi TREU 2143.
column A = sheep 950: column B = sheep 945.
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FIGURE 4.3 (d) FACS frequency histograms of peripheral blood y8 T cell
changes in sheep infected with T. evansi TREU 2143. column
A - 950; column B = 945.
FIGURE 4.3 (e) FACS profiles showing changes in slg+ cells in sheep infected
with T. evansiTREU 2143. column A = sheep 950; column B =
sheep 945. Dotted lines represent negative control profiles.
A B
FIGURE 4.3 (f) FACS frequency histograms showing changes in CD45R+ cells
in sheep infected with T. evansi TREU 2143. A = sheep 950; B
= sheep 945. Note that increases were more in sheep 945
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FIGURE 4.3 (g) FACS frequency histograms showing changes in CD1+ cells in
peripheral blood of sheep infected with T. evansi TREU 2143.
A = sheep 950; B = sheep 945. Dotted lines represent profiles
of negative control samples.
FIGURE 4.3 (h) FACS profiles showing changes in MHC Class II+ cells in
peripheral blood of sheep infected with T. evansi TREIJ 2143.
A = sheep 950; B = sheep 945. Much higher increases were
seen in sheep 945. Dotted lines represent prfiles of negative
control samples.
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Table 4.4a The CD4:CD8 ratios in sheep infected with
T. evansi TREU 2143. Group B animals
selfcured. The ratios were calculated from
the mean proportions of cells reactive with
each monoclonal antibody.
CD4:CD8

























Table 4.4b Mean absolute numbers (x 106 ml1) of CD5+, CD4+, CD8+ and y5 T
cells In sheep infected with T. evansi TREU 2143. Group B animals
selfcured 50 and 54 days after the infection.
CD5 CD4 CD8 y8 T cell
Day Group A Group B Group A Group B Group A Group B Group A Group B
-13 2.4 2.2 1.1 0.9 0.7 0.7 0.4 0.4
- 6 2.5 2.3 1.1 0.9 0.7 0.7 0.4 0.4
5 1.8 1.5 0.9 0.8 0.5 0.4 0.3 0.2
8 2.1 1.8 1.1 1.2 0.6 0.5 0.2 0.2
12 2.5 1.6 1.2 1.0 0.8 0.6 0.4 0.2
15 2.8 1.8 1.3 0.9 1.0 0.5 0.2 0.1
19 2.3 1.5 1.0 0.8 0.9 0.6 0.2 0.1
22 3.0 1.8 1.2 1.0 0.6 0.4 0.1 0.2
26 2.7 2.4 0.7 0.8 0.6 0.5 0.2 0.1
29 2.1 2.3 0.8 0.9 0.5 0.5 0.1 0.1
33 2.3 2.1 0.8 0.9 0.6 0.3 0.2 0.1
36 2.3 1.6 0.7 0.7 0.4 0.3 0.2 0.1
40 2.3 1.7 0.6 0.6 0.5 0.2 0.2 0.1
43 2.3 2.2 0.8 0.9 0.6 0.4 0.2 0.1
47 2.4 2.0 0.9 1.0 0.7 0.4 0.4 0.2
50 2.7 2.5 0.7 1.0 0.5 0.4 0.2 0.1
54 2.6 2.8 0.8 1.3 0.6 0.5 0.2 0.1
57 2.4 1.9 1.1 0.8 0.7 0.4 0.2 0.1
61 2.6 2.2 0.9 1.1 0.6 0.5 0.2 0.1
69 3.1 2.2 1.7 1.3 0.7 0.7 0.2 0.2
78 3.2 3.1 1.3 1.8 0.6 0.7 0.3 0.3
85 2.6 2.7 0.8 1.3 0.5 0.7 0.2 0.2
92 3.1 2.4 1.0 1.1 0.7 0.7 0.2 0.1
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Table 4.5 Mean absolute numbers (x 106 ml"1) of slg+, CD45R+, CD1+ and MHC
Class II+ cells in sheep infected with T. evansi TREU 2143. Group B
sheep selfcured 50 and 54 days after the infection.
slg CD45R CD1 MHC II
Day Group A Group B Group A Group B Group A Group B Group A Group B
-13 2.4 1.7 2.6 1.9 3.1 2.1 2.7 2.7
- 6 2.7 1.9 2.7 2.0 3.3 2.4 2.6 2.6
5 2.9 1.7 2.3 1.1 2.8 1.9 3.0 1.8
8 2.3 1.7 2.3 0.8 3.0 1.6 3.3 1.4
12 2.8 1.1 3.3 1.2 3.6 1.2 3.5 1.4
15 4.0 1.1 4.4 1.3 4.1 1.4 4.5 1.3
19 4.0 1.9 4.4 1.9 4.3 2.5 4.3 2.0
22 6.0 3.4 6.4 2.9 6.6 3.1 7.2 3.5
26 6.9 3.3 5.6 2.8 7.2 3.3 7.2 3.5
29 7.0 3.3 7.1 3.6 7.1 3.6 7.7 3.8
33 7.7 3.5 7.3 2.9 7.9 3.7 8.2 3.9
36 6.6 3.0 6.5 3.0 6.4 3.0 6.9 3.0
40 7.6 1.9 7.9 2.7 7.7 2.8 8.1 3.0
43 8.1 3.2 8.0 3.0 8.3 3.1 8.4 3.0
47 7.6 2.8 8.1 3.3 8.4 3.2 9.0 3.6
50 8.1 3.4 7.9 3.1 8.3 3.4 8.5 3.4
54 8.4 4.4 8.4 3.8 8.7 4.7 9.1 4.2
57 7.1 3.2 7.7 3.2 7.9 3.3 8.2 3.2
61 7.2 2.8 6.4 2.1 7.9 2.8 7.8 2.7
69 6.8 2.5 7.6 2.5 6.3 2.2 8.2 2.3
78 6.2 2.4 6.2 2.4 6.0 2.9 7.4 3.2
85 6.1 2.2 6.1 2.5 5.2 2.6 6.5 2.9



























Mean numbers (x 106 ml*1) of cells positive for MHC Class I
and the leucocyte common antigen (CD45) in sheep infected with
T. evansi TREU 2143. Group B sheep selfcured by day 50 and 54
postinfection.
MHC I



















































FIGURE 4.5 Sequential changes in the (Mean + S.D.) proportions of SIg+ CD45R+,
CD1+ and MHC Class II+ cells in PBLs of T. evarxsi infected sheep.
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4.3.2.2 Changes in Circulating B Cells
Changes in B cell kinetics were monitored by the quantitation of slg+ cells
using F(ab') RAS serum and by the use of mAb 20-96 (SBU-LCA p220) to determine
CD45R+ B cells and SBU-T6 (CD1) which stains peripheral blood B cells.
In group A. there were no significant changes (p > 0.05) in the mean
proportions (Figure 4.5a, b and c) and numbers (Table 4.5) of slg+, CD45R+ and
CD1+ cells until approximately day 22 p.i. when there were significant increases
(p < 0.01) in the proportions of cells reactive with each of the antibodies. At this
time, the mean numbers of slg+, CD45R+ and CD1+ cells had more than doubled,
increasing to more than three times the preinfection levels by day 54 p.i. (Table 4.5)
and remaining high even four weeks after tiypanocidal drug intervention.
In group B, there was an initial decrease in the proportion of slg+,
CD45R+ and CD1+ cells up to day 15 p.i. (Figure 4.5a, b and c respectively). The
proportions increased gradually between days 19 to 36 for slg+ cells, 12 to 47 for
CD45R+ cells and 15 to 40 for CD1+ cells. Thereafter, they gradually returned to
preinfection levels and by day 61 p.i. the proportions were similar to preinfection
levels. The increase in absolute numbers of cells reactive with each of the
antibodies was moderate, barely reaching twice preinfection levels (Table 4.5). By
day 61 p.i. they had all returned to preinfection levels.
4.3.2.3 Changes in Major Histocompatibility Complex and
Leucocyte Common Antigen Expression
Changes in the number of MHC Class I+ and CD45+ cells mirrored the
changes observed in total leucocyte counts (Appendix v, see also Table 4.6). The
mean values for all eight sheep showed significant increases (p < 0.001, day 22,40)
over time in both the proportions and numbers of cells expressing MHC Class II
antigen (Appendix v, see also Figure 4.5d; Table 4.5).
4.3.3 Parasite-Specific Serum Antibody Responses
In the six sheep which remained persistently infected until treated,there
was a 4-fold increase in serum IgM antibody levels 8 days after the infection and a
steady rise was maintained throughout the infection to a 7-fold increase by day 61
p.i. (Figure 4.6). After treatment there was a gradual decline in the IgM antibody
level although remaining high at 6-fold preinfection levels even 5 weeks after
trypanocidal drug therapy. There was a 2-5-fold increase in the IgGj antibody
response in group A which also showed a steady increase until day 43 p.i. It then
plateaued between days 43 to 61 p.i. (Figure 4.6), rose again after treatment before
beginning to decline.
On the contrary, both the IgM and IgG] antibody responses were
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FIGURE 4.6 Parasite-specific serum antibody responses in sheep infected with T.
evanst Group B sheep underwent selfcure.
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response had risen by 5 times preinfection levels, continuing to rise until it peaked
at 7 times preinfection levels by day 26 p.i. It then dropped slightly by day 29 p.i.
before rising to maximum second peak of 9-fold increase by 36 days after the
infection. Thereafter, there was a steady decline to the level of the first peak of 7-
fold increase by day 50 p.i. and then a third peak which plateaued at 8-fold
preinfection levels between days 61 to 78 p.i. before beginning to decline again
(Figure 4.6). The IgGj antibody response was slower, but there was a steady
increase so that by 47 days after infection there was a 7-fold increase, peaking at an
8-fold increase by day 69 p.i. and then slowly declining (Figure 4.6).
4.4 Discussion
T. evansi produces a chronic infection in sheep which precipitates changes
in the cellularity and dynamics of expression of various lymphocyte subsets in the
blood; the degree of these changes seems to correlate with the ability of the animals
to control the parasites.
There was a wide variation in the prepatent periods (p.p.p.) observed from
8 to 15 days p.i. Such variations in p.p.p. have been observed in sheep infected
with T. congolense and were attributed to variations in the virulence of the
metacyclic inocula used which were derived from different culture cocktails (Mwangi,
1991). However, since similar numbers of the same clone of T. evansi passaged in
immunosuppressed mice were used in this study, it is possible that the variations in
p.p.p. observed in this case may have arisen instead, from differences in individual
animals' immune response. In fact, the p.p.p. was longer (14 and 15 days
respectively) in the two sheep which eventually selfcured. Similar examples of
prolonged p.p.p. have been observed in T. congolense infected N'dama cattle which
eventually selfcured in contrast to infected Boran cattle which required drug
intervention (Williams et al, 1991). The parasitaemia observed in the sheep was
very low and frequently cryptic. Such low parasitaemias and infrequent detection of
parasites in the blood often characterise T. evansi infections and have been observed
in rabbits (Luckins et at, 1978), goats and sheep (Boid et al., 1981) with natural and
experimental T. evansi infections. Despite the low parasitaemias, there were
decreases in the PCV and erythrocyte counts which were indicative of anaemia.
Death in trypanosomosis is usually a result of severe anaemia and animals which
are able to stem the reduction in the PCV and erythrocyte indices during the course
of the infection often survive. Although the reduction in PCV and erythrocyte counts
was not severe, the fact that the sheep which showed lesser decreases and even
occasional increases in their PCV and erythrocyte, were able to selfcure, suggests
the potential importance of the maintenance of normal PCV and erythrocyte levels in
the ability of infected animals to control the infection and survive.
There was an initial reduction in the TWBC counts followed in by large
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increases after the onset of parasitaemia. This sequence is in agreement with
previous reports in which an early leucopaenic phase, usually corresponding to the
onset of parasitaemia, is followed by persistent leucocytosis in cattle and sheep
experimentally infected with T. congolense (Fiennes et al, 1946; Naylor, 1971;
Wellde et al, 1974; Valli and Mills, 1980; Ellis et al., 1987; Mwangi, 1991; Williams
et al, 1991). The leucocytosis was a result of marked lymphocytosis since both the
proportions and numbers of neutrophils decreased irrespective of the increase in
TWBC. Lymphocytosis is a prominent feature of rodent trypanosomosis where it is
associated with polyclonal expansion of circulating B cells (Mansfield, 1978;
Mansfield and Bagasra, 1978) and has also been observed in trypanosome infections
in cattle and sheep (Ellis et al, 1987; Mwangi, 1991; Williams et al, 1991). Only
moderate increases in the TWBC was observed in the two sheep which selfcured and
although there were marked increases in the proportion of their lymphocytes, in
absolute numbers, they represented marginal increases. Such observations were
also made in sheep infected with metacyclic T. congolense where animals in which
no increase in TWBC occurred were better able to control infection (Mwangi, 1991).
Flow cytometric analysis of peripheral blood leucocytes in animals infected
with T. congolense showed that marked alterations occurred in the proportions and
numbers of various lymphocyte subsets (Ellis et al, 1987; Mwangi, 1991; Williams
et al, 1991). Similar changes were seen in sheep infected with T. evansi.
Although all sheep showed significant changes in their lymphocyte subsets, there
were apparent differences in the magnitude of the changes in the dynamics of the
major T cell phenotypes and circulating B cells between those sheep which selfcured
and those that remained persistently parasitaemic. While the proportions of CD4+,
CD8+ and y5 T cell phenotypes were reduced in in all sheep, the degree of the
reduction in CD8+ and y5 T cells was more in the selfcured sheep, resulting in an
increasing CD4:CD8 ratio. The reduction of CD8+ cells and the maintenance of the
level of CD4+ cells in these selfcure animals may have accounted partly for the
better control of parasitaemia and eventual selfcure seen in them. This is because
such responses in the CD4+ and CD8+ subsets could subsequently enhance the
helper activity of the CD4 phenotype and ensure a proper regulation of B cell
proliferation and switch from IgM to IgG synthesising cells through its cytokine
activity. Similar observations have been made in N'dama and Boran cattle infected
with T. congolense. While the CD4+, CD8+ and y8 T cell subsets were depleted in
Boran cattle which had to be treated to avoid death, only the CD8+ subpopulation
was depleted in the N'dama, all of which eventually selfcured (Williams et al, 1991).
Moreover, it has been shown in rats infected with T. brucei that the in vivo depletion
of CD8+ cells using specific anti-CD8 mAb resulted in the abrogation of IFN-y
production, suppression of parasite growth and prolonged survival of the rats
(Bakhiet et al, 1990). The TH2 subset of CD4+ T cells, which is a potent B cell
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activator and provider of antigen-specific help to B cells, is strongly inhibited by IFN-
y (Mosmann and Moore, 1991). IFN-y is a product of CD8+ cells and the TH1 subset
of CD4+ cells. Hypothetically, it is possible that in these selfcure sheep, the
reduction in CD8+ cells enhanced the TH2 action which in turn may have
potentiated its provision of specific help to B cells by producing IL-10. IL-10 actively
inhibits cytokine release by TH1 (Mosmann and Moore, 1991).
The decrease in the proportions of the CD5+ cells did not result in a
decrease in the absolute numbers of this subpopulation. A number of reasons could
possibly account for this. One simple explanation is that the drop in the
proportions of CD5+ cells is merely a reflection of the large increase in the
proportion and numbers of B cells. However, the absolute numbers of CD4+, CD8+
and y5 T cells decreased, though to a relatively lesser extent in comparison to the
decreases observed in their respective proportions. Nevertheless, reductions in
these three phenotypes no matter how minor, should ideally be reflected in the
numbers of CD5+ cells since they are all positive for the CD5 antigen. Hence,
although it was not investigated, it is tempting to speculate that the absolute
numbers of CD5+ cells may have remained unchanged because they had possibly
been added to by increased numbers of the B cell population expressing the CD5
antigen after the infection. This speculation derives support from recent reports
that there is a considerable increase in the proportion and numbers of CD5+ B cells
in cattle infected with T. congolense (Williams et al., 1991).
Analysis of the slg+, CD45R+ and CD1+ cells revealed significant
increases in the dynamics of B cells in all the sheep. While there was more than 3-
fold increase of B cells in the sheep which remained persistently infected until
treated, the increase in the two that selfcured was only 2-fold. Moreover, the
increase in the latter sheep was biphasic with the second peak coinciding with the
period of parasite control and selfcure. Increases in circulating B cells are a
prominent feature of tiypanosome infections (Labohm, 1982). In cattle and sheep
infected with T. congolense, large increases in circulating B cells were reported as
the infection progressed (Mwangi, 1991; Williams et ai, 1991). However, Ellis et al
(1987) were unable to demonstrate such increases in circulating B cells in cattle
infected with T. congolense, although this may have been a result of the short
duration of their experiment, which lasted for only 21 days. In the present work,
significant increases in circulating B cells commenced by approximately day 22 p.i.
and this finding corroborates the work of Mwangi (1991) and Williams et at. (1991)
in which increases were observed to commence on days 25 and 21 p.i. respectively.
It is interesting that the findings by Mwangi (1991) in sheep, were similar
to those of Williams et al. (1991) in cattle similarly infected with T. congolense and
even more important that the observations made with T. evansi in sheep in this
study parallel both their findings. The significance of this is that sheep which are
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easily available and easier to handle, can therefore serve as an appropriate
experimental model for the study of various trypanosome species despite criticisms
that they are better studied in their various natural hosts.
Although the presence of higher levels of circulating B cells has been
suggested as a possible reason for the ability of N'dama cattle to control T.
congolense infection (Ellis et al, 1987), the results of this study suggest that this
may not depend simply on increasing B cell numbers per se, but probably on the
rate and pattern of B cell proliferation and its interaction with the pattern of CD4+
and CD8+ T cell responses in relation to the isotype specificity and affinity of the
antibodies produced.
Increases in the proportion and numbers of cells expressing the MHC
Class II antigen in all sheep showed similar trends to those of the circulating B cells.
High levels of MHC Class II antigen expression has been reported in cattle and sheep
infected with T. congolense (Ellis et ai, 1987; Mwangi et al, 1990; 1991; Mwangi,
1991). Such increases in MHC Class II expression may be a reflection of the
increases in circulating B cells which express the Class II antigens constitutively
(Singer and Hodes, 1983; Hopkins et al, 1986; Lalor et al, 1986; Emery et al,
1987). However, MHC Class II antigen is also expressed by activated T cells (Singer
and Hodes, 1983) and can thus also be an important indicator of the state of
activation of T cells and therefore of utility in assessing the T cell responses to
parasites (Ellis etal, 1987).
The microELISA results for T. evansi-specific antibody responses showed
that both IgM and IgGj antibodies were produced during the course of the infection.
This is generally similar to reports from both naturally and experimentally induced
trypanosome infections. For example, natural or experimental infection of cattle
with T. brucei, T. congolense or T. vivax resulted in increases in the serum IgM and
IgG antibody levels of up to 2-10 times and 2 times preinfection levels respectively
(Luckins, 1972; 1976). Similarly, in sheep naturally infected with T. congolense
alone or with a mixture of T. congolense and T. vivax, and in those experimentally
infected with T. brucei or T. congolense (Mackenzie, Boyt and Nesham, 1979), there
were significant increases in both the IgM and IgG antibody levels during the course
of the infection.
However, it might be necessary to point out that whereas these similarities
occur, there are fundamental differences between the present study and those of the
aforecited authors. Whilst this study was concerned with parasite-specific antibody
responses, the earlier authors assayed pathological increases in serum antibody
responses without selection for their parasite specificity. More significant is that the
findings of this study are very similar to those reported in experimental infection of
cattle and goats with clones of T. vivax which resulted in high titres of parasite-
specific serum IgM and IgGj antibodies with the IgGj antibody response appearing
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at levels comparable with IgM antibody 4 days later than the IgM response (Vos and
Gardiner, 1990). However, the increase in serum IgGj observed in our study,
differed from those observed in Zebu cattle infected with T. congolense and T. vivax
in which there was little change in the serum IgG j and IgG2 antibody levels for up to
130 days post infection (Luckins, 1976a). It also differed from those of Houba et al.
(1969) who found no increases in IgG antibody levels in monkeys infected with T.
brucei, T. gambiense and T. rhodesiense. Again these differences may be as a result
of the fact that the authors did not assay for parasite specificity of the IgG isotypes.
Although there were increases in the serum IgM and IgGj antibody levels
in all sheep in this study, there was a definite difference in the pattern of responses
in the two animals which selfcured and those which remained parasitaemic until
treated. The latter animals showed a steady rise in IgM antibody level until
treatment when there was a slow decline, whereas IgG] rose until it plateaued
between days 43-61, rising again above the IgM level only after treatment. On the
other hand, in the former sheep, there were three definite peaks of IgM antibody
response and two of IgG i response with the second peak in both cases exceeding the
first. Moreover, while the IgGj levels showed further increases by day 47 p.i., those
of IgM declined, remaining so until the end of the experiment. Noteworthy is the fact
that this further increase in the level of IgG] isotype response when the IgM level
was declining, coincided with the onset of selfcure and it is tempting to infer that
their ability to eliminate the parasites was a result of this later increase in IgGj
response. In the past, drug intervention has hindered observation of changes in Ig
isotypes associated with selfcure in tiypanosome-infected animals. This is the first
report in which it has been possible to compare the changes in lymphocyte subsets
and Ig isotype responses associated with selfcure. However, the ability of wildebeast
and Zebu cattle to control infection with T. brucei has been linked to a classical
sequence of antibody production and isotype switch from initial high levels of IgM
antibody to subsequent IgG! and IgG2 antibodies (reviewed by Mulla and Rickman,
1988). The secondary increase in IgG! levels in the six sheep which remained
parasitaemic occurred only after drug treatment. This may be as a result of the
release of common antigens from the killed and disintegrating trypanosomes to
which the animals had been sensitised. On the other hand, it could be that the
clearance of the tiypanosomes by trypanocidal therapy effectively removed the
pathological barrier to Ig isotype switching, thus enabling a secondary IgG i response
at a time when IgM level was declining.
It is significant to note that while the pattern of Ig response differed in
these sheep, the two selfcure animals at all time points, showed apparently higher
levels of both IgM and IgG i antibodies than the rest, which suggests depressed or
reduced parasite-specific antibody response in the persistently parasitaemic sheep.
Such reduction in the level of parasite-specific antibody response has been observed
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in rodents infected with T. brucei (Hudson and Terry, 1979; Sacks and Askonas,
1980) and in cattle infected with T. brucei or T. congolense (Nantulya et al., 1982;
Morrison et aL, 1985). Thus while there was apparent persistent
hypergammaglobulinaemia of IgM and IgG] in these persistently parasitaemic group,
it was not enough to effect parasite clearance. In the circumstances, such
differences can only be attributed to the observed differences in the levels and
patterns of expression of CD4+ and CD8+ T cells and on the expansion of the
circulating B cell population. It is paradoxical that while there was significant
increases in the proportions and numbers of circulating B cells in the persistently
parasitaemic animals, their IgM levels still remained below those of the selfcure
sheep. The rapid and uncontrolled expansion of B cells has often been used to
explain the superabundance of IgM in trypanosome infections (Teny et al., 1973;
Urquhart et at., 1973; Murray et al., 1974a) and the presence of heterophile
antibodies (Houba et al, 1969; Klein et al, 1970; Boreham and Facer, 1974;
Mackenzie and Boreham, 1974). Results of this study, apparently argue against B
cell expansion as the main reason for high IgM levels in trypanosome infections
since IgM levels were higher in the selfcure sheep which had smaller increases in B
cells than the rest of the sheep. Note however, that without the accident of having
animals which selfcured and thus the benefit of observing the changes associated
with selfcure, the findings in all sheep would simply have corroborated previous
reports as that of sustained and increasing IgM responses associated with large
increases in circulating B cells. In any case, it may be worth mentioning again that
this study assayed IgM responses against the specific clone of T. evansi which
elicited it, a fact which is not true for the majority of the previous reports of IgM
hypergammaglobulinaemia during tiypanosomosis.
In conclusion, this study has shown that T. evansi infection significantly
alters the dynamics of expression of the major effector lymphocyte subsets in the
peripheral blood which appeared to be associated with the level and trend of
antibody responses to infection. Sheep which maintained normal levels of CD4
expression concurrently with reduced CD8 expression by T cells and had moderate
B cell increases produced sterilising levels of antibody and were able to apparently
switch from IgM to IgGj production. On the other hand, in sheep in which
concurrent reduction in CD4+ and CD8+ T cell subsets was accompanied by marked
increases in circulating B cells, lower parasite-specific antibody level was observed.
Moreover, the animals failed to eliminate the parasites and it seemed that Ig isotype
switch did not occur until after trypanocidal drug treatment.
It is therefore opined that although T cell subsets play no direct role in
tiypanosome killing, it is likely that alterations in their demographics by an ongoing
infection affects the level and pattern of antibody responses and therefore, the
eventual outcome of tiypanosome infection as a disease. Interesting as the findings
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in this experiments may be, speculation on the phenomenon of selfcure during
tiypanosomosis is based on data drawn from only two animals in which the process
occurred. It will therefore be premature to attach too much significance to or draw
far reaching conclusions from the observations so far made. However, the sheep
appears to be a good experimental model for the study of the immunopathology of
pathogenic tiypanosomes and further study of the subject in a much larger
population of sheep will greatly enhance the validity or otherwise of the conclusions
drawn from this study.
This notwithstanding, the effect of T. evansi infection on the various
parameters measured in this study was subjected to statistical analysis using the
Student's t-test. Paired t-test of the preinfection values of all parameters against
those at various time points after the infection showed significant differences
between pre- and post-infection values. Details of the analysis of the pooled data for
all the sheep are presented in appendix five.
CHAPTER FIVE




In T. evansi infection in sheep there are decreases in the relative
proportions of CD5+, CD4+, CD8+ and y8 T cell phenotypes but increases in the
proportions and numbers of circulating B cells. In addition, it emerged that the
degree of these changes especially in the relative proportions of CD4+ and CD8+
cells appeared to affect the pattern and level of parasite-specific IgM and IgG
antibody responses and the ability to control the infection. For instance, in infected
sheep which eventually selfcured, there was little reduction in the proportion of
CD4+ cells while that of CD8+ cells was considerably reduced (Chapter 4).
Moreover, although there were increases in B cell proportions and numbers, they
were higher in the animals which failed to selfcure.
The implication of this is that increases in circulating B cells during
trypanosomosis do not per se result in the production of higher levels of parasite-
specific antibodies capable of controlling the infection. This has remained the
paradox of the immunopathology of tiypanosome infections in general. However, in
T. congolense infection in cattle, similar increases occur in circulating B cells and it
has recently been shown that up to 90 percent of such B cells express the CD5
antigen (Williams et al., 1991). Such B cell populations in human and mouse are
known to produce antibodies which are auto- and polyreactive in action and bind
antigen with low affinity (Hayakawa et al, 1983; 1984; Casali and Notkins, 1989).
If, as in the case of T. congolense infection in cattle, T. evansi also induces expansion
of CD5+ B cell population in infected sheep, then it might explain why these sheep
failed to produce sterilising antibodies despite the increased numbers of B cells.
It is possible that the suppression of immune responses against
heterologous antigens during the course of tiypanosome infection in animals may
also be related to these alterations in the proportions of various effector lymphocyte
phenotypes. Such relationships have been established in various diseases of
animals and man. For instance, infection of sheep with bovine respiratory syncytial
virus (BRSV) results in marked decreases in the proportion of CD5+ and CD4+ T
lymphocytes and is characterised by non-specific immunosuppression resulting in
increased susceptibility to secondary Pasteurella haemolytica infection (Sharma and
Woldehiwet, 1990; 1991b; Sharma et al., 1990). In humans, the increased
susceptibility to secondary infections seen in AIDS patients results in part from the
selective depletion and expansion of the CD4+ and CD8+ T cells respectively (Giorgi
and Detels, 1989). Moreover, activation of the CD8+ T cell phenotype (putative T
suppressor cells) is implicated in the specific suppression of immune responses to
Plasmodiumfalciparum antigens during acute malaria (Riley et al., 1988; 1989).
In the following experiments, the effects of T. evansi infection on the local
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skin reaction and systemic humoral immune responses of sheep to Pasteurella
haemolytica vaccine were studied. The ovine B cell population was also analysed by
two-colour indirect immunofluorescence technique and flow cytometry in order to
establish whether infection with T. evansi induces increased expression of the CD5
antigen on B cells. In addition, the effects of the infection on the dynamics of
expression of the major T cell subsets and the MHC Class II antigen following the
administration of Pasteurella vaccine were studied.
5.2 Materials and Methods
5.2.1 Experimental Animals, Trypanosomes and Infection of Sheep
Suffolk sheep of either sex aged 9 months were purchased from Moredun
Research Institute, Edinburgh and used in this study. None of the animals had
been vaccinated previously against pneumonic pasteurellosis. They were housed
and fed as described in section 3.1. Three of the sheep were infected i.v. with
2 x 106 bloodstream trypomastigotes of T. evansi TREU 2143 as shown in Table 5.1.
5.2.2 Pasteurella vaccine and vaccination procedure
The Pasteurella haemolytica vaccine used in this study, the dosage and
the route of administration have been described in Section 3.8.1. The vaccination
schedule is as shown in Table 5.1.
Table 5.1 Experimental Design
0, r c , , Days after infection when Days of trypanocidalSheep Infection status . , . . , , J, , ,
vaccine was administered drug treatment
Primary dose Booster dose




479 " 28 57 90




* Selfcured, no drug treatment; ** Vaccinated simultaneously with the infected
sheep
5.2.3 Sampling Methods
Blood was collected for serum preparation and isolation of peripheral
blood leucocytes. Samples were obtained once weekly for two weeks prior to
infection and/or vaccination, twice weekly during the week immediately after the
primary and secondary vaccination and once weekly at other times. PBLs for two-
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colour indirect immunofluorescence were isolated by tris-ammonium chloride lysis
as described in Section 3.5.1. Serum for the assay of Pasteurella-speciTic antibodies
was prepared as described in Section 3.8.1. Cytospin smears and thin blood films
for the study of granulocyte responses following infection and vaccination were
prepared as described in Sections 3.5.3 and 3.5.4 respectively.
5.2.4 Local Responses at the Site of Vaccine Administration
Local inflammatory responses at the site of Pasteurella vaccine
administration were assessed visually, by palpation and by the measurement of skin
thickness at the vaccination site. These assessments were facilitated by cleanly
shaving the area of vaccine administration. The skin thickness at the site of
inoculation was measured daily with a pair of vernier calipers for up to 30 days after
the primary and secondary vaccine administration respectively.
5.2.5 Two-colour Immunofluorescence Staining
The monoclonal antibodies SBU-T1 and VPM 30 (Table 3. la) were used for
the two-colour indirect immunofluorescence staining to assess the responses of
peripheral B cell and CD5+ T cell subsets to Pasteurella vaccine administration and
how prior infection with T. evansi TREU 2143 affected them. SBU-T4, SBU-T8,
SBU-T19 and SBU-II were used to assess the effect of infection on CD4, CD8, y5 T
cell subsets and MHC Class II responses respectively, to Pasteurella vaccine
administration. The staining techniques used are fully described in Section 3.6.3.2
and the method of acquisition and analysis of cell data in Section 3.6.5.
5.2.6 Immunoassay of Pasteurella-SpeciRc Antibodies
Total antibody response as well as isotypic (IgG^, IgG2, IgM) serum Ig
responses to Pasteurella vaccination were assayed using indirect and double-
sandwich microELISA techniques respectively. Results were quantified
photometrically and recorded as optical densities (O.D).
5.3 Results
5.3.1 Parasite Kinetics
Parasitaemia was characteristically scanty, the tiypanosomes first being
detected by HCT on day 9 p.i. in sheep 445 and on day 13 p.i. in sheep 322 and
479. Parasitaemia peaked in all sheep on day 23 p.i. when an average of one
parasite/16 microscope fields was detected in wet blood film preparations. Sheep
322 ceased to show detectable parasitaemia by day 48 p.i. and mice inoculated with
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FIGURE 5.1 Skin thickness after Pasteurella vaccination in T. evansi infected and
uninfected sheep.
Sheep 316 and 522 =






it was concluded that this sheep had undergone selfcure 48 days after infection.
Sheep 445 and 479 remained parasitaemic until after they were treated on day 90
p.i. with 5 mg kg1 of Cymelarsan (Mel Cy). Mouse inoculation with blood collected
from these sheep 7 days after treatment showed that the single injection of Mel Cy
was sufficient to clear the parasites.
5.3.2 Responses to Pasteurella Vaccine Administration
5.3.2.1 Local Primary Responses
Primaiy inoculation of control sheep 316 and 522 with Pasteurella
haemolytica vaccine elicited classical local inflammatory responses represented by
swelling, erythema, warmth and tenderness upon touch within the first three days
of vaccination. However, in sheep 322, 445 and 479 all of which had been infected
with T. evansi TREU 2143 28 days previously, this response was largely suppressed.
The active inflammatory response was also accompanied, 3 days after vaccination,
by a painless induration and thickening of the skin at the site of vaccination. In the
uninfected sheep there was up to an 8-fold increase in the skin thickness compared
with only a 3-fold increase in the infected animals (Figure 5.1). This painless skin
induration generally abated by day 14 p.v. and by day 23 p.v. the skin had returned
to prevaccination thickness. There was no tissue destruction and sloughing-off at
the site of vaccination.
5.3.2.2 Local Secondary Responses
Following secondary (booster dose) administration of Pasteurella
haemolytica vaccine, the inflammatory response was not as acute as in the primary
response. In the uninfected sheep, the erythematous skin induration appeared in
the form of a plaque reminiscent of a delayed type hypersensitivity reaction two days
post booster dose (p.b.) administration, peaked between days 3 to 8 p.b. and by day
19 p.b. had receeded to pre-vaccination levels (Figure 5.1). This secondary response
was anamnestic in that there was up to an 11-fold increase in skin thickness from
pre-vaccination level of 3 mm to 35.6 mm on day 5 p.b. in sheep 522. In the
infected animals, sheep 445 and 479 showed no differences in the thickness in
response to primary and secondary vaccine administration (Figure 5.1). In contrast,
sheep 322 which subsequently selfcured responded anamnestically as the
uninfected controls, with up to a 7-fold increase in its skin thickness following
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FIGURE 5.2 Serum antibody responses to Pastcwclla vaccine in T. cvansi infected and
uninfected sheep.
Sheep 316 and 522 = Uninfected/vaccinated
Sheep 445 and 479 = Infected/vaccinated/drug cured
Sheep 322 = Infected/vaccinated/selfcured
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5.3.2.3 Systemic Leucocytic Responses
Plates 5.2a-d are representative photographs of point cytospin
preparations of sheep PBLs following primary Pasteurella vaccine administration.
Primary vaccination was accompanied by early systemic mobilisation of neutrophils
in both control sheep (Plate 5.1a). This response was absent in the infected animals
(Plate 5.1b) but was replaced by persistent lymphocytic leucocytosis orchestrated by
the trypanosome infection. Seven days after vaccination, the neutrophilia of the
control animals had receeded and was replaced by a mixture of lymphoblasts, small
lymphocytes and neutrophils (Plate 5.2c). In contrast, in the infected sheep, there
was continuing lymphocytic leucocytosis, comprising mainly blastoid cells (Plate
5. Id).
Following booster vaccination, the response in the control animals was
characterised largely by the presence of both lymphocytes and neutrophils. Sheep
445 and 479 on the other hand, continued to show lymphocytic response, but a
similar response to that seen in the controls was observed in sheep 322.
5.3.2.4 Pasteurella-Specific Serum Antibody Responses
The Pasteurella-specific serum antibody responses were assayed in both
indirect and double-sandwich microELISA techniques. Evaluation of whole IgG
responses following primaiy and secondary Pasteurella vaccination showed that
Pasteurella-specific antibody was detectable one week after vaccination in the
uninfected sheep. This peaked between 2 and 3 weeks p.v. and was still
considerably high 4 weeks p.v. at the time of secondaiy vaccine administration.
Following booster vaccination there was a slight secondary response although this
was not much higher than the primaiy response, probably due to the relatively short
duration between the primary and booster dose administrations. However, eight
weeks after booster inoculation when the experiment was terminated, the serum
antibody level of these animals was still high (Figure 5.2). In contrast, in the serum
of the infected sheep 445 and 479, antibody response to both primary and
secondaiy vaccine administration was severely suppressed (Figure 5.2). On the
other hand, in sheep 322 which selfcured, whilst the primaiy serum anti-Pasteurella
antibody response was severely suppressed there was considerable secondaiy
response even though the level of antibody was not as high as those of the control
animals.
A panel of 3 mAbs was used in a double-sandwich ELISA to evaluate the
Pasteurella-specific IgGl, IgG2 and IgM isotype responses after primary and
secondary inoculation with Pasteurella vaccine. The predominant isotype produced
in response to both challenges was IgGl. In the control sheep, IgGl response
PLATE 5.1 Systemic leucocytic responses to Pasteurella vaccination in T. evansi
infected and uninfected sheep.
a) Presence of strong neutrophilic response after primary
vaccination in normal sheep.
b) Absence of neutrophilic response after primary vaccination in
infected sheep.
c) A mixture of lymphoblasts, small lymphocytes and neutrophils
7 days after primary vaccination in normal sheep.
d) Persistent lymphocytic blast response 7 days after primary
vaccination in infected sheep.
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FIGURE 5.3 Isotype specific serum antibody responses to Pasteurella vaccination in T.
evansi infected and uninfected sheep.
(a) IgGl; (b) IgG2; (c) IgM.
Sheep 316 and 522 = Uninfected/vaccinated controls
Sheep 445 and 479 = Infected/vaccinated/drug cured
Sheep 322 = Infected/vaccinated/selfcured
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peaked at two weeks p.v. and 3 weeks p.b. with the secondaiy response being higher
than the primary (Figure 5.3a). A similar response was also seen in their IgG2
responses although only very low serum level of this antibody isotype was produced
(Figure 5.3b). IgM antibodies did not show a biphasic response but rose
considerably during the four weeks after primary vaccination and steadily dropped,
even after the secondary booster (Figure 5.3c). In the infected sheep 445 and 479,
the primary IgGl response as well as the secondary responses were severely
suppressed (Figure 5.3a). In contrast, while sheep 322 showed a depressed primary
response, on booster vaccination, an enhanced secondary IgGl response was
observed, even though the level did not reach those of sheep 316 and 522. The IgG2
response differed in three infected sheep. Primary IgG2 response was suppressed in
both sheep 322 and 479 whereas sheep 445 showed a continuous rise in the level
until one week after boosting when it peaked at a level even higher than in the
uninfected animals and rapidly declined thereafter (Figure 5.3b). The secondary
response to booster dose administration remained suppressed in sheep 479 while
322 showed a considerable secondary response. The IgM response of sheep 322 was
similar to those of the uninfected group. However, both 445 and 479 showed a
steady rise in serum IgM levels after both primary and secondary vaccination until
after trypanocidal drug treatment when the level rapidly declined (Figure 5.3c).
5.3,3 Lymphocyte Subsets in Response to Infection and/or Vaccination
5.3.3.1 Alterations in B Lymphocytes
In the uninfected sheep, there was only slight increases in the proportion
and number of circulating B cells following primary and secondary Pasteurella
vaccine administration (Table 5.2f; Figure 5.5). This is in contrast with the situation
in the infected animals. In agreement with findings in Chapter 4, infection resulted
in increases in cells positive for VPM 30 mAb (B cells). Following primary and
secondary vaccinations, there were more than 2-fold increases in the proportion of
circulating B cells in sheep 445 and 479 and this high level was maintained even 4
weeks after trypanocidal drug therapy (Table 5.2f; Figure 5.5). Sheep 322, which
eventually selfcured had higher levels of circulating B cells than 445 and 479 prior
to infection and vaccination. Following infection and vaccination, the increase in
circulating B cells was relatively small in comparison to sheep 445 and 479 (Table
5.21).
5.3.3.2 CD5+ B Cell Expression
Two-colour indirect immunofluorescence staining using biotinylated VPM
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FIGURE 5.4 CD5+ B cells in sheep after infection and/or Pasteurella vaccination.











peripheral blood B cells bore the CD5 antigen prior to infection with T. evansi
and/or exposure to primaiy and secondary Pasteurella vaccination. Following
vaccine administration, there was a slight increase in the proportion of CD5+ B cells
in the uninfected sheep from a pre-vaccination level of 8.9 and 10.9 percent to 16.9
and 17.8 percent three days p.v. in sheep 316 and 522 respectively. By the second
week after vaccination, the levels of B cells expressing the CD5 antigen was 14.9
and 15.5 percent respectively. After the animals were boosted the maximum
proportion of CD5+ B cells did not exceed 18.7 percent (Figure 5.4).
In contrast, there were marked increases in the proportion and number of
CD5+ B cells in the infected sheep both after T. evansi infection (data not shown)
and following vaccine administration (Figure 5.4). During primary vaccination,
whilst all infected animals showed further rises in CD5+ B cells, it was higher (up to
70 percent) in sheep 445 and 479 than sheep 322 which selfcured (Figure 5.4). In
these two animals, the proportion of CD5+ B cells was beginning to drop by day 28
p.v., but then rose again following boosting to over 50 percent. In contrast, sheep
322 maintained a steady decline in the proportion of CD5+ B cells even after the
booster dose admninistration, and by day 5 p.b. the levels had become similar to
those of the uninfected control sheep (Figure 5.4). Figure 5.5 shows representative
FACS contour profiles of sheep 316 and 445 to illustrate the changes in CD5+ B
cells following T. evansi infection and/or primaiy and secondary Pasteurella
haemolytica vaccine administration.
5.3.3.3 Alterations in MHC Class II antigen expression
Table 5.2g shows that the kinetics of MHC Class II expression in all
animals was similar to those shown by B cells. Control animals showed moderate
increases while increases in MHC Class II+ cells of up to three times pre-infection
levels were produced two weeks after primary vaccination in infected sheep.
5.3.3.4 Alterations in T Cell Subsets
The kinetics of the various T cell phenotypes following primary and
secondary vaccine administrations differed in the uninfected and infected groups of
sheep. In the control sheep, vaccination was accompanied by an initial slight
decrease in the proportion of CD5+ T cells. Subsequently, within two weeks of
vaccine inoculation, the proportion of CD5+ cells had returned to prevaccination
levels or shown some increases (Table 5.2a). CD4+ cells on the other hand,
increased above prevaccination levels at all time points (Table 5.2b). In contrast,
CD8+ cells decreased after primary vaccine challenge, but following secondary
administration of the vaccine, the proportions returned to prevaccination levels
FIGURE 5.5 Representative FACS contour profiles showing increase in CD5+ B
cells in peripheral blood of sheep infected with T. evansi TREU 2143.
Profiles in panel A are derived from the uninfected/vaccinated sheep
316 while those in panel B are from sheep 445 which was infected
and vaccinated.
In all case : Quandrant 1 = B cell population
Quadrant 2 = CD5+ B cell population
Quadrant 3 = non T/non B cell population
Quadrant 4 = CD5+ T cell population
Note the progressive decrease in CD5+ T cells in the infected sheep
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(Table 5.2c). Thus, an increase was observed in the ratio of CD4:CD8 expression as
a result (Table 5.2d). There was no definite trend in the expression of 78 T cells in
these animals but it generally remained within prevaccination levels (Table 5.2e).
In the infected group there were decreases in the proportions of all T cell
subsets following infection and this persisted after the vaccine administration.
Despite the increases in CD5+ B cells, the total proportions of CD5+ T cells still
decreased in the infected sheep. This decrease was less marked in sheep 322. For
instance, the proportion of CD5+ cells in the infected sheep 445 and 479 decreased
from a pre-infection mean of 67.8 percent to 34.4 and 37.5 percent in the second
week following primary and secondary vaccine inoculations respectively (Table 5.2a;
Figure 5.5). In contrast, only a 12 and 14 percent decrease from a pre-infection
value of 46 percent to 34 and 32 percent respectively were seen during the same
periods in sheep 322 (Table 5.2a). Similarly, there was a greater decrease in CD4+
cells in sheep 445 and 479 than in sheep 322 (Table 5.2b) but the decreases in
CD8+ and 78 T cells were similar in all three sheep (Table 5.2c, d).
5.4 Discussion
It is apparent that primary and secondary cellular and humoral immune
responses to inoculation with Pasteurella haemolytica serotype A1 vaccine were
suppressed in sheep infected with T. evansL Both cellular and humoral immune
responses are required for effective protective immunity against pneumonic
pasteurellosis (Confer et al., 1988). Cellular immunity involves the mobilisation of
neutrophils and cells of the monocyte/macrophage lineage which ingest and kill
opsonised Pasteurella organisms. It has been shown that factors which impair this
mobilisation usually result in hypersusceptibility to pasteurellosis (Noel et al., 1988).
It was clearly shown in the present study, that T. evansi inhibited systemic
mobilisation of neutrophils and local erythematous skin response in infected sheep
and that the sheep subsequently failed to produce significant levels of anti-
Pasteurella antibody. It is not clear how T. evansi infection inhibited the local
erythematous induration at the site of vaccination or the systemic mobilisation of
neutrophils observed in the control sheep. However, since the secondary responses
were partially restored in sheep 322 which had selfcured by the time of the
secondary vaccine inoculation, active infection is a necessary condition for the
suppression. Suppression of cell-mediated DTH response to PPD associated with
active trypanosome infection has been reported in rabbits and rats infected with T.
congolense and T. brucei respectively (Mansfield and Wallace, 1974; Mackenzie,
Sibley and White, 1979). Moreover, both the formation of a local erythematous
induration at the site of vaccine administration and systemic mobilisation of
Table 5.2 Changes in the proportions of peripheral blood leucocyte
subsets in sheep infected with T. evansi and/or inoculated
with P. haemolytica vaccine.
Sheep 316 and 522
Sheep 322
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(a) CD5+ cells (%)
Weeks 316 522 322 445 479
-2 51.8 44.3 41.4 64.4 71.2
-1 50.5 42.9 46.1 64.7 71.8
Primary vaccination
1 48.7 41.6 30.9 45.9 42.8
2 55.9 44.6 34.4 38.8 30.1
3 59.6 47.2 39.4 45.4 50.6
4 56.6 47.0 46.3 44.3 59.7
Secondar y vaccination
1 50.4 44.4 34.8 40.9 53.6
2 64.3 45.4 32.2 36.3 38.7
3 65.5 49.0 40.6 44.4 55.6
4 60.3 44.2 37.6 55.8 53.9
Trypanocida I drug treatmei it
2 52.2 41.7 41.8 46.8 52.3
4 54.9 42.6 43.2 58.3 58.6










































































(c) CD8+ cells (%)
Weeks 316 522 322 445 479
-2 18.2 13.7 16.5 15.1 17.8
-1 18.0 13.5 15.2 14.9 18.4
Primary vaccination
1 18.6 9.3 8.1 9.7 7.7
2 16.2 8.6 8.1 6.7 7.0
3 16.4 12.6 8.6 7.7 8.9
4 14.7 11.6 9.1 9.7 10.7
Secondai y vaccination
1 18.5 13.7 9.6 7.8 11.0
2 19.3 13.6 7.4 6.7 7.8
3 20.7 16.5 9.4 12.3 17.0
4 19.0 14.6 7.9 8.4 11.9
Trypanocida drug treatme; it
2 17.3 13.1 13.7 8.5 13.1





























































(e) yd T cells (%)
Weeks 316 522 322 445 479
-2 9.4 7.4 9.8 7.2 11.7
-1 8.2 6.2 9.3 8.8 11.0
Primary vaccination
1 8.6 8.2 3.7 4.0 5.1
2 8.0 7.5 4.1 2.5 4.7
3 9.2 6.3 5.3 2.8 3.6
4 12.8 5.7 5.7 3.2 5.0
Secondai y vaccination
1 9.9 7.7 3.9 2.0 4.9
2 10.3 7.8 4.2 2.4 6.2
3 9.1 6.1 4.3 6.9 6.5
4 8.9 8.6 4.2 5.6 6.9
Tiypanocida drug treatme: at
2 10.7 7.0 7.3 3.6 9.7
4 10.4 8.2 5.8 6.5 8.8
109
(f) VPM 30+ cells (%)
Weeks 316 522 322 445 479
-2 40.7 39.5 45.9 25.9 26.0
-1 32.7 40.7 47.5 26.9 21.4
Primaiy vaccination
1 38.5 42.6 63.6 62.8 523.5
2 40.0 47.1 66.0 68.2 60.5
3 44.8 46.6 57.3 62.2 54.3
4 42.7 45.2 59.6 60.5 48.4
Secondai y vaccination
1 43.1 46.4 56.6 53.1 43.8
2 40.1 44.2 56.9 57.7 58.4
3 44.2 48.2 61.1 50.2 58.8
4 45.3 42.7 57.5 59.4 51.9
Trypanocida drug treatme; it
2 33.2 49.7 48.2 56.0 47.5
4 35.8 49.5 53.7 47.4 48.5
(g) MHC II+ cells (%)
Weeks 316 522 322 445 479
-2 41.7 50.6 45.8 24.4 41.3
-1 37.8 51.2 47.4 26.8 39.1
Primaiy vaccination
1 45.3 57.1 66.3 68.6 67.0
2 47.0 56.0 72.4 76.0 70.3
3 55.0 58.8 68.2 70.1 70.0
4 44.7 50.8 69.3 63.3 60.3
Secondai y vaccination
1 44.8 53.2 61.3 50.1 53.5
2 41.4 54.2 67.4 40.6 67.2
3 42.4 51.9 63.9 44.6 58.7
4 52.1 60.3 66.3 61.0 69.1
Trypanocida I drug treatme] it
2 52.8 55.1 62.7 60.5 57.3
8 49.9 51.9 60.4 47.4 48.5
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neutrophils, require the production of the cytokines granulocyte-macrophage
colony-stimulating factor (GM-CSF) and IL-3. Both of these act on the bone marrow
for the mobilisation and maturation of inflammatory cells (Stadnyk and Gauldie,
1991). These cytokines are products of CD4+ and CD8+ T cells (Mosmann and
Moore, 1991), both of which were markedly reduced in proportion by the T. evansi
infection. Thus, it is possible that the suppressed local skin response and systemic
neutrophilic responses to the vaccine in the infected/immunised sheep may in part
have resulted from a reduced level of cytokine release by these T cell phenotypes.
The assay for Pasteurella-specific antibody responses showed that in the
uninfected control sheep IgGl antibody was the predominant antibody produced.
This is in agreement with previous reports in which IgG 1 antibody was shown to be
the most important antibody class mediating protection in pasteurellosis (Donachie
et al, 1986; O'Brien and Duffus, 1987; Mosier et al., 1989; Nelson and Frank,
1989). In contrast, in sheep with a 28-day old T. evansi infection, both primary and
secondary humoral responses to Pasteurella vaccine were suppressed and this
suppression particularly affected IgGl levels. There are virtually no studies of T.
evansi induced suppression of immune responses to vaccine antigens in livestock
except for that of Shien (1979), in which the humoral antibody response to Brucella
abortus S-19 vaccinations in goats infected with T. evansi was found to be
significantly suppressed. That report, in addition to the present study, shows that
T. evansi is capable of inducing generalised immunosuppression similar to that
induced by the tsetse transmitted trypanosomoses.
The IgG2 response in sheep 445 was unusual since it was higher than
that observed in the other infected sheep as well as the uninfected sheep. In mice,
IgG2 production by B cells is mediated by the TH1 subset of the CD4+ T cells
through its synthesis of IFN-y (Snapper and Paul, 1987; Coffman et al, 1988).
Moreover, IFN-y on the other hand suppresses the production of IgGl by B cells
through its potent inhibition of Th2 proliferation and growth (ColTman and Carty,
1986; Mosmann and Moore, 1991). Sheep 445 had relatively the highest
parasitaemia of all the infected sheep. Since increased parasitaemia is associated
with increased levels of IFN-y and activation of macrophages (Bancroft et al, 1983;
Grosskinsky et al, 1983; Bakhiet et al, 1990), it is possible that the higher IgG2
response may have resulted from higher IFN-y production by CD4+ and CD8+ T cell
subsets.
Although IgM antibody was detected in all 5 sheep following primary
vaccine administration its importance as an anti-Pasteurella antibody is not clear. It
has been shown that low levels of IgM are detected following exposure to Pasteurella
antigen but it does not play any major role as a specific protective anti-Pasteurella
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antibody (O'Brien and Duffus, 1987; Mosier et ai, 1989) and therefore has no major
role in resistance against the disease. It is noteworthy that there was no difference
in the IgM response in all 5 sheep following primary exposure to the vaccine and
that while the level steadily declined, even after boosting, in 316 and 522 as well as
in 322 which selfcured, it continued to rise in sheep 445 and 479 until after
trypanocidal drug treatment. Moreover, the results revealed that much higher IgM
antibody levels were already detectable in the serum collected from these animals
following tiypanosome infection and prior to administration of the Pasteurella
vaccine. This means that not all the IgM produced in infected/vaccinated sheep
could have been elicited specifically by the vaccine antigen. This is not entirely
surprising since tiypanosome infections are known to induce an IgM hyper-
gammaglobulinaemia resulting in production of heterophile antibodies which react
with a variety of other antigens (Henderson-Begg, 1946; Houba, Brown and Allison,
1969; reviewed in Parratt and Herbert, 1979).
In the control sheep, alterations in T cell subsets were relatively minor
and involved an initial transient drop in CD5+ cells. This drop was a reflection of
the increase in the percentage of circulating neutrophils during that period which
also resulted in a transient decrease in the relative proportion of circulating
lymphocytes. The slight rise observed subsequently in the proportion of CD5+ cells
did not result from increased expression of CD5+ B cells since the proportion of this
B cell population after vaccination did not differ from the prevaccination values. In
addition, a marginal increase in CD4:CD8 ratio in the control sheep following
vaccination occurred as a result of a slight increase in CD4+ cells. This differs from
the rises seen in infected, selfcured sheep in which the increase occurred as a result
of a greater reduction in the proportion of the CD8+ cells. However, regardless of
the manner of this increase, results of the tiypanosome- and Pasteurella-specific
antibody assays conducted in these experiments seem to indicate that a higher
proportion of CD4+ cells, no matter how marginal, is necessaiy for a more effective
specific antibody response against the tiypanosomal and Pasteurella antigens.
In the infected animals, infection resulted in decreases in the proportions
of all the T cell subsets similar to those described in Chapter 4. Decreases in the
percentage of CD5+ T cells did not result in decreases in the absolute number of
cells expressing this antigen. This was accounted for by the expansion in the
number of CD5+ B cells. After vaccination however, the CD5+ T cells decreased
dramatically both in proportions and absolute numbers despite the increase in
CD5+ B cell proportion and numbers. It is not clear why vaccination exacerbated
the selective depletion of the CD5+ T cell subset in the two infected sheep (445 and
479). One possible reason could be the massive expansion in the B cell population.
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However, the two-colour immunofluorescence staining of B cells and T cells for CD5
antigen clearly showed that infection and vaccination resulted in progressive
reduction in the proportion of CD5+ T cells, in line with the decrease in the
percentage of other T cell phenotypes. Hypothetically, it is possible that vaccination
of the infected animals resulted in a hyperactivation of mature T cells which drove
them to lose their surface antigens. Several studies have produced evidence that
CD3, CD4 and CD8 antigens may be lost from mature human and murine T cells
upon activation in vitro (Bensussan et al, 1985; Cantrell, Davies and Crumpton,
1985; Hoxie et al., 1986; Isakov et al, 1987; Takada and Engleman, 1987; Weyand,
Goronzy and Fathman, 1987). Moreover, in vivo as well as in vitro, activation of
mature peripheral T cells in sheep results in the loss of the CD5 antigen (Hopkins
and Dutia, 1989). However, the loss of surface antigen expression per se does not
account for the terminal decrease in the number of circulating T lymphocytes, and
the accompanying immunological malfunction. It has been suggested that single
positive mature T cells shift to a transient double positive state upon activation
(Blue et al, 1985). Co-expression of CD4 and CD8 (double positive, DP) is
characteristic of immature thymocytes, which mature into single CD4+ or CD8+ T
cells or are eliminated prior to leaving the thymus (Blackman, Kappler and Marrack,
1990). Outside the thymic environment cells exhibiting immature characteristics
are eliminated by a normal physiological process known as programmed cell death
or apoptosis (Ameisen and Capron, 1991; Young, 1992). If tiypanosome infection
induces T cells to co-express the CD4 and CD8 antigens upon activation, or to
mobilise immature CD4+CD8+ cells from the thymus, then it might prime them for
destruction by apoptosis. This could explain the reduction in the proportion of
circulating T cells. However this hypothesis is speculative and was not investigated
further. The decrease in peripheral T cell proportions may well have arisen from
their depletion in the T cell dependent areas in the lymphoid organs. In
longstanding trypanosome infections in cattle the paracortical areas of the lymph
nodes become depleted of cells (Morrison and Murray, 1979). Similarly, the T cell-
dependent areas of lymph nodes draining local skin reactions at site of metacyclic T.
congolense infection in sheep are depleted of small lymphocytes (Mwangi et al,
1991). Moreover, the large reductions in the proportions of T cell phenotyes is also
partly a reflection of the marked B cell lymphocytosis observed in the infected
animals.
Analysis of B cells in the infected sheep revealed large increases in the
proportions and numbers of circulating B cells in sheep 445 and 479. This increase
was partly due to the considerable increase in the CD5+ B cell population which
appeared early in infection and persisted after vaccination. The underlying
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mechanisms behind the T. euansi-induced increase in CD5+ B cells is not clear.
However, similar increases in CD5+ B cells have been reported in cattle Infected with
T. congolense where between 49-90 of B cells express the CD5 antigen by day 19 p.i.
(Williams et al., 1991). Moreover, infection of mice with T. cruzi also led to the
expansion of CD5+ B cells. These cells were implicated in the generation of
immunoglobulins that were non-restrictive, did not recognise specific parasite
antigens and reacted with self components instead (Minoprio et al, 1988; 1989a, b;
Spinella et al., 1990; Minoprio, 1991). Increases in CD5+ B cells have also been
reported in other chronic diseases presenting with disorders of the immune system.
For instance, this B cell phenotype is increased in cattle infected with bovine
leukaemia virus (Depelchin et al, 1989), in human patients sulfering from
rheumatoid arthritis (Burastero et al, 1988) and systemic lupus erythmatosus
(Casali et al, 1987; 1989) and in autoimmune mice (Hayakawa et al, 1983). It
would appear that the production of high levels of non-specific IgM observed in
tiypanosome infection is a result of the expanded CD5+ B cell population since this
cell phenotype is known to produce poly-reactive, low affinity IgM (Casali and
Notkins, 1989). In the course of trypanosome infection, the persistence of CD5+ B
cells and their action is compounded by the marked reduction in the proportion of
CD4+ and CD8+ cells. Thus antigen-specific help by CD4+ cells to conventional B
cells is compromosed as well as the regulation of immune responses by CD8+ cells.
However, since these reductions in CD4+ and CD8+ T cells were minimal in terms of
their absolute numbers, it is probable that other mechanisms also operate to
undermine the immune competence of infected animals. In any case, that these
alterations in the proportions of various cell phenotypes account, at least in part, for
the failure of infected animals to mount an efficient immunological response to the
vaccine antigen or even to the parasite antigens is supported by the response of the
selfcured sheep. For instance, there was a minor rise in both the conventional B
cells and in CD5+ B cells in sheep 322 which selfcured. This animal, as well as
others which selfcured, showed alterations in the proportions of their CD5+, CD4+
and CD8+ cells such that an increase in the CD4:CD8 ratio was observed. The net
result of this was that not only did they rid themselves of the trypanosome infection,
but sheep 322 was also able to respond to secondary Pasteurella vaccine
administration at a level which approximated those of the uninfected control sheep.
These results also showed that the proportionate reduction in T cell subsets and
increased mobilisation of conventional B cells and CD5+ B cell population was not
simply an index of lymphocyte activation by antigen since they were not precipitated
by primary and booster Pasteurella vaccinations in the control sheep.
CHAPTER SIX




Sheep infected with T. evansi show considerable alterations in the
proportions of circulating lymphocytes in the peripheral blood, in particular,
pronounced increases in B cells, decreases in T cell phenotypes and increased
expression of the CD5 antigen on B cells (Chapters 4 and 5). It is likely that these
changes play a key role in compromising the defence mechanisms of infected
animals against both the invading parasites and other heterologous antigens.
However, the blood is only a part of the mammalian lymphoid system and although
it serves as a traffic route for circulating lymphocytes, immunological events
occurring in it may not reflect the cellular changes taking place immediately upon
the introduction of an antigen via the intradermal or subcutaneous portal of entry.
It is the nature of early interaction between the pathogen and hosts effector cells
which determine the outcome of the infection. Ineffectual responses result in
disease whilst strong responses render the pathogen innocuous. Such early local
changes in individual cell populations or expression of immunologically important
cell surface molecules are best studied by chronically cannulating lymphatic ducts
draining the site of infection and collecting lymph from the fully conscious animal.
It is then possible to assess whether cellular changes such as occur in the blood
also occur in the lymphatic system of infected animals and to determine the
immunological implications.
A number of studies conducted in sheep have shown that the early
immunological events occurring in lymph nodes draining sites of antigen deposition
and inflammatory lesions are reflected by the cell content of the efferent lymph
draining that node (Trnka and Cahill, 1980; Hopkins, Dutia and McConnell, 1986;
Bujdoso et at, 1989). For instance, the cellular composition of efferent lymph
draining unstimulated lymph nodes is entirely of small lymphocytes, consisting of
approximately 30 percent B cells and 70 percent T cells (Hopkins et al, 1985).
However, following an antigenic stimulus, the cell content and composition changes,
resulting in an increased output of small lymphocytes and lymphoblasts and in
some circumstances may include a mixture of erythrocytes and granulocytes (Hall
and Morris, 1962; 1965a, b; McColgan, Buxton and Miller, 1987; Kerlin and
Watson, 1987; Huang et ai. 1991; Mwangi, 1991). Moreover, the changes in
cellular composition is also accompanied by kinetic changes in the expression of cell
surface molecules by the efferent lymphocytes. The nature and trend of these
kinetic changes depend on the type of antigenic stimulus. For instance, in sheep,
following stimulation of the node with ovalbumin [OVA] or purified protein derivative
[PPD] of tuberculin, the increased cell output in the draining efferent lymph is
accompanied by an increase in the percentages of CD4+ and CD8+ cells and in T
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cells expressing the MHC Class II antigen (Hopkins et al., 1986; Bujdoso et al,
1989). Similarly, in sheep persistently infected with border disease virus (BDV) or
those infected with the orf virus or Chlamydia psittaci, there is increase in cells
expressing the T cell-associated molecules CD5, CD4, CD8 and T19, and also
increases in cells expressing CD1 and MHC Class II molecules (Huang et al., 1991;
Yirrell etal., 1991; Entrican etal., 1992).
In contrast, in efferent lymph of prefemoral lymph node draining the site
of infection of sheep with culture-derived metacyclic T. congolense, an initial decline
in the various T cell subsets is followed by a transient increase before steadily
declining again; while B cells as well as MHC Class II positive cells show marked
increases (Mwangi, 1991). These findings are similar to observations made in the
peripheral blood leucocyte subsets in cattle and sheep infected with T. congolense or
sheep infected with T. evansi (Ellis et al., 1987; Mwangi, 1991; Williams et al., 1991;
Chapters 4 and 5). Thus, it appears that alterations in lymphocyte subsets
engendered by tiypanosome infections is not restricted, but affects other
compartments of the lymphoid organ system. Since cells leaving the efferent lymph
of an antigen primed lymph node are responsible for the systemic dissemination and
amplification of the local immune response it is important that such primed cells
leave the node expressing their immunologically important effector molecules in
adequate numbers and proportions as are necessaiy for effective immunity.
To investigate further the effects of T. evansi on the immunological events
taking place in infected sheep experiments were conducted to study the cellular
demographics of efferent lymph draining the site of Pasteurella haemolytica vaccine
administration in T. evansi infected sheep.
6.2 Materials and Methods
6.2.1 Animals, Infection and Vaccination
Six, 6-month old Finnish Landrace sheep and two 8-month old Suffolk
sheep were used in this study. All the animals were housed and fed as described in
Section 3.1. Prior to the experiments all the animals tested negative for significant
anti-Pasteurella antibody in an ELISA system. Four of the sheep were infected with
T. evansi as described in Section 3.2.3, 10 or 23 days prior to cannulation (Table
6.1). The sheep were each primed by s.c. injection of a 2 mg dose of Pasteurella
vaccine in the draining area of the prefemoral lymph node on the days specified in
Table 6.1. For the infected sheep this corresponded to 17 days post infection, at
which time they had all become parasitaemic by HCT.
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6.2.2 Surgery and Lymph Collection
The cannulation of the efferent lymphatic duct of the prefemoral lymph
node was according to the technique of Hall and Morris (1965, 1967), and was
briefly described in Section 3.6. In some animals lymph flow ceased before the
secondary vaccination. It was therefore necessary in such animals to cannulate the
contralateral duct for secondary vaccine challenge and data collection. In such
cases, animals were allowed six weeks of recovery before the second operation. All
cannulations were allowed to stabilise for 5 days following surgery before lymph
collection for analytical purposes was begun. Lymph was collected quantitatively as
described in Section 3.6.2. Each collected lymph was processed to obtain volume,
cell count, total cell output and blast cell numbers. Trypanosome numbers in the
lymph were determined using a haemocytometer when possible.
6.2.3 Phenotypic Analysis of Efferent Lymphocytes
Indirect immunofluorescence staining and flow cytometry described in
Sections 3.5.3 and 3.5.2 respectively were used to analyse phenotypic changes in
efferent lymphocytes following i.v. infection of sheep with T. evansi and/or in vivo
stimulation of the lymph node with Pasteurella vaccine. S-T8 and biotinylated SBU-
T4, both visualised as described under 2-colour analysis of cell phenotypes in
Section 3.5.3, were used to monitor the coexpression of CD4 and CD8 antigen on
efferent lymphocytes derived from the primed lymph node. The expression of CD5
antigen on efferent lymph B cells was similarly monitored using the anti-sheep CD5
mAb, SBU-T1 and biotinylated VPM 30 (anti-sheep B cell) mAb. The mAb SBU-II
(anti-sheep MHC Class II) was used with VPM 30-biotin to assay Class II expression
on B cells. In addition y5, CD1, CD45 and MHC Class I expression by the cells was
monitored using SBU-T19, SBU-T6, SBU-LCA and SBU-I mAbs respectively.
6.3 Results
Eight animals, four infected with T. evansi TREU 2143 and four
uninfected controls, were used to study the effects of infection on the cellular
demographics in efferent lymph of the lymph node draining the site of Pasteurella
vaccine administration. Cannulations of the prefemoral efferent duct was successful
in seven sheep but flow of lymph for a sufficiently long period to permit collection of
samples for pre- and post-primaiy and secondary vaccination analysis was
successful in only two infected and two uninfected sheep (Table 6.1). The results
reported here are therefore based on observations made on these four animals.
Because the two infected animals showed similar trends in their responses and also
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FIGURE 6.1 Parasite kinetics in the efferent lymph of sheep infected intravenously
with 2 x 106 T. evansi ml1. Figures represent mean counts per ml of
lymph from two sheep. Two peaks were observed. The first peak was
relatively minor and occurred between days 22 to 24 p.i. when
approximately 3 x 166 parasites ml-1 were detected. The second peak
occurred between days 82 to 86 p.i. when up to 6 x 107 parasites
ml"1 of lymph was detected, a 22-fold increase in parasitosis. This
larger increase may be a reflection of depressed immune competence
of the sheep.
FIGURE 6.2 Daily lymph output in sheep after infection with T. evansi and/or
vaccination with P. haemolytica. Values represent Means + S.D. of
two infected/vaccinated and two uninfected/vaccinated sheep. In the
infected sheep, values for days 8-12 after booster vaccination
represent those of sheep 662 only, while those of days 6-12 in the
uninfected sheep were from sheep 569 only.
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presented as mean values of two infected/vaccinated and two uninfected/vaccinated
sheep.
6.3.1 Parasite Kinetics
Trypanosomes were detectable in the lymph 12 days after the infection.
Two peaks of parasitosis were observed. The first minor peak occurred between
days 22 to 24 p.i. when up to 2.7 x 106 parasites ml1 were counted. A second,
much higher tiypanosome count was observed between days 82 to 86 p.i., when up
to 6 x 107 trypanosomes ml1 were counted (Figure 6.1). At other times, parasitosis
was low or undetectable.
6.3.2 Lymph Output
Lymph output was slightly higher in the infected sheep prior to
vaccination. Following primaiy vaccination, there was increase in lymph output in
both groups of sheep but the output became higher in the uninfected sheep during
the first 4 days post vaccination, p.v. (Figure 6.2). Thereafter, the daily lymph
output became much higher in the infected group. After secondary (booster)
vaccination, increase in lymph output was not as high as during the primary
response in either group until day 8 post booster (p.b.) in the infected group.
Challenge of the uninfected sheep 569 with 2 x 106 trypanosomes on day 7 p.b.
resulted in a decrease in lymph output (Figure 6.2).
6.3.3 Cell Composition and Output
In both groups of sheep, prefemoral efferent lymph contained 95 percent
lymphocytes, 2-3 percent granulocytes and 2-3 percent erythrocytes during the first
3 to 4 days following surgical cannulation of the lymphatic duct. By day 5 post
surgery, the cellular composition had become 100 percent lymphocytic as assessed
by the examination of Giemsa-stained cytospin smears. However, following primary
vaccine inoculation, prefemoral efferent lymph contained 98.5 to 99 percent
lymphocytes and 1 to 1.5 percent granulocytes on day one p.v. Subsequently, the
cell composition was once again entirely lymphocytic.
The cell output in both groups of sheep is shown in Figure 6.3a. Initially,
cell output was higher in the infected sheep. This increased further after primary
vaccination, peaking at 18.1 x 107 cells hr1 by day 8 p.v. (day 25 p.i.). The output
then decreased between days 10 to 13 p.v. (days 27-30 p.i.) before beginning to rise
again. Booster vaccination was not accompanied by further increases but rather,
the cell output steadily declined until day 11 p.b. (day 88 p.i.) when there was again
a marked increase (Figure 6.3a). In the uninfected sheep, primary vaccination was
a
FIGURE 6.3 (a) Total cell output per hour in efferent lymph of sheep after
infection with T. evansi and/or vaccination with P. haemolytica (Mean
+ S.D.). Following primary vaccination, output was higher in
uninfected sheep than the infected ones. A secondary response
occurred in the uninfected sheep while cell output continued to
decline in the infected animals even after booster vaccination. A large
secondary response occurred following a decline in the second peak of
parasitosis (see Figure 6.1).
(b) Hourly output of lymphoblast (Mean + S.D.) in the same
sheep. This largely mirrored the trend in cell output with the
secondary response in infected sheep again occurring after a drop in
the second peak of parasitosis.
In all cases, values for days 6-12 and 8-12 post booster in the










FIGURE 6.4 System 9000 histogram of efferent lymph cell count in sheep after
infection with T. evansi TREU 2143 and/or inoculation with
Pasteurella haemolytica vaccine. Column A = sheep 569
(uninfected/vaccinated) Column B = sheep 669 (infected/vaccinated)
Gate 1 = small Lymphocyte population; Gate 2 - Lymphoblast
population.
Note the decrease in the infected sheep 669 and also in sheep 569
after it was challenged with 2 x 106 T. euonsiTREU 214 3 (Day 11 p.b)
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accompanied by a marked increase in cell output over and above what it was in the
infected sheep, peaking at more than 2-fold prevaccination values on days 4 and 5
p.v. (Figure 6.3a). Thereafter, there was a gradual decline although the cell output
still remained higher than the prevaccination values. Increase following secondary
vaccination was generally less marked, except on day 4 post booster and challenge
of sheep 569 with T. evansi on day 7 p.b. resulted in a sharp decrease in cell output
(Figure 6.3a).
6.3.4 Output of Lymphoblasts
The infected sheep had higher numbers of lymphoblasts than the
uninfected ones prior to vaccination. Following primary vaccination, there was up to
a 2-fold increase which peaked by day 8 p.v. (Figure 6.3b). Thereafter and even after
booster vaccination, lymphoblast numbers decreased until day 11 p.b. when there
was a sharp increase. The increase in the number of lymphoblasts in the uninfected
sheep following primary vaccination was quite dramatic, rising up to an 8-fold
increase by day 3 p.v. (Figure 6.3b). Booster vaccination was accompanied by even
higher increases of up to 14-fold prevaccination values. The challenge of sheep 569
intravenously at day 7 p.b. with 2 x 106 T. evansi resulted in further decrease in the
output of lymphoblasts. Figure 6.4 is a System 9000 automatic cell analyser
printout of frequency histograms of efferent lymph cell counts and shows increases
in the cell and lymphoblast output in sheep 569 and 669.
6.3.5 Phenotypic Analysis of Efferent Lymphocytes
6.3.5.1 T Cell Phenotypes
Prior to vaccination, the number and proportion of CD5+ T cells were
higher in the infected group. Approximately 88 percent, which represents a mean
absolute number of about 20 x 106 cells ml1, were CD5+ (Table 6.2; Figure 6.5a).
Following vaccination, the mean numbers of CD5+ cells showed an initial decrease
but this was followed by partial recovery between days 3 and 4 p.v. (20 and 21 p.i.).
Thereafter, the general trend was that of a continued decline, with a marked
decrease occurring 11 days p.v. Secondary vaccination was followed by a slight
increase during the following week but further marked decreases corresponding with
the period of the second peak of parasitosis had occurred by day 8 after booster
vaccination (Figure 6.5a). The absolute numbers of CD4+ as well as the numbers
and proportions of yd T cells decreased generally (Figure 6.5b, d; Table 6.2). The
decreases in the number of CD4+ cells occurred despite the minor alterations in
their proportion (Table 6.2) and were therefore a reflection of the decreases in total
cell output. Following both primary and booster vaccinations, there was no marked
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Table 6.2 Proportional changes in T cell subsets in efferent lymph of sheep infected with
T. evansi and/or inoculated with P. haemolytica vaccine. Figures are Mean +
S.D. of data from 2 sheep in each group except on days 6-12 and 8-12 post
booster in the uninfected and infected sheep respectively when data was taken
from one animal each.
Days Post CD5 CD4 CDS y5 T cells
Infection Uninfected I nfected Uninfected Infected Uninfected Infected Uninfected Infected
16 75.9+6.1 88.8+0.5 67.7+2.4 55.0+6.5 13.4+2.3 26.1+2.6 6.4+0.6 6.2+0.7
17 76.2+6.4 87.4±2.9 56.4+4.8 51.3+3.5 13.1+3.0 25.0+2.5 6.4+0.7 7.1 + 1.0
Primary Vaccination
18 87.4+6.0 88.9+0.8 65.9+2.5 52.9+6.5 18.3+2.8 29.0+3.5 7.5±0.5 7.0+0.2
19 78.8+8.9 88.6+3.1 58.0+3.5 56.9+7.8 16.2+1.5 32.1+2.7 6.8+0.3 5.9+0.1
20 81.9+8.9 90.1+4.5 59.2+2.7 62.2+5.7 16.7+1.3 32.2+2.1 6.4+0.2 5.4+0.1
21 81.8+8.9 87.8+5.8 59.1+2.4 57.4+5.1 17.3±3.0 34.2+3.6 6.0+0.1 5.1±0.3
22 76.4+7.2 81.5+6.1 57.0+3.2 52.7+2.8 16.4+2.0 31.7+0.4 6.2+0.2 3.9+0.2
23 76.3+6.3 84.1+6.2 57.4+1.2 50.2+5.6 16.0+2.5 34.4±1.8 6.4+1.0 3.3+0.4
24 76.8+8.0 81.6±0.5 55.1±8.5 48.9+2.1 14.9+1.3 33.3+3.5 6.1+0.1 3.1+0.1
25 76.2+6.0 71.2+5.3 54.5+8.1 41.1+0.4 16.5±1.5 29.3±2.8 4.9±0.3 2.6+0.1
26 78.4+5.5 75.6+2.7 56.0+4.8 46.5+3.5 16.9+2.5 31.7+2.6 5.2+1.0 3.0±0.2
27 79.7+9.0 84.2+2.1 56.9+6.1 51.0+2.7 17.7±1.7 32.7+2.8 8.3+1.1 2.8±0.2
28 74.6+7.7 85.7±0.9 57.3+4.7 51.2+5.9 13.5+1.5 35.7±2.8 4.4+0.4 3.6+0.3
29 74.5+6.8 83.3+5.1 55.8±3.5 50.5+5.1 13.8±1.4 29.9±3.5 3.1+0.9 3.1+0.7
30 - 76.9+1.0 - 47.9±2.9 - 31.0+3.9 - 3.6+0.5
31 - 74.8+1.2 - 40.2+3.4 - 26.4±1.7 - 2.5+0.3
Secondary Vaccination
78 79.9+6.0 79.4+4.8 58.6±4.9 48.7+6.0 15.7+1.1 32.7+1.4 4.4+0.2 4.2+0.1
79 75.8+9.9 81.8+2.9 55.4+8.2 49.1+0.3 15.2+1.4 33.1+2.2 5.0+0.2 3.4+0.1
80 77.2±6.5 87.1 + 1.4 53.8+3.6 59.0+4.3 15.6+1.6 33.5±1.2 5.0±1.0 3.7+0.1
81 79.7+6.2 86.7+4.5 57.5+2.6 59.3+5.1 15.9+2.0 26.5+2.4 6.2+0.6 3.7+0.7
82 74.5+5.4 68.9+6.6 53.8+8.2 40.3+3.1 14.1 + 1.4 24.2+0.6 5.0+0.5 3.5+0.5
83 67.9+0.0 78.2+0.4 40.8+0.0 52.8+3.5 11.6+0.0 26.7+3.0 9.3+0.0 2.8+0.8
84 77.5+0.0 80.4+2.9 41.5+0.0 55.2+5.0 11.4+0.0 27.1 + 1.5 14.7+0.0 2.9+0.4
85 75.6+0.0 76.7+0.0 34.3+0.0 51.1+0.0 11.4+0.0 26.8+0.0 8.0+0.0 3.4+0.0
86 59.9+0.0 76.9+0.0 34.5+0.0 51.4+0.0 9.4+0.0 28.9+0.0 6.5+0.0 4.2+0.0
87 73.6+0.0 77.4+0.0 4O.4+0.0 46.8+0.0 11.7+0.0 29.1±0.0 7.1+0.0 3.0+0.0
88 85.8+0.0 79.1+0.0 55.5+0.0 46.6+0.0 11.3+0.0 35.7±0.0 11.6+0.0 2.7+0.0
89 88.1+0.0 68.6+0.0 66.3+0.0 49.5+0.0 13.1+0.0 24.2+0.0 2.6+0.0 2.7+0.0





5 7 9 11 13 1 3 5
DAYS POST VACCINATION
— UKUFECTED — ■ — WCCTtD




-21 3 5 7 9 11 13 ' 1 3 5 7
DAYS POST VACCINATION
— □ — UN^ECTED — ■ — t«CTH>
FIGURE 6.5 T cell subset responses in sheep infected with T. evansi and/or
inoculated with P. haemolytica vaccines. Values represent Mean +
S.D. of two animals in each case except for days 6-12 and 8-12 post
booster in the uninfected and infected sheep respectively when they
represent values derived from one animal each.
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variation in the absolute number of CD8+ T cells until day 11 p.v. and 8 p.b. when
marked decreases were also observed (Figure 6.5c). This was because of the
increases observed in the percentages during those periods (Table 6.2). Thus,
throughout the period of the experiments, the CD4:CD8 ratio decreased and
remained below 2 at most times (Figure 6.5e).
In the uninfected animals about 76 percent of prefemoral efferent
lymphocytes (Table 6.2), representing an approximate mean number of 11 x 106
cells ml'* were CD5+ before priming with Pasteurella vaccine (Figure 6.5a). Both
primary and secondary vaccine administration was accompanied by large increases
in the number of efferent lymphocytes expressing the T cell associated antigens
CD5, CD4, CD8 and y5 surface molecules (Figure 6.5a, b, c and d), even though
their percentages remained largely unchanged or showed only marginal increases
(Table 6.2). Except for CD8+ T cells where the numbers were similar to those of the
infected group, the numbers of CD5+, CD4+ and y5 T cells were more than twice
their corresponding values in the infected group at all time points which again was a
reflection of the large increases in total cell output. Moreover, the CD4:CD8 ratio in
this group was over two times greater than in the infected group (Figure 6.5e).
However, following challenge of sheep 569 with T. evansi on day 7 p.b., all T cell
subsets showed a decrease in their numbers and proportions.
6.3.5.2 B Cell Kinetics
Following T. evansi infection and/or inoculation with Pasteurella vaccine
in sheep, the kinetics of efferent B cells were monitored using VPM 30 (anti-sheep B
cell) and SBU-T6 (anti-sheep CD1 which recognises B cells as well as cortical
thymocytes and Langerhans cells). In the uninfected sheep, primary and secondary
vaccinations were accompanied by marked increases of up to 3-5-fold
prevaccination values in the number of circulating B cells (Figure 6.6a, b). This is
as a result of the increases observed in their proportions (Table 6.3) and also of the
large increases in the cell output following the vaccinations.
In contrast, in infected sheep, although marked increases occurred in the
proportions of CD1+ and VPM 30+ cells after both primary and booster vaccinations
(Table 6.3) there was little variation in their absolute numbers until after days 10
and 7 post-primary and booster vaccinations respectively when there was a marked
decrease as a result of decrease in total cell output (Figure 6.6a, b). Moreover, the
output of B cells was much less in these animals in comparison to the output in the
uninfected control sheep.
121
Table 6.3 B cell kinetics as shown by the percentages of VPM 30+, CD1+ and MHC Class
II+ cells in efferent lymph of sheep infected with T. evansi and/or inoculated
with P. haemolytica vaccine. Figures represent Mean + S.D. of two sheep in
each case except during days 6-12 and 8-12 post booster in the uninfected and
infected sheep respectively when figures were taken from only one sheep each.
Days Post VPM 30 CD1 MHC Class 11
vaccination Uninfected Infected Uninfected Infected Uninfected Infected
-2 19.2+0.4 10.9+1.3 8.0+1.4 9.1 + 1.5 23.8+2.5 26.8+1.7
-1 20.5+2.7 13.1 + 1.0 8.7+1.1 10.5+0.6 25.3+3.1 25.6+1.8
Primary Vaccination
1 23.7+2.9 15.0+2.6 12.3+0.6 9.7+0.3 26.0+0.5 16.0+1.5
2 21.6+1.8 12.6+1.5 16.8+2.1 12.0+1.8 27.8+2.3 18.1 + 1.2
3 30.4+3.2 14.2+1.8 17.3+1.8 14.9+1.7 29.6+2.8 22.2+1.8
4 26.0+1.2 17.9+2.9 16.2+1.9 13.2+1.4 26.5+1.6 23.5+1.7
5 33.9+0.5 19.1+2.0 15.6+2.2 23.4+0.7 32.5+3.5 38.3+1.2
6 31.4+1.6 16.4+1.6 20.0+3.0 17.1 + 1.2 33.4+2.0 29.2+2.7
7 37.3+2.3 17.6+1.1 19.4+2.6 25.5+1.3 32.4+2.5 35.1 + 1.1
8 33.6+1.8 20.9+2.0 24.7+3.1 27.3+1.7 33.3+4.1 40.0+2.1
9 29.3+0.7 21.5+1.9 21.9+1.7 22.4+1.4 32.4+2.6 42.2+2.5
10 26.2+1.9 14.5+0.7 17.7+1.8 17.4+1.9 31.9+3.8 31.2+2.5
11 29.2+0.8 17.8+1.5 13.4+1.6 17.9+1.9 34.1+4.0 30.1+1.0
12 35.3+0.8 15.7+1.4 13.7+1.6 20.2+2.0 31.4+3.9 28.7+1.9
13 - 19.4+1.2 - 31.6+0.6 - 42.1 + 1.0
14 - 15.8+0.6 - 27.5+1.4 - 32.9+2.2
Secondary Vaccination
1 34.1+2.1 18.2+1.9 11.9+0.7 31.4+1.6 31.4+3.6 43.3+2.9
2 31.9+3.0 18.6+1.4 18.0+1.9 21.4+1.9 31.7+4.2 37.9+3.2
3 47.2+5.1 18.5+1.2 6.1+0.4 28.3+2.2 33.8+2.7 30.9+1.8
4 37.9+2.1 16.8+0.9 9.1+0.8 25.3+1.0 34.8+2.6 26.5+2.4
5 36.6+2.6 22.6+0.3 19.6+0.4 31.2+1.7 36.5+2.1 32.8+0.7
6 39.3+0.0 23.5+2.4 24.4+0.0 30.2+2.9 53.6+0.0 45.4+2.0
7 53.9+0.0 19.8+1.8 ND 22.0+1.6 51.9+0.0 44.4+2.5
8 40.0+0.0 12.8+0.0 ND 27.6+0.0 54.0+0.0 18.0+0.0
9 39.9+0.0 11.8+0.0 ND 33.5+0.0 60.4+0.0 12.4+0.0
10 42.6+0.0 11.6+0.0 ND 28.4+0.0 55.9+0.0 17.9+0.0
11 43.1+0.0 10.6+0.0 ND 21.9+0.0 59.8+0.0 11.3+0.0
12 22.3+0.0 23.2+0.0 ND 30.8+0.0 50.8+0.0 11.0+0.0
ND = Not determined
— □ — UN^FECTCD — ■ — X-tCltD
FIGURE 6.6 B cell kinetics in efferent lymph of sheep infected with T. evansi
and/or inoculated with P. haemolytica vaccine. Figures represent
Mean absolute cell counts per ml + S.D. Infection resulted in a
depressed B cell response to the vaccine antigen being much less in
the infected sheep.
Table 6.4 Mean percent of (a) CD4+ cells coexpressing the CDS antigen, (b)
CD8+ cells coexpressing the CD4 antigen and (c) CD5+ B cells in







% CD4+ for CD8
Uninfected Infected
Mean
% CD8+ for CD4
Uninfected Infected
Mean
CD5+ B cells (%)
Uninfected Infected
-2 4.6 9.6 12.9 30.8 18.7 53.3
-1 4.2 11.8 10.6 33.3 12.9 54.0
Primary va< :cination
1 5.8 15.1 14.7 35.1 18.7 60.6
2 5.9 16.6 16.9 42.2 14.6 70.0
3 5.9 18.3 17.8 56.7 13.6 67.4
4 4.8 21.1 15.9 55.1 17.8 74.2
5 5.1 17.4 15.8 42.2 14.2 56.7
6 4.6 13.4 13.8 31.4 14.3 66.3
7 6.2 13.9 12.2 28.5 14.1 62.6
8 5.7 17.5 13.5 19.0 14.8 58.2
9 5.1 18.0 11.8 20.0 12.1 59.0
10 5.4 19.8 12.2 20.5 11.7 65.3
11 4.3 15.6 12.1 27.5 14.5 69.4
12 4.2 20.3 11.3 30.3 14.1 60.2
13 15.2 21.8 58.3
14 12.7 17.3 34.4
Secondary v rccination
1 6.5 12.5 12.8 26.9 17.5 47.8
2 7.8 14.1 16.7 27.8 16.9 50.7
3 5.7 20.5 13.6 31.2 16.9 59.4
4 4.8 14.5 13.0 32.6 10.0 49.4
5 6.2 8.4 11.6 26.9 17.2 71.9
6 5.9 13.8 10.7 28.7 10.9 67.6
7 5.2 13.5 15.1 33.9 15.2 75.2
8 11.0 30.1 61.1
9 9.6 15.4 19.1 37.3 15.6 74.2
10 6.2 17.3 11.4 31.7 17.3 84.6
11 16.9 24.0 13.2 57.3 19.4 76.2
12 13.6 21.3 18.7 45.9 10.4 70.3
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6.3.5.3 Coexpression of CD4 and CD8 by Efferent Lymphocytes
Two colour immunofluorescence staining using the anti-CD8 mAb, S-T8
and the biotinylated anti-CD4 mAb, SBU-T4 and flow cytometry revealed one of the
most surprising and interesting finding of these studies. It was observed that T.
euansi infection induced the coexpression of the CD4 and CD8 molecules by efferent
lymphocytes, which was made more obvious by stimulation of the lymph node with
Pasteurella haemolytica vaccine. For instance, following primary and booster
vaccination, there were further increases in the proportion of CD4+ population
coexpressing the CD8 molecule and vice versa (Table 6.4)
In contrast, in the uninfected group, few CD4+CD8+ (double positive) T
cells were observed prior to or after primary and secondary vaccinations. The
proportion of CD4+ cell population bearing the CD8 antigen at no time exceeded 6
percent nor did that of CD8+ cells bearing the CD4 antigen exceed 15 percent at any
time point. Figure 6.7 shows FACS contour profiles of representative animals (sheep
569, uninfected and 669, infected) illustrating these increases in CD4+CD8+ double
positive efferent lymphocytes. The percentages of CD4+ cell population bearing the
CD8 antigen and vice versa in the two groups of sheep at various time points are
shown in Table 6.4.
6.3.5.4 Expression of CD5 Antigen on Efferent B Cells
In common with the finding in peripheral blood, T. evansi induced
increased expression and output of CD5+ B cells by prefemoral efferent
lymphocytes. Prior to vaccination and at about 17 days p.i., up to 50 percent of B
cells bore the CD5 antigen in the infected sheep. This was further increased by
primary vaccination when an average of 60 to 74 percent of B cells were CD5+.
Following booster vaccine administration, the proportions and numbers of CD5+ B
cells remained high with an average of between 40 to 85 percent (Table 6.4). In
contrast, the uninfected group showed no marked difference between the pre- and
post-vaccination levels of CD5+ B cells remaining between 10 and 20 percent
throughout the experiment (Table 6.4). Figure 6.8 are FACS contour profiles
illustrating CD5+ B cell expression in infected and uninfected animals.
6.3.5.5 Expression of MHC Class I, CD45 and MHC Class n
Antigens
In both groups, the proportion of cells expressing the MHC Class I and
CD45 antigens exceeded 98 percent at all time points. Their absolute numbers
therefore, mirrored the increases or decreases in total cell output. There were
marked increases in MHC Class II expression following vaccination in the infected
FIGURE 6.7 Representative FACS contour profiles of sheep 569
(uninfected/vaccinated) and sheep 669 (infected/vaccinated) illustrating differences
in the induction of CD4+CD8+ T cell population in efferent lymph after infection
with T evansi TREU 2143 and/or immunisation with PasLeurella haemolytica
vaccine
Panel A = sheep 569; Panel B = sheep 669
In each of the profiles :
Quadrant 1 = CD4+ cell population
Quadrant 2 = CD4+CD8+ cell population
Quadrant 3 = CD4~CD8~ cell population
Quadrant 4 = CD8+ cell population
Note that challenge of sheep 569 on day 7 p.b. with T evansi TREU 2143 was
followed by the appearance of double positive cells (Panel A , day 8 and 10 p.b.) and
that in sheep 669, the terminal decrease in double positive cells was accompanied
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FIGURE 6.8 FACS contour profiles illustrating CD5+ B cell population in efferent
lymph of sheep 569 (uninfected/vaccinated) and sheep 669
(infected/vaccinated).Panel A = sheep 569 and Panel B = sheep 669.
Quadrant 2 = CD5+ cell population.
A B
FIGURE 6.8 FACS contour profiles illustrating CD5+ B cell population in efferent
lymph of sheep 569 (uninfected/vaccinated) and sheep 669
(infected/vaccinated).Panel A = sheep 569 and Panel B = sheep 669.
Quadrant 2 = CD5+ cell population.
A B
FIGURE 6.8 FACS contour profiles illustrating CD5+ B cell populaiion in efferent
lymph of sheep 569 (uninfected/vaccinated) and sheep 669
(infected/vaccinated). Panel A = sheep 569 and Panel B = sheep 669.







FIGURE 6.9 Contour profiles of a two-colour staining for B cell and MHC Class II
expression. In both infected and uninfected sheep all B cells
expressed the Class II antigen at all time points.
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group (Table 6.3), although this represented only occasional marginal increases in
the absolute number of cells expressing the antigen (Figure 6.6c). Dual colour flow
cytometiy revealed that at all times, all B cells expressed the MHC Class II antigen
(Figure 6.9). In the uninfected sheep, there was more than a 4-fold increase in the
number of cells expressing the MHC Class II antigen following primary and
secondary vaccinations (Figure 6.6c). Similar to observations in the infected sheep,
all B cells expressed Class II antigen as shown by double colour
immunofluorescence (Figure 6.9).
6.4 Discussion
The intravenous infection of sheep with T. evansi resulted in the
appearance of trypanosomes in the efferent lymph at higher numbers, and for
periods longer than was observed in the peripheral blood (Chapters 4 and 5). This
observation, tends to reaffirm the proposition that trypanosomes of the brucei group
are 'humoral' since they have greater tropism for tissues and body fluids other than
the blood (Losos and Ikede, 1972). For instance, T. brucei has the capacity to leave
the blood circulation, invade tissues and enter central lymphatics in large numbers
(Losos and Ikede, 1972), although similar observation has been made in goats
infected with T. vivax (Emery, Barry and Moloo, 1980) and sheep infected with T.
congolense (Mwangi, 1991). The relatively greater number of trypanosomes in the
lymph than blood, despite the fact of the intravenous route of infection, also
supports suggestions that the lymphatic system is the major route for trypanosome
dissemination and that the lymph node constitutes a secondary locus for the
proliferation of the parasites (Luckins and Gray, 1979; Gray and Luckins, 1980;
Dwinger et al., 1990). Thus, the parasites were not only able to persist in the
efferent lymph, but also produced a much higher secondary level of parasitosis
almost three months after the initial infection. However, this higher level of
secondary parasitosis may also be a reflection of a depression in the immune
competence of the sheep at this stage of the infection.
Infection of sheep with T. evansi affected the response of the draining
lymph node to Pasieurella vaccine administration in terms of cell output and
phenotypic composition. By comparing prevaccination figures for the infected and
uninfected sheep, T. evansi induced a much higher cellular output. However, after
vaccination, although infected animals showed further increases in cell output
during the following 9 days, the increase was actually lower than in the uninfected
group. In addition, as the infection progressed, so did the decrease in cell output in
the infected animals. It has been shown that the cellular responses taking place
within the lymph node draining a site of antigen deposition is reflected by marked
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increase in the cellular output from the draining efferent lymphatic duct (Hall and
Morris, 1962; 1965a, b). For instance, there is increase in cell output from the
popliteal efferent lymphatic duct following subcutaneous inoculation of sheep with
Toxoplasma gondii (McColgan et al., 1987) or with C. psillaci (Huang et aL. 1991). In
addition, intradermal infection of sheep with metacyclic T. congolense resulted in
increased cell output from the prefemoral efferent duct draining from the local
lymph node (Mwangi, 1991). This increase is bimodal with the initial response
coinciding with the onset of parasitosis and as such differed from the observed
increases with T. gondii and C. psittaci in which there was one peak. These studies
are similar to observations made in the present study. Uninfected animals showed
one peak each, in cellular output, after primary and secondary vaccinations. The
peak following the secondary Pasteurella vaccination occurred after a 24 hr dip in
the total cell output. This is similar to observations by Hall and Morris (1965b) and
Hopkins et al (1981b) that there is marked reduction in efferent lymph cell output
during the first 6-20 hrs after secondary challenge of the node with antigen even
though lymph flow is unaltered. This phenomenon, known as cell shutdown (Hall
and Morris, 1965b), is followed by increased output of cells which, it has been
suggested, comprises lymphocytes which entered the node during cell shutdown
and those generated within the node in response to the antigen (Hay and Hobbs,
1977). On the other hand, the kinetic changes in cell output following vaccination
was altered by prior infection with T. euansl First, the overall increase was not only
less than in the uninfected sheep but was gradual and peaked 4 days later than in
the uninfected animals, declining rapidly thereafter, before beginning to rise to a
minor second peak. Secondly, following a booster vaccination, there was hardly any
increase, the cell output continuing to drop until 10 days later when it began to rise
again. It seems that the combined stimulus provided by the trypanosomes and the
Pasteurella vaccine either results in cell depletion, a prolonged cell shutdown or in
the release of factors which inhibit lymphocyte migration from the node. Whichever
is the case, it is also apparent that for this to occur trypanosomes must be present,
since subsequent challenge of the previously vaccinated/uninfected sheep with T.
evansi resulted in immediate and marked decrease in cell output. Trypanosome
infection activates macrophages (Askonas, 1985) and it is possible that increased
PGE2 production by the activated macrophages may act to inhibit lymphocyte
migration from the node. PGE2 is not only an inhibitor of lymphocyte proliferation,
but also a potent suppressor of lymphocyte migration even at very low
concentrations (McCarty and Goetzl, 1979; Hopkins et al., 1981a; Van Epps, 1981).
Perhaps the hyperplastic nature of peripheral lymph nodes of trypanosome infected
animals may result from such lymphocyte migration inhibition occasioned by PGE2
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production. A similar situation has been observed in tumour conditions. For
instance, it has been observed that tumours in laboratoiy animals produce
increased quantities of prostaglandins (Pelus and Bockman, 1979) and this has
been used to explain why lymph nodes draining sites of tumour lesions are not only
hyperplastic (Alexander et aL, 1969), but contain cells which are incapable of
reacting to either antigen or mitogens (Mavligit et al., 1974). Surgical removal of the
main tumour mass and therefore, decrease in PG production, not only results in the
mass exit of lymphocytes and blast cells from the node in question, but also in
subsequent immunity to tumour challenge (Alexander et al., 1969; Hopkins et aL,
1981b).
The stimulation of a lymph node by i.d., s.c. or i.m. injection of antigen
also results in increased output of lymphoblasts and plasmablasts in the efferent
lymph of the node peaking between 3 to 14 days of the antigen administration
(Hopkins et al., 1981a, b; McColgan et aL, 1987; Huang et aL, 1991; Mwangi, 1991;
Yirrell et aL, 1991). The result obtained with the uninfected sheep following primary
and secondary vaccination is in agreement with these reports. However, although
increases in output of lymphoblasts occurred also in the infected animals, it was
limited, showing marked increase only at day 11 post booster (88 days p.i.) after the
decline in the second peak of parasitosis. It is of interest to note that the increase in
output of lymphoblasts in the infected sheep prior to vaccination was in the order
observed by Mwangi (1991) in sheep infected with T. congolense and that following
primary vaccination there was even a greater increase before the decline by day 11
p.v. Thus, without the benefit of observing uninfected animals, the conclusion
would have been that the infection had no depressive effect on lymphoblast response
to the antigen. The reduced output of lymphoblasts in the infected sheep to the
vaccine antigen could be due to a number of reasons. Since the subsequent
challenge of the uninfected/vaccinated sheep also results in rapid reduction in blast
output, it is posible that hyperactivation of APCs by the parasite and Pasteurella
antigens induces them to increased production of PGE2 which may then act in one
of two ways. First, it may act through its suppressive action on lymphocyte effector
function to limit Pasteurella-specific T cell proliferation and thus blast production in
the node. It has been shown in sheep that efferent lymph of a node stimulated with
either BCG and Johne's disease vaccine or Keyhole Limpet Haemocyanin (KLH),
non-specifically suppresses the proliferation of normal PBLs when stimulated in vitro
with a variety of antigens and that the suppressor factor is PGE2 (Hopkins et aL,
1981b). Secondly, PGE2 which mediates cell shutdown (Hopkins et aL, 1981a) could
by this action limit the output of blasts and by so doing induce the suppression of
immunity to the antigen by limiting systemic dissemination of specific-antigen
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primed blast cells.
The effects of T. evansi infection on the changes in output of lymphocyte
populations in efferent lymph were similar in many, but also differed in some,
respects to what obtains in the peripheral blood. For instance, in the peripheral
blood of infected sheep, there is marked decrease in the proportions of all T cell
subsets but only a small decrease in their absolute numbers, whilst both the
proportions and numbers of B cells showed marked increases. Following primary
and secondary vaccination, the proportions of all T cell subsets showed minor
variations but their absolute numbers progressively decreased as the cell output
decreased. Moreover, although the proportion of B cells increased, their absolute
numbers showed little alteration during the first week after vaccination, but
thereafter also decreased. In the uninfected sheep, the trend of events in the
efferent lymph was similar to the peripheral blood after both primaiy and secondary
vaccinations in that only minor variations occurred in the proportions of the various
lymphocyte subsets. However, in absolute numbers there was much larger increase
in CD5+, CD4+, CD8+, y8 T cells as well as B cells in the efferent lymph than in the
blood of uninfected sheep following vaccine administration which was a result of the
large increases in total cell output.
One of the most surprising findings of this study is the appearance of
CD4+CD8+ cells in the infected sheep, a feature not associated with mature
peripheral T cells. However activation-dependent coexpression of CD4 and CD8
antigens has been described for both human and rat polyclonal (Blue et al, 1985;
1986; Green and Jotte, 1985) and clonal (Ottenhoff et al., 1986; Ellerman et al,
1988) T cell populations and for PHA-activated sheep efferent lymphocytes (McClure
and Hein, 1989). It is therefore possible that the coexpression of CD4 and CD8 in
the infected sheep may have been activation induced. However, two-colour
immunofluorescence analysis of Con A-stimulated sheep PBLs (Mackay et al., 1986)
and of sheep prescapular efferent lymphocyte after in vivo stimulation with either
OVA or PPD (Bujdoso et al, 1989) indicates that coexpression of CD4 and CD8 is
not a feature of both in vivo and in vitro activated mature sheep T cells. This is
supported by observations in this study, in the uninfected animals, that in vivo
activation of efferent lymphocytes using Pasteurella vaccine did not induce the
coexpression of CD4 and CD8 as seen in the infected sheep.
It therefore follows that T. evansi possibly provides a secondary stimulus
which induces hyperactivation and production of double positive T cells or the
increased mobilisation of immature thymocytes. Since extra-thymic T cells showing
immature CD4+CD8+ characteristics are destroyed by activation-induced
programmed cell death (PCD) or apoptosis (MacDonald and Lees, 1990; Swat et al.
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1991; Young, 1992; Vasquez et al, 1992), it was hypothesised in Chapter 5 that the
marked decreases in the proportions of various T cell subsets in the blood of
infected/vaccinated sheep may have arisen from cell depletion, by PCD, of cells
induced to terminally differentiate into CD4+CD8+ expression by the trypanosomes.
This hypothesis is supported to some extent by the findings of these
experiments. The increase in CD4+CD8+ cells was later accompanied not only by
marked reductions in the absolute numbers of all lymphocyte populations but also,
by a reduction in the total and blast cell output from the draining lymph node.
Trypanosome infections have been shown to induce cell depletion from the
paracortical T cell areas of lymph nodes of infected cattle and sheep (Morrison and
Murray, 1979; Mwangi et ai, 1991), thus the reduction in cell output may not be a
result of prolonged cell shutdown in the node but possibly a combination of cell
death and PG action. Moreover, it has also been shown that initial increases in
cellular output and in the proportion and numbers of T cell subsets in the efferent
lymph of node draining the site of sheep infected with T. congolense was followed
subsequently by marked decreases in the T cell numbers and proportions (Mwangi,
1991).
These notwithstanding, it could be argued that the increase in double
positive cells may be a result of increased mobilisation of immature thymocytes and
not a hyperactivation-induced priming of the cells for self-destruction by apoptosis,
since there was a marked increase in cells expressing CD1, an antigen normally
present on immature thymocytes. If this had been the case, then the coexpression
of CD4 and CD8 would also have been greater in the uninfected/vaccinated sheep,
since the increase in CD1+ cells was much greater in them. In any case, CD1 is also
present on mature B cells and its expression in both groups paralleled those of VPM
30+ (B) cells. In the absense of a CD4/CD1 and CD8/CD1 two-colour flow
cytometry to clarify the issue, one would conclude that the increase in CD1+ cells
was a result of B, and not of CD4+CD8+, cell increase.
Furthermore, since T cell maturation progresses through a phase of CD4"
CD8" to CD4+CD8+ state before the final differentiation into mature single positive
(CD4+CD8~ and CD4"CD8+) cells (Kadish and Basch, 1977; Fowlkes and Mathieson,
1985; Scollay et al, 1988; Guidos et al, 1989) it could be reasoned that the
CD4+CD8+ cells are antigen activated T cells in the process of differentiating into
mature single positive cells. An inherent difficulty in this argument is, why if this is
so, did the population not increase in the uninfected sheep? Moreover, if they were
maturing activated and dividing cells, then the end result would have been that of
increases and not of decreases in the cell output and various T cell subsets in the
infected animals.
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Therefore, it is likely that the appearance of CD4+CD8+ cells in the
efferent lymph of trypanosome-infected sheep, followed by subsequent decrease in
various lymphocyte subsets, is an indication that the cells are being depleted by the
process of activation-induced cell death. It is not known how trypanosomes bring
about the coexpression of these antigens or what finally induces them to self-
destruct. However, it is known that when thymocytes are activated in culture, a
distinct population coexpressing reduced levels of CD4 and CD8, and which
represents cells undergoing PCD arises, and that further activation of the cells by
the addition of a second stimulant (ionomycin), accelerates the process of cell death
(Swat et al, 1991). Furthermore, the engagement of the TcR complex of immature
double positive cells by antigen, initiates the process of PCD (Jenkinson et al, 1989;
Smith et al, 1989). It is therefore hypothesised here that whilst trypanosomes by
some mechanism(s) trigger the coexpression of CD4 and CD8 by activated T cells, it
is the introduction of a second antigen (Pasteurella vaccine) which provides the
ultimate signal for intrinsic self-destruction of the cells by engaging the TcR complex
of the CD4+CD8+ cells. Trypanosome infection of sheep without a second antigenic
challenge, coupled with two-colour immunofluorescence analysis of their efferent
lymphocytes should validate or nullify this hypothesis. Similarly, the confirmation
as to whether the CD4+CD8+ cells are actually activated cells driven to spontaneous
self destruction by PCD, mobilised immature thymocytes or activated cells
undergoing normal differentiation and maturation, will depend on sorting out the
cells by FACS, isolating their DNA and analysing it by agar gel electrophoresis. If
the cells represent a population dying by apoptosis, then such an analysis should
demonstrate the degradation of the DNA into oligonucleosomal fragments
characteristic of cells underoing activation-induced death by apoptosis (Jenkinson et
al, 1989; Smith etal., 1989; Swat et al, 1991). On the other hand, confirmation as
to whether they are immature cells undergoing normal cell division could be carried
out by FACS sorting them and looking at the pattern of rearrangement of the T cell
receptor genes. If they are normal double positive immature cells they will have far
lower proportions of rearrangement patterns of the TcR genes.
A second interesting finding of this study, is the very large increases in
the population of CD5+ B cells in the infected animals, which confirms that this cell
population is not restricted to the blood (Chapter 5). However, the proportion of this
B cell population in the efferent lymph is far more than the blood and in some
instances nearly 100 percent of B cells are CD5+- Nevertheless, it has been shown
that up to 90 percent of peripheral blood B cells express the CD5 antigen in cattle
infected with T. congolense, which suggests that increased expression of this cell
type could be an important feature of trypanosome infections in animals.
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Furthermore, T. cruzi infections in mice have been shown to preferentially induce
the expansion of CD5+ B cells (Minoprio et al., 1989b).
It is not known how trypanosome infection induces increased expression
of this B cell population, especially in the efferent lymph, since it has been shown
that CD5+ B cells are not detectable within ovine lymph node or efferent lymph
(Mackay, 1988). However, in adult sheep, CD5+ B cells are most numerous in the
spleen where up to 20 percent of B cells express the CD5 molecule (Mackay, 1988).
It is therefore possible, that following tiypanosome infection, there is increased
mobilisation and recirculation of CD5+ B cells from the spleen to lymphoid organs
where they would not normally be found. On the other hand, it could be that the
activation of conventional B cells by the parasites induces them to express the CD5
antigen in large proportions. Support for this comes from observations that in vitro
activation of conventional human PBL B cells resulted in up to 70 percent of them
becoming CD5+ (Miller and Gralow, 1984; Freedman et al., 1987; Werner-Favre et
al, 1989). However, the fact that cell transfer experiments in mice have shown that
CD5+ B cells have a capacity for self-renewal, suggests that they represent a
separate cell lineage distinct from conventional B cells and are not mere activation
markers for B cells (Hayakawa et al., 1985; Hardy and Hayakawa, 1986; Herzenberg
etal., 1986; Forster and Rajewsky, 1987).
The significance of CD5+ B cell population in the induction of
trypanosome-specific immunity or in the immunopathology of the disease is not
known and would have to await the characterisation of their antibody production.
However, in human and rodent, CD5+ B cells are committed to the production of low
affinity, polyreactive IgM auto-antibodies (Hayakawa et al., 1983). Since these
heterophile IgM autoantibodies have been demonstrated in tiypanosome-infected
animals (Henderson-Begg, 1946; Houba etal, 1969; Parratt and Herbert, 1979) it is
likely that the CD5+ B cells may be responsible for their production. If this is so,
then it would add to the explanation not only of the reported increase in
immunoglobulin destruction occurring in infected animals (Nielsen et al, 1978a,
1978b) but also of the reduction in cell numbers as already shown. This is because
the polyreactive IgM autoantibodies produced by CD5+ B cells have been shown to
bind both to Fc fragment of IgG antibodies and to thymocytes (Hayakawa et al.,
1984; Casali et al, 1987; Hardy et al., 1987; Burastero et al, 1988; Nakamura et
al, 1988). It would therefore follow that since the primary target in vivo, of anti-TcR
autoantibodies is the CD4+CD8+ cells (Smith et al, 1989) the increased production
of polyreactive autoantibodies by the increasing numbers of CD5+ B cells following
tiypanosome infection would result in increased destruction of the equally
increasing CD4+CD8+ cell population. Similarly, binding of the Fc fragments of the
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IgG antibodies would result in the increased Ig catabolism reported.
Given the persistence of this cell population in infected animals in
addition to the alterations in T cell subsets the net result of these sequence of events
would be generalised immunosuppression as demonstrated in infected animals.
Obviously a lot more work is needed to elucidate fully the exact implications of the
observations made in this study in the immunopathology of trypanosome infection.
For instance, the assay of the type and level of cytokine production in the lymph of
infected animals would have given a fairly clear indication as to which T cell subset
is being suppressed or activated by the infection and would have helped in
explaining the eventual failure in both T and B cell functions. It would have also
been useful to assay for Pasteurella and parasite-specific antibodies in the lymph of
the animals. Unfortunately, neither the assay of T cell derived lymphokines nor of
antigen-specific antibody production in the efferent lymph was possible due to the
loss of the entire batch in an arson attack on CTVM. Such assays would have
provided further evidence as to whether the phenotypic changes observed affected
the parasite or Pasteurella specific antibody responses in the lymph as was observed
in the serum.
CHAPTER SEVEN




One of the hallmarks of African trypanosomosis in rodents is the
induction of profound immunosuppression to a variety of antigens, with both B and
T cell functions impaired. In vitro, the impaired B and T cell functions is shown by
profound reduction in DNA synthetic responses of leucocytes to stimulation with
such mitogens as pokeweed mitogen (PWM), Con A and LPS (Goodwin et al, 1972;
Corsini et cd., 1977; Jayawardena and Waksman, 1977; Pearson et al., 1978;
Roelants et al., 1979a, b; Gasbarre et al., 1981). Moreover, similar lympho-
proliferative experimental assays, employing mononuclear cells derived from rodent
spleen and lymph node organs, have been used to extensively study the underlying
mechanisms surrounding the generalised immunosuppression. Evidence from these
studies suggests that the suppression is multifactorial and may include: exhaustion
of antigen-reactive B cells which are driven to terminal differentiation (Greenwood,
1974; Hudson et al., 1976; Corsini et al, 1977), generation of suppressor T cells
(Eardley and Jayawardena, 1977; Jayawardena and Waksman, 1977; Jayawardena
et al., 1978) and generation of suppressor macrophages (Corsini et al., 1977;
Wellhausen and Mansfield, 1979; Sileghem et al., 1989a, b; Borowy et al., 1990).
Suppressor T cells and macrophages produce cytokines and prostaglandins
respectively, which act in a series of complex immunoregulatory mechanisms to
suppress the capacity of helper T cells to provide help for antigen-specific responses
by B cells (Alcina and Fresno, 1985; Sileghem etal., 1989a, b; Darji et al., 1991a, b;
Nabors and Tarleton, 1991; Sileghem et at., 1991).
In the case of cattle, infection with pathogenic trypanosomes has also
been shown to cause suppression of systemic humoral responses to bacterial and
viral vaccine antigens (Scott et al, 1977; Whitelaw et al, 1979; Rurangirwa et al,
1983). However, attempts to investigate the underlying mechanisms using in vitro
cell culture systems are limited and have not gone beyond the assessment of the
responsiveness of mononuclear cells from infected animals to mitogenic or
homologous tiypanosomal antigenic stimuli in vitro. Results from such studies have
demonstrated suppression of the responsiveness of these cells to stimulation with
either Con A, PWM, LPS or homologous tiypanosomal antigen (Emery et al, 1980c;
Masake et al, 1981). This suppression is associated with active infection only and
is abrogated by treatment of the infected animals with a trypanocidal drug. This
suggests a role for trypanosome antigens in the immunosuppression. However, cells
from cattle previously immunised with formalin-fixed T. congolense responded to
subsequent specific stimulation with the ultrasonicated homologous antigen (Emery
et al, 1980), suggesting that other mechanisms apart from the presence of
trypanosomal antigens per se may be operative. Moreover, it has recently been
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shown that cells from T. congolense-infected Boran and N'dama breeds of cattle can
actually proliferate in response to stimulation with soluble homologous T.
congolense antigen even though the response is transient (Flynn, Sileghem and
Williams, 1992). Hence, the mechanisms underlying the immunosuppression seen
in trypanosome infected ruminants still remain under-investigated and poorly
understood.
Recent studies have shown that infection of cattle with T. congolense
causes alterations in their cell population dynamics which possibly underlies the
immune dysfunction seen (Ellis et al, 1987; Mwangi, 1991; Williams et al, 1991).
Moreover, infection of sheep with T. evansi precipitates substantial reductions in the
proportions of effector T cell subsets which is accompanied by persistent expansion
of circulating B cells and suppression of humoral responses to primary and
secondary inoculations with P. haemolytica vaccine antigen (Chapters 4 and 5).
Although the reductions in the proportions of these cell phenotypes in the blood are
marked, their absolute numbers show relatively smaller reductions and yet
suppression of antibody responses to the vaccine antigen occurs. In sheep which
had undergone selfcure, where the changes in both the proportions and numbers of
the various lymphocyte subsets are minimal, suppression still occurs. Furthermore,
even after selfcure when trypanosomes have been eliminated, secondary responses
to Pasteurella vaccine are not restored to the levels seen in uninfected, control
sheep. These findings suggest that in addition to the role of parasite antigens and
alterations in the dynamics of various lymphocyte surface molecules, other
mechanism(s) might operate in compromising the immune competence of infected
livestock.
This chapter describes in vitro lymphocyte transformation assays using T
and B cell mitogens and specific antigenic stimuli to provide further information on
factors contributing to the immunosuppressive effects of T. evansi in infected sheep.
In addition, since suppressor T cells and macrophages have been shown to play
central roles in the immunosuppression seen during rodent tiypanosomosis
(Askonas, 1985; Sileghem et al, 1989a; b; 1991; Bakhiet et al, 1990; Borowy etal,
1990), and in cattle infected with T. congolense (Flynn and Sileghem, 1991),
experiments were also carried out to deplete these cell types from the cell population
prior to initiation of cultures. This was in order to assess whether they play any role
in T. euanst-induced immunosuppression in sheep.
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7.2 Materials and Methods
7.2.1 Animals, Vaccination, Infection and Experimental Design
Six Suffolk sheep, housed and fed as described in Section 3.1 were used
in these studies. Four animals, 225, 476, 443 and 766, were each primed and
boosted with 2 mg dose of Pasleurella vaccine four weeks apart as described in
Section 3.8.1. Two weeks after secondary vaccination, sheep 443 and 766 were
each infected intravenously with 2x 106 T. euansi TREU 2143 using the external
jugular vein. Sheep 225 and 476 were used as uninfected, vaccinated controls. The
mitogenic and antigen specific responses of peripheral blood leucocytes from these
animals were tested in in vitro cell culture assays. Assays were initiated 7 days after
infection in both infected and control sheep and subsequently were conducted
weekly until three weeks p.i., when the infected animals were treated with
Cymerlarsan. Thereafter, three further assays were conducted in the
infected/treated sheep at ten day intervals in order to assess the effect of
tiypanocidal drug therapy on the cell responses.
In a follow-up experiment, two more sheep, 222 and 396 were vaccinated
and infected as described above. Cells from these sheep were used in depletion
assays in order to assess the effects of removal of CD8+ and monocyte cell
populations on proliferative responsiveness to mitogenic and antigenic stimulation
in vitro. CD8+ cells and monocytes were depleted as described in Sections 3.9.2.2
and 3.9.2.3 respectively. Assays were initiated three weeks prior to infection and
thereafter were conducted every four days for 40 days p.i. and subsequently at ten
day intervals until 80 days after infection. Treatment with Cymelarsan was on day
50 p.i.
7.2.2 Mitogens, Antigens and Cell Cultures
Con A and LPS were used as T and B cell mitogens respectively. P.
haemolytica A1 capsular antigen, live T. evansi TREU 2143 or soluble tiypanosomal
antigens, prepared as described under Sections 3.8.2 and 3.10.1, were used as
specific antigenic stimuli. Both the mitogens and the antigens were freshly
reconstituted to their various working dilutions in RPMI-1640 complete culture
medium (Appendix 11(7]) shortly before use. The cell culture systems were optimised
as described in Section 3.9.3.
Ovine peripheral blood leucocytes were prepared from defibrinated
venous blood by density gradient centrifugation over Lymphoprep as described in
Section 3.10.2 and Appendix 11(2), and adjusted to 107 cells ml1 using complete
culture medium. For the assays, triplicate cultures were set up in 96-well flat-
bottomed NUNC microculture plates in a final volume of 200 pi RPMI-1640 complete
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FIGURE 7.1 Proliferative responses of PBLs of T. evansi infected and uninfected
sheep to in vitro stimulation with Con A and LPS in the presence or
absence of live or soluble homologous T. evansi antigen.
(a) Responses to Con A in infected sheep
(b) Responses to Con A in uninfected sheep
(c) Responses to LPS in infected sheep
(d) Responses to LPS in uninfected sheep
In each case values represent mean + S.D. of triplicate cultures for
each treatment from 2 infected and two uninfected sheep. In
cocultures of cells with either Con A or LPS and T. evansi antigen,
soluble parasite antigen was used on days 14 p.i. (for both infected
and uninfected sheep) and on day 20 after treatment (infected sheep
only) while live organisms was used at all other times.
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culture medium as described under Section 3.9.4. Cells were dispensed in 5 pi
volumes to give a final cell concentration of 105 cells per well (5 x 105 cells ml1) and
stimulated with either 2.5 pg ml1 Con A, 75 pg ml"1 LPS, 50 pg ml"1 P. ag and/or
5x 105 T. evansi TREU 2143 or 12.5 pg ml"1 of its soluble antigen (T. ag).
Unstimulated cell cultures were also set up, as well as cultures of live tiypanosomes
with Con A and LPS to assess the possible uptake of these mitogens by the
trypanosomes. Cultures were incubated, pulsed with thymidine, harvested and
counted as described in Section 3.9.3.1 and results presented as mean counts per
minute (CPM) of the cultured cells and tiypanosomes.
7.3 Results
7.3.1 Cell Responses to Con A and LPS Stimulation
The proliferative responses to both mitogens of peripheral blood
leucocytes from T. euansf-infected sheep were substantially reduced when compared
with uninfected controls. This reduction was associated with active infection as the
responses were restored after trypanocidal drug treatment of infected sheep (Figure
7.1a, c). To assess whether live tiypanosomes or soluble trypanosomal antigen exert
similar depression in vitro, 5 x 105 parasites or 12.5 pg ml"1 of soluble antigen were
added to the Con A or LPS stimulated cells from infected and uninfected control
sheep. Results showed that at these concentrations, T. evansi or its soluble antigen
neither suppresses the responsiveness of cells from uninfected sheep to Con A or
LPS stimulation nor exacerbates the depression seen in cells from actively infected
sheep. On the contrary, a small relatively insignificant mitogenic effect was
observed as slightly higher thymidine uptake was observed in cells cocultured with
live or soluble T. evansi antigen than in cells cultured with Con A or LPS alone
(Figure 7.1a, b, c & d). However, a separate experiment showed that at higher
concentrations, live but not soluble T. evansi antigen depressed the ability of cells
from normal uninfected sheep to proliferate in vitro when stimulated with Con A or
LPS (Table 7.1). Furthermore, to assess whether the depression was as a result of
live tiypanosomes depleting Con A or LPS during culture, 8 x 106 parasites ml"1
were cocultured in a FALCON tissue-culture flask with 2.5 pg ml"1 Con A or 75 pg
ml"1 LPS in a total volume of 8 mis RPMI-1640 complete culture medium. At the
end of 72 hour culture, the parasites and debris were removed by centrifugation and
the supematants used to stimulate cell cultures from normal sheep without further
addition of mitogens. Table 7.2 shows that enough Con A and LPS concentrations
were left in the supernatants to induce marked proliferative responses in the cells.
Moreover, cultures of parasites alone pulsed with thymidine and counted in a liquid
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FIGURE 7.2 Proliferative responses of PBLs of Pasleurella vaccine immunised/T.
euansi infected and uninfected sheep to specific in vitro stimulation
with Pasleurella and T. evansi antigens, (a) Response to P.ag in
uninfected sheep, (b) Response to P.ag in infected sheep, (c)
Responses to stimulation with live or soluble T. evansi antigens in
infected and uninfected sheep. In all cocultures with tiypanosomal
antigen, soluble antigen was used on days 14 p.i. and 20 post
treatment while live organisms was used at all other times.
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7.2).
7.3.2 Cell Responses to Pasteurella Antigen
The effect of T. evansi infection on the ability of PBLs from sheep
previously immunised with Pasteurella vaccine to proliferate when stimulated in vitro
with the specific P. ag was tested. Cells from infected animals were essentially
unresponsive to stimulation with P. ag alone or to stimulation with a combination of
P. ag and live or soluble T. ag in vitro (Figure 7.2b) when compared with that of the
vaccinated control sheep (Figure 7.2a). This defect was abrogated by anti T. evansi
treatment, although the responses observed were still less than those of the control
sheep. However, treatment resulted in an additive effect on the responsiveness of
cells co-stimulated with P. ag and live or soluble T. ag (Figure 7.2b).
7.3.3 Cell Responses to Trypanosomal Antigens
The responsiveness of PBLs from infected and uninfected sheep to
stimulation in vitro with homologous trypanosome or the soluble antigen was also
tested. Cells from infected sheep failed to respond to stimulation with either
antigen. This suppressive effect was abrogated by trypanocidal drug treatment.
Cells taken 10, 20 and 30 days after treatment showed significant increase in
responsiveness to these antigens (Figure 7.2c). At no time did cells from the
uninfected control sheep respond significantly to stimulation with either of the
antigens (Figure 7.2c).
7.3.4 The Role of CD8+ Cells and Monocytes in T. euansi-induced
immunosuppression
In an attempt to elucidate further the mechanisms responsible for the T.
euansi-induced immunosuppression, monocytes and/or CD8+ (suppressor) T cells
were deleted from the cells obtained from infected sheep prior to culture with
mitogens or antigens. T. evansi infection resulted in the depression of responses to
Con A, LPS and P. ag stimulation.
The depletion of CD8+ cells resulted in a transient restoration of the
responsiveness of cells to Con A stimulation between day 12-20 p.i. (Figure 7.3a, b).
At other times, the responses of cell populations depleted of this cell type were
similar to those of the undepleted cell population (Figure 7.3a, b). The removal of an
adherent cell population (monocytes) produced a greater proliferative response to
Con A stimulation between days 4-32 p.i. Between days 36-50 p.i. and after drug
treatment, there was no difference between the responses of cells depleted of
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Table 7.1 Effect of increasing numbers and concentration of live or soluble T.
evansi antigens respectively on the proliferative responses of
peripheral blood leucocytes from normal sheep to Con A and LPS in
vitro . 5 x 105 cells ml"1 were cultured in the presence of different
concentrations of live or soluble T. evansi antigen and stimulated




Mean C.P.M. + S.D.
Live (no. ml1) Soluble (pg ml"1) Live Soluble
2.5 x 105 12.5 77,024.8+3839.8 84,066.2+4499.9
5 x 105 25.0 81,363.0±4662.2 83,496.0±4081.9
106 50.0 60,329.0±4605.0 83,009.2+4047.4
2 x 106 100.0 24,709.0+2742.7 83,523.8±6801.9
4 x 106 200.0 19,943.1±2435.9 77,621.6+5339.6




Mean C.P.M. + S.D.
Live (no. ml1) Soluble (pg ml-1) Live Soluble
2.5 x 105 12.5 52,929.3+3741.8 52,536.3±3980.6
5 x 105 25.0 57,356.3±4203.6 51,439.9±3949.6
106 50.0 49,543.9+2714.0 51,323.7+2872.2
2 x 106 100.0 11,798.8±1491.0 46,058.9±2705.6
4 x 106 200.0 4,850.2+ 440.8 43,651.3+1542.3
8 x 106 400.0 4,148.3+ 268.0 43,651.3± 990.7
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Table 7.2 Uptake of mitogens by T. evansi and the effect on cell responses.
8 x 106 T. evansi TREU 2143 were cultured for 72 hours in 8 mis of
RPMI-1640 complete culture medium containing either 2.5 pg ml"1
Con A or 75 pg ml1 LPS. Aliquots of 5 x 105 trypanosomes were then
pulsed with 3H-thymidine and DNA synthesis determined in a liquid
scintillation counter. Trypanosomes were removed from the rest by
centrifugation and the supernatant used to culture 5 x 105 PBLs from
normal sheep, and DNA synthesis determined as above. Three
experiments were conducted and results are presented as mean cell




Mean C.P.M. + S.D.
Con A LPS
1 78,271.3+3,072.0 47,478.1± 8
68.4




5 x 105 1 129.5 ± 11.4 63.8 ±
6.2
T. evansi ml"1 2 134.9 + 5.6 60.9 ±
6.4
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FIGURE 7.3 Effect of the depletion of CD8+ T cells and/or monocytes on the
proliferative responses of PBLs of T. evansi infected sheep to in vitro
stimulation with Con A and LPS. (Values are Mean + S.D. of triplicate
cultures in each animals).
(a) Effect of CD8 and/or monocyte removal on the responses of
cells from sheep 222 to Con A.
(b) Effect of CD8 and/or monocyte removal on the responses of
cells from sheep 396 to Con A.
(c) Effects on responses to LPS in sheep 222.




monocytes and undepleted cells. Simultaneous removal of both CD8+ cells and
monocytes produced a greater enhancement in the responsiveness of the cells to
Con A between days 4-20 p.i. Between days 24-32 p.i., the responses of cells
depleted of both cell types were similar to those depleted of monocytes only. By day
40-50 p.i., the responses to Con A of all cell populations, whether depleted or not,
were similar (Figure 7.3a, b).
The depletion of either CD8+ cells or monocytes or removal of both cell
types simultaneously, restored the responsiveness to LPS stimulation of PBLs from
sheep 396 (Figure 7.3d). However, the effect in sheep 222 was transient and limited
(Figure 7.3c). From day 25 p.i. onwards until after drug treatment, the
responsiveness of the undepleted cell population to LPS stimulation increased by up
to 4-fold exceeding, by a considerable margin, the responses obtained with the
depleted cell populations during the same period (Figure 7.3c, d). Following
treatment, the responses returned to levels similar to those obtained prior to
infection.
Depletion of the CD8+ T cells resulted only in a transient restoration of
cell responses to P. ag stimulation between days 12-20 p.i. Thereafter, CD8+ cell
depletion had no effect and in fact, responses obtained with the undepleted cell
population slightly exceeded those of the depleted population (Figure 7.4a, b). Both
responses however, remained below pre-infection levels until after treatment when
an enhanced proliferative response to P. ag stimulation was obtained.
Parasite-specific T cell responses remained suppressed throughout the
period of infection except for day 12 and 16 p.i. (sheep 222, Figure 7.4c) and day 8-
16, 24-28 p.i. (sheep 396, Figure 7.4d) when a slight increase was observed in cells
depleted of CD8+ T cells. Following treatment, more than 8-fold increase was
observed in the proliferative responses of PBLs to stimulation with homologous
trypanosomal antigen whether the CD8+ cells were depleted or not (Figure 7.4c, d).
7.4 Discussion
In rodent trypanosomosis, it is generally agreed that 'suppressor' cells
arise during the infection. Several reports employing in vitro co-culture and cell
transfer experiments showed that these cells are either T cells or macrophages and
that the immunosuppression seen during infection is mediated either by these
suppressor macrophages, T cells or both (Roelants and Pinder, 1984; Askonas,
1985; Bancroft and Askonas, 1985; Sileghem etal, 1986). The contradictory nature
of these reports prevented the unequivocal identification of the cell type to which the
suppressor cells belong. Recent studies, employing more sophisticated and efficient
cell separation or depletion methods, have confirmed that although CD8+ T cells do
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FIGURE 7.4 Effect of the depletion of CD8+ cell population on the proliferative
responses of PBLs of T. evansi infected sheep to in vitro stimulation
with Pasleurella and trypanosomal antigens.
(a) Effect on cells from sheep 222 to P.ag
(b) 396 to P.ag
(c) 222 to T.ag
(d) 396 to T.ag
Values are Mean + S.D. of triplicate cultures.
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play some role (Bakhiet et aL, 1990), the cells which play the central role in the
induction of generalised immunosuppression during rodent trypanosomosis are
macrophages (Sileghem et aL, 1989b; Borowy et al., 1990; Daiji et aL, 1991a, b;
Sileghem et al.. 1991; Cerrone et aL, 1992). In addition, it has also been shown that
the depletion of the monocyte-macrophage population of cells derived from the
lymph node or peripheral blood of T. cone/olense-infected cattle, effectively abrogated
the previously observed immunosuppression to Con A stimulation (Flynn and
Sileghem, 1991). This indicates that macrophages/monocytes also play a key role in
the induction of trypanosome-associated immunosuppression in cattle.
Results presented in this chapter show that T. evansi infection in sheep
depresses the responsiveness of PBLs to mitogenic and antigenic stimuli in vitro.
The decrease in Con A and LPS responses are similar to those described by Masake
et aL (1981) in which the stimulatory effects of LPS, PWM and Con A on PBLs from
T. congolense-infected cattle were significantly decreased. Co-culture of 5 x 105
trypanosomes ml"1 with PBLs from normal sheep did not depress the responses of
the cells to mitogens or specific antigen. This also confirms the work of Masake et
aL (1981) in which co-cultivation of 2 x 105 live T. congolense with 2 x 106 PBLs
ml-1 from normal cattle, did not depress the responsiveness of the cells to Con A
stimulation. However, subsequent results obtained in the present study showed
that higher concentrations of parasites were able to induce the suppression of
proliferative responses to mitogenic stimulation. Such suppression was not as a
result of the exhaustion of either Con A or LPS by the large population of
trypanosomes as tiypanosomes failed to incorporate any of the mitogens to any
measurable extent. Moreover, culture medium supernatant obtained after culture of
8x 106 tiypanosomes ml"1 for 72 hours, and which originally contained optimal
concentrations of Con A and LPS, was still able to induce cell proliferation to levels
comparable to those obtained with cells cultured in freshly prepared medium
containing optimal concentrations of mitogen. This result supports observations in
rodents which show that the degree of immunosuppression is dependent upon the
level of parasitaemia, being more severe in hosts that have high parasitaemias and
least marked in hosts that have low parasitaemias (Vickerman and Barry, 1982). In
addition, this supports earlier results in this thesis (Chapters 4 and 5) in which it
was observed that although T. evansi infections in sheep are generally chronic with
low or cryptic parasitaemias, the suppression of parasite-specific and anli-
Pasteurella antibody responses was greater in sheep in which parasitaemia was
relatively high enough to be detectable by HCT throughout the course of the
infection.
Suppression of responses to stimulation with either Con A, LPS or
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Pasteurella antigen is associated with active infection with T. euansi and cell
proliferative responsiveness is restored after treatment with trypanocidal drug.
Moreover, cells from infected animals failed to respond to stimulation with soluble
homologous trypanosomal antigen until after treatment. These results are in
agreement with those obtained using T. euansi-infected ponies in which PBLs failed
to respond to different concentrations of a soluble fraction of the parasite until the
animals were treated (Ahmed et al, 1988). Furthermore, the results are similar to
what was obtained with T. congolense infected cattle, in which PBLs failed to exhibit
specific blastogenesis in vitro in response to incubation with ultrasonicated T.
congolense antigen, while cells from infected/treated cattle responded normally
(Emery, et al, 1980). However, those and the present results contrast with a recent
report claiming that mononuclear cells from the blood and spleen of T. congolense-
infected Boran and N'dama breeds of cattle exhibited antigen-specific proliferation
when stimulated in vitro with a soluble protein lysate of the homologous parasite
(Flynn, et al, 1992). It is noteworthy that the antigen-specific responses observed
by these authors was transient and also very inconsistent, occurring either on day
21 or 28 on one occasion and on day 7, 14 or 20 on another, after which the
responses either disappeared or remained detectable at very low levels. Moreover,
lymph node cells from these animals did not show any responsiveness to specific
trypanosomal antigen.
Although in this study, the blastogenic responses of cells from
vaccinated/infected sheep to stimulation with Con A, T. ag and to some extent P. ag
remained depressed throughout the period of infection, the responsiveness of the
cells to LPS was not only restored from day 24 p.i., but was much higher than the
preinfection levels. In addition, while responses to Con A, T. ag and P. ag rose after
treatment, that of LPS decreased. This is probably explained by the fact that LPS is
a B cell-specific mitogen and that in T. evansi infected sheep there is marked B cell
lymphocytosis (Chapters 4 and 5). Similarly, there is lymphoid organ hyperplasia
and increased proliferation of B cells in tiypanosome-infected cattle and sheep
(Morrison and Murray, 1979; Masake and Morrison, 1981; Ellis et al, 1987; Mwangi
et al, 1990, 1991; Mwangi, 1991; Williams et al, 1991). It is therefore possible that
the increased response to LPS stimulation is a reflection of the non-specific B cell
activation and expansion resulting from failure in regulatory T cell function.
Interestingly, this responsiveness to LPS stimulation commenced at about the same
period of infection when increased B cell responses were observed in the blood of T.
euansi-infected sheep (Chapters 4 and 5). On the other hand, the depression in Con
A and specific antigen T cell responses could be due to the decrease in the
proportion of T cells in infected sheep since T. evansi infection results in marked
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decreases ofT cell subsets (Chapters 4 and 5).
Cell depletion experiments showed that although CD8+ T cells and cells
of the monocyte/macrophage lineage both play a role in the T. euansi-induced
suppression of blastogenic responses to mitogens and antigens, the latter cell type
seems to be the main mediator of suppression. Restoration of responsiveness to
Con A and LPS stimulation was less in cells depleted only of CD8+ cells and was
more limited and transient in the case of antigen-specific responses. The depletion
of CD8+ T cells in vivo in rats infected with T. bnicei by intraperitoneal injection of
anti-CD8 mAb was shown to have suppressed parasite growth and prolonged
survival of infected rats but failed to induce selfcure and prevent death of the rats
(Bakhiet et al, 1990). This effect was said to have resulted from the abrogation of
IFN-y production in the CD8-depleted rats, and it was suggested that CD8+ T cells
are directly or indirectly involved in the induction of the immunosuppression seen
during the infection (Bakhiet et al, 1990). However, since the rats failed to control
the parasitaemia, with all of them dying subsequently, it suggests that although
CD8+ cells may be involved in the immune dysfunction, their role may be limited
and secondary to other suppressive factors. Moreover, with the human parasite T.
cruzl spleen cells collected from acutely or chronically infected mice and depleted of
Lyt 2.1+ cells by mAb treatment and complement lysis, failed to produce a better
response than that mounted by untreated cells when stimulated with lysed
homologous T. cruzi antigen (Kierszenbaum, 1981). This report is similar to the
finding in the present study since the removal of CD8+ cells had little or no effect on
improving the responsiveness of treated cells to Pasteurella or trypanosomal antigen
stimulation.
The effect of the removal of monocytes on the responsiveness of the cells
to Con A and LPS stimulation clearly shows that monocytes are the predominant
suppressive cell types during the infection. Depletion of monocyte/macrophage
population from the mononuclear cells of T. conqoiense-infected cattle, has also been
shown to restore their proliferative response to Con A stimulation (Flynn and
Sileghem, 1991). In rodent models, it has been established with a reasonable degree
of confidence, that macrophages have a central role in the progressive
immunosuppression induced by tiypanosome infections (Grosskinsky and Askonas,
1981; Wellhausen and Mansfield, 1980; Askonas, 1985; Bancroft and Askonas,
1985; Sileghem et al, 1989b; 1991; Borowy et al., 1990; Daiji et al, 1991a, b;
Cerrone et al, 1992). The findings of the present study are consistent with these
reports, indicating that macrophages are important in T. evansi immunosuppression
in sheep. Although these results demonstrate the importance of macrophages, they
do not in any way preclude other immunosuppressive mechanisms, as the complex
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aberrations in immune functions observed during tiypanosomosis cannot be fully
explained by, or assigned to, a single empirical event.
The question of how macrophages mediate suppression still remains.
Some of the hypotheses included impaired processing and faulty presentation of
trypanosome antigens, and altered secretion of macrophage-derived immuno-
regulatoiy factors. It has been shown however, that macrophage function is not lost
during the infection and that particulate antigens, including tiypanosome
organisms, can be internalised and degraded by macrophages during infection
(Murray et aL, 1974b; McAskill et aL, 1981; Askonas, 1985). However,
prostaglandins (PGEj & E2), superoxide anion and hydrogen peroxide secretion by
macrophages are increased at the peak of parasitaemia (Grosskinsky et cd., 1983;
Fierer, Salmon and Askonas, 1984; Askonas, 1985), and the secretion of interleukin
1 (IL-1) from macrophages derived from infected mice is also markedly increased
(Sileghem et al, 1989c). Prostaglandins of the E series (PGEi and PGE2) have been
widely implicated as potent suppressors of both B and T lymphocyte activation and
proliferation (Smith et aL, 1971; Kurland et al., 1977; Goodwin et al, 1977;
Kingston and Ivanyi, 1979; Hopkins et aL, 1981b). Moreover, the action of PGs is
not limited to the suppression of cellular activation and mitogenesis but has been
shown to inhibit a variety of lymphocyte effector functions, including lymphokine
secretion (Gordon et al., 1976) and direct cytolysis (Henney et al., 1972; Melmon et
aL, 1974). In addition, PGs are not only suppressive to lymphocyte effector
functions but also inhibit unstimulated and stimulated lymphocyte random
migration (McCarty and Goetzl, 1979; Hopkins et aL, 1981a; Van Epps, 1981).
Based on these findings it has been proposed that macrophages mediate
immunosuppression in tiypanosome infected rodents by at least two separate
effector mechanisms which block different T cell regulatory steps (Sileghem et aL,
1986; 1989a, b; Tarleton, 1988b). Firstly, the PG produced by the trypanosome-
pulsed macrophages directly inhibits IL-2 secretion by CD4+ T cells which in turn
results in the suppression of T cell proliferation. Secondly, through a PG-
independent mechanism, the pulsed macrophages trigger lymphocytes to a faster
production of IFN-y which inhibits IL-2R expression on CD4+ and CD8+ T cells
(Sileghem et al., 1987b; 1989a, b; 1991; Tarleton, 1988b; Darji et aL, 1991a, b). The
increased amount of IL-1 produced by macrophages activates further synthesis of
PG (Pentreath, 1991) and IFN-y synergises this action through its macrophage
activating property by stimulating further PG release and thus aggravating the
immunosuppression seen (Darji et al., 1991a, b). Whether this sequence of events
takes place in T. euansi-infected sheep or T. conpofense-infected cattle is too early to
speculate. Certainly more work is required on the effects of different cell types on
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the immunosuppression seen.
Finally, results in this chapter have shown that infection of sheep with T.
evansi depresses the responsiveness of their PBLs to in vitro mitogenic and antigenic
stimuli, and that the depression is associated with active infection. Treatment of
infected sheep abrogates the suppressive effective. Moreover, examination of the
roles of CD8+ (suppressor) T cells and monocytes by cell depletion assays showed




Despite the emphasis on the study of tiypanosome immunopathology, the
principles underlying the induction of the generalised immunopathological
consequences in tiypanosome infected livestock remains poorly understood. One of
the main reasons for this is that the majority of current efforts in this area have
concentrated on "immunity" to the parasite during the course of infection, and have
largely ignored the "immunology" of the infectious process. That is the general
alterations in the host immune effector cells orchestrated by the infection.
Furthermore, although a considerable amount of literature dealing with the
immunity of infections caused by pathogenic trypanosomes now exists, relatively
little of it deals with the non-tsetse transmitted trypanosome, T. evanst The work
described in this thesis set out to provide more information than is currently
available on the immune responses to T. evansi in sheep and also to attempt to
determine the extent of the immunopathological consequences of the infection and
the possible underlying mechanisms. This immunological study was carried out by
utilising the advantages offered by modern cell typing and separation techniques,
the use of monoclonal antibodies and in vitro cell culture assays.
Basically, the studies on sheep have shown that infections with T. evansi
cause marked alterations in the expression of different lymphocyte phenotypes in
the blood and efferent lymph and suppression of the responses of animals to both
heterologous vaccine antigens and homologous trypanosomal antigens. The work
has achieved the following principle observations:
1) Significant increases in both percentages and numbers of circulating
peripheral blood B lymphocyte subsets many of which express the CD5
antigen (i.e. there is increase in CD5+ B cells).
2) Consequent significant reduction in subsets expressing the T cell associated
molecules CD5, CD4, CD8 and y8 TcR.
3) Infection apparently depresses serum antibody responses to the
tiypanosomes and suppresses the responses to Pasleurella haemolytica
vaccine, causing reduced inflammatory responses, suppression of the
neutrophilia seen in normal sheep and a reduction in serum antibody
responses, particularly IgGl levels; infection appears to have no effect on
immunological memory since animals which selfcure respond to secondary
vaccination at a similar level to normal, uninfected sheep.
4) The significant alterations in T cell subsets and B cells seem to play a role in
the depression of serum antibody responses since in animals which selfcure,
there is a greater reduction in CD8+ than CD4+ T cells with a resultant
increase in CD4:CD8 ratio, less increases in circulating B cells and virtually
no increase in CD5+ B cells.
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Furthermore, examination of the effects of infection on local responses was
investigated by cannulation of the efferent duct of peripheral lymph nodes draining
the site of Pasteurella haemolylica vaccine administration, and the following
principal observations were made. T. evansi infection results in:
1) The appearance of CD4+CD8+ (double positive, DP) lymphocytes
2) Large increases in CD5+ B cell populations
3) Consequent decreases in efferent T cell populations
4) Terminal (late) decreases in efferent B cells output.
In addition, in vitro functional assays established that active infection
depressed the ability of peripheral blood lymphocytes to respond to specific
stimulation with either P. haemolylica or tiypanosomal antigens or to
stimulation with either the T or B cell mitogens. Con A or LPS respectively.
Moreover, in vitro functional studies utilising both cell depletion and
separation assays identified CD8+ cells and cells of the
monocyte/macrophage series as playing key roles in tiypanosome-induced
immunodepression but showed that the monocyte plays the predominant
role.
These observations suggest that trypanosomes induce generalised
immunosuppression by a combination of immunological events originally intended
for protection, but which eventually contribute to immunological defects. The early
appearance of large numbers of CD5+ B cells is probably directed towards increased
production of natural IgM autoantibodies which usually act as first line of defence in
infectious processes by enhancing phagocytosis and complement-mediated lysis
(Casali and Notkins, 1989) and also by the enhancement of an ongoing specific
immune response. Indeed, it has been shown that RF-like IgM antibodies derived
from CD5+ B cells completely protect rats from infection with Trypanosoma lewisi
(Clarkson and Mellow, 1981). However, the autoantibodies produced by CD5+ B
cells are polyreactive, binding a variety of self and exogenous antigens with low
affinity (Casali et al., 1987; Casali and Notkins, 1989; Minoprio, 1991). The
persistence and continued expansion of the CD5+ B cell population as the infection
progresses undermines clonal selection for the generation of antigen specific B cells
producing enough VAT-specific, monoreactive, high affinity IgM and IgG antibodies
capable of eliminating the parasites. This results in nonspecific B cell hyperplasia
and IgM hypergammaglobulinaemia which is incapable of controlling the infection.
The failure to control B cell activation and the production of polyreactive IgM
antibodies is likely to be related to the alterations in the proportions and numbers of
CD4+ and CD8+ T cells in the blood and lymph of infected animals and the
appearance of double positive T cells. Both CD4 and CD8 play a central role in
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immune mechanisms and impart sensitivity and plasticity to immune responses.
They enhance the avidity of T cell interaction with its APCs and promote TcR
interaction with its appropriate antigen. In addition, these subsets are produced at
certain optimal physiological ratios which enables them to interact and synthesise
cytokines for effective and controlled cellular and humoral immunity against
invading organisms. The roles of the CD4+ and CD8+ cells in the induction and
regulation of sterile immunity dictates that adverse alterations in their production
will determine the course and outcome of a disease process. Thus, in infected
sheep, where there was a greater decrease in CD4+ than CD8+ cells, with a resulting
decrease in CD4:CD8 ratio, it is likely that an enhanced IFN-y production by the
CD8+ T cells would have inhibited CD4+ T cell proliferation and provision of
antigen-specific help to B cells.
Alterations in CD4+ and CD8+ cells leading to an upset in cytokine balance
and failure of regulatory or stimulatory signals play a significant role in the
induction of sterile immunity or mediation of aberrant immunological responses and
have been demonstrated in both human and animal diseases. In the mouse for
instance, where CD4+ T cells have been subdivided on the basis of cytokine
production into TH1 and TH2 subsets (Mosmann et al, 1986), it has been shown
that the predominance of one or the other of these subsets and their respective
cytokines promotes resistance or susceptibility to Leishmania major infection
(Bogdan et al., 1990; Locksley and Scott, 1991). Recovery from infection by
resistant mouse strains is closely associated with higher levels of thi and
production of IL-2 and IFN-y. Increased numbers of TH2 in other mouse strain is
associated with high levels of IL-4 and susceptibility to L. major infection (reviewed
in Bogdan et al, 1990; Locksley and Scott, 1991).
In man, the progressive depletion of CD4+ cells and expansion of the CD8+
subset in subjects infected with HIV results in subsequent severe cellular and
humoral immune dysfunction syndrome known as AIDS (Kornfeld et al, 1982;
Fahey, et al, 1984; Lewis et al., 1985; Melbye et al, 1986; Cooper et al., 1988).
Furthermore, it has been shown experimentally, that T. cruzi in man mediates
immunosuppression through the inhibition of CD4 and CD8 expression by activated
T cells and by the suppression of both IL-2 production and IL-2 receptor expression
by activated CD4+ and CD8+ cells (Sztein et al., 1990). Moreover, activation of
CD8+ T cell phenotype (putative T suppressor cells) is implicated in the suppression
of cellular immune responses to Plasmodium falciparum antigen during acute
falciparum malaria (Riley et al, 1988; 1989). In sheep, the depletion of the CD4+
cells and increase in CD8+ cells caused by respiratory syncytial virus (RSV) infection
is accompanied by enhanced susceptibility to P. haemolytica infection. The
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enhanced susceptibility is characterised by increased bacterial growth and mortality
rates, with the alterations in lymphocyte phenotypes occurring 5-10 days after RSV
infection. This coincides with the period of heightened susceptibility to
superinfection with P. haemolylica (Sharma and Woldehiwet, 1990, 1991a, b;
Sharma etal., 1990).
Aberrations in the expression of CD4 and CD8 has also been noted in sheep
infected with Chlamydia psiltaci where early increased output of the subsets from
lymph node draining the site of infection was followed by marked depletion in CD4+
cells and a reduction in CD4:CD8 ratio from 3.5 to 1.7 (Huang et al., 1991). In
bovine T. congolense trypanosomiasis where changes in CD4+ and CD8+ cells have
been reported (Ellis et al., 1987; Williams, et aL, 1991), it has also been suggested
that these changes probably underlie resistance or susceptibility of the host to the
infection. For instance, in both primary and challenge infections of
trypanosusceptible Boran cattle with T. congolense, there was persistence in the
decreases in CD4+ and CD8+ cells in the blood with the animals requiring drug cure
to stop death, whereas in the trypanotolerant N'dama, only the CD8+ T cells
decreased between days 7-21 p.i., after which they selfcured (Williams et al., 1991).
The finding that monocyte removal substantially restores in vitro proliferative
responsiveness to Con A while the removal of CD8+ cells alone did not fully restore
their responsiveness to specific antigen stimulation indicates the complexity of the
immunosuppressive action of trypanosomes.
Based on the observed increase in CD4+CD8+ cells, the subsequent changes
in CD4+ and CD8+ T cells, the B cell hyperplasia and increase in CD5+ B cells, and
the effects of the removal of the monocytes and CD8+ cells on cell proliferative
responses in vitro, it is possible to formulate a working hypothesis explaining the
mechanisms responsible for tiypanosome-induced immunosuppression. It is
possible that trypanosomes interact initially with monocytes which are triggered to
increased production of PGE2 and release of IL-1. The released IL-1 potentiates
PGE2 synthesis by further activation of macrophages. PGE2 directly inhibits IL-2
secretion by CD4+ cells (Darji et al., 1991b) and thus T cell proliferation and
differentiation are inhibited. Moreover, the IL-1 produced by macrophages induces
the Th1 subset of CD4+ T cells and CD8+ cells to increased production of IFN-y
which in turn inhibits the expression of IL-2R on CD4+ and CD8+ T cells (Sileghem
et al., 1989a,. b; Daiji et al., 1991a, b). The inhibition of IL-2R expression prevents
the binding and internalisation of IL-2 by T cells and a failure in the signal
transduction required for activated lymphocytes to progress through their full cell
proliferation and differentiation cycles. This results in failure of T cell function and
may also explain the presence of double positive lymphocytes which are then
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possibly destroyed by apoptosis with the consequent decrease in cell numbers.
Furthermore, the failure in T cell differentiation and function will result in inability
to regulate conventional and CD5+ B cell hyperplasia and in the failure of the
provision of antigen specific help to B cells for the production of sterilising amounts
of antigen-specific antibodies.
Obviously, a lot more work will be needed to fully elucidate the exact role of
the changes observed in this study and to validate the above hypothetical sequence
of events which is based on the principal observations made in this study and on
other published work on the subject. In other words the following line of future
work might be contemplated:
1) Cell sorting of the CD4+ and CD8+ T cells from infected animals and assays
of their cytokine production in vitro. This will not only shed some light on
the effects of their altered expression on cytokine production but will
highlight which subset of CD4+ cells is being activated or suppressed.
2) Cell sorting of the CD4+CD8+ population and studying their functional
behaviour, if any, in vitro, isolating their DNA and studying the pattern of
their oligonucleosomal degradation fragments and the pattern of the
rearrangement of their TcR genes in order to establish whether they
represent a population dying by apoptosis or normal immature cells
undergoing differentiation.
3) FACS sort the CD5+ B cell population and study their antibody production
patterns in vitro. This will establish whether they actually produce
polyreactive low affinity rheumatoid factor-like autoantibodies in infected
livestock.
4) Further in vitro lymphoproliferative studies on the role of macrophages
through PGE2 and H202 synthesis and release during T. evansi infections in
ruminants by employing PG and H202 synthesis inhibitors such as
indomethacin and catalase respectively.
Few scientific investigative studies have in the end provided answers to all
the initial questions without succeeding in raising more questions than have
actually been answered. It is clear from the various results and discussions that
this thesis (is one of those studies that) has also managed to provide more questions
than answers. It is hoped however that in addition to its moderate contribution to
efforts geared towards unravelling the mechanisms underlying trypanosome-induced
immunosuppression, it has been able to suggest clearly where next to look in search
of answers to the enigmatic subject of tiypanosome-induced immunopathology.
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Phosphate Buffered Saline Glucose (PSG, pH 8.0)
(a) Preparation of stock phosphate saline (PS stock)
Disodium hydrogen phosphate, anhydrous
(Na2 HP04) - 14.38 g
Sodium dihydrogen phosphate (NaH2 P04.2H20) - 0.78 g
Sodium chloride (NaCl) - 4.25 g
Make up in warm distilled water to 1000 ml
(b) To prepare PS for use dilute 6 parts of PS stock with 4 parts of distilled
water.
(c) Prepare PSG by adding glucose to give a 1 percent (1 gm per 100 ml)
solution.
Diethylaminoethyl Cellulose (DE-52)
(a) Suspend 100 g DE-52 in 400 ml PSG
(b) Adjust pH to 8.0 with Molar orthophosphoric acid
(c) Wash four times with 400 mis PSG per wash
(d) Store overnight at 4°C or freeze at -20° until needed
Immunofluorescence Buffer (IFB)
Bovine serum albumin (Sigma)
Sodium azide
Heparin
Make up in Phosphate Buffered Saline pH 7.2
Paraformaldehyde Fixative
(a) Preparation of Phosphate Buffered Saline (PBS, pH 7.2)
Sodium Chloride (NaCl)
Posassium Chloride (kCl)
Disodium hydrogen phosphate (Na2HP04)
Potassium dihydrogen phosphate (KH2P04)
Dissolve in 1000 ml distilled water
(b) Dissolve 1 gm paraformaldehyde in 50 ml warm PBS. Add 1M sodium
hydroxide (NaOH) dropwise until the paraformaldehyde dissolves.
Adjust pH to 7.2 and store at 4°C.
Tris-ammonium Chloride Buffer (Tris-NH^l)
(a) 0.17M Tris (hydroxymethyl) aminomethane - 20.6 g
Distilled water - 1000 ml
(b) 0.16M Ammonium Chloride - 8.3 g
Distilled water - 1000 ml
(c) To prepare lysing solution add 10 ml of (a) to 90 ml of (b) and adjust














RPMI 1640 Complete Culture Medium
RPMI 1640 supplemented with 2 mM L-glutamine, 100 IUml-1 benzyl
penicillin, 100 IU ml1 Streptomycin, 5 x 10"5 M 2-mercaptoethanol, 2 g litre-1
sodium bicarbonate and 10 percent heat inactivated fetal calf serum (FCS)
RPMI 1640 Culture Wash Medium
RPMI 1640 supplemented with 2 mM L-glutamine, 100 IU ml-1 benzyl
penicillin/streptomycin, 2 g litre1 NaHC03 and 1 percent FCS.
Tris-HCI Buffer (pH 8.4)
Dissolve 12.1 g Tris (hydroxy methyl) aminonrethane in 100 ml distilled water
to prepare a 1.0M stock solution. Titrate in a pH meter using 1M HC1 to pH




1. Anion Exchange Chromatography for the Separation of Bloodstream
Trypanosomes
(a) Collect infected mouse blood in a heparinised container.
(b) Pack equilibrated DE-52 in a mounted 20 ml syringe after partially
plugging the outlet with sterile glass wool.
(c) Place a piece of sterile Whatman filter paper disc on top of the packed
column and wash with 50 ml of sterile PSG.
(d) Place the tiypanosome-containing blood on top of the column and elute
it with PGS.
(e) Collect the trypanosome containing eluate in a sterile plastic universal
bottle kept cool in an ice bath.
(0 Centrifuge at 2260 r.p.m. for 20 minutes at 4°C and discard the
supernatant.
(g) Resuspend the pelleted trypanosomes and wash three times in 25 ml
sterile PSG.
(h) Count trypanosomes using an improved Neubauer Haemocytometer
chamber and adjust the concentration to 107 trypanosomes ml"1 of
sterile PSG.
2 lymphoprep (Density gradient) Separation of Peripheral Blood Leucocytes
(a) Draw 20 mis of jugular blood into sterile glass universal bottles
containing sterile glass beads.
(b) Defibrinate the blood by gentle shaking for three minutes or until a
discernible white fibrin clot forms.
(c) Remove fibrin clot and glass beads and centrifuge the blood at 1000 g
for 20 minutes at 4°C.
(d) Carefully aspirate the buffy coat layer and mix it with an equal volume
of PBS.
(e) Carefully layer over 8 mis of Lymphoprep (Nycomed) and centrifuge at
800 g for 30 minutes at 4°C.
(1) Using a sterile long-tipped Pasteur pipette recover the lymphocytes
from the lymphoprep/plasma interphase.
(g) Wash cells three times using IFB or culture wash medium by
centrifugation at 350 g for 10 minutes at 4°C.
(h) Resuspend cells in fresh buffer or medium, count and adjust to 107
cells ml"1.
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3. Tris-ammonium Chloride (Hypotonic lysis) Separation of PBLs
(a) Prepare Tris-ammonium chloride as detailed in Appendix 11(5).
(b) Collect 10 ml jugular blood into heparinised vacutainer (Becton-
Dickinson).
(c) Mix blood with 35 ml prewanned (37°C) tris-ammonium chloride and
allow to stand at room temperature for approximately three minutes for
complete lysis of the red blood cells to occur.
(d) Centrifuge at 800 g for 15 minutes at 4°C and discard supernatant.
(e) Resuspend cell pellet, wash three times, count and adjust cell
concentration as above.
4. ELISA Protocol
I. Coat a 96 well ELISA plate with 100 pis of appropriately diluted
Pasteurella or trypanosomal antigen and incubate overnight at 4°C.
II. Discard contents and wash plates 3 times using PBS/Tween 20.
III. Dispense 100 pis of the appropriately diluted test and reference serum
samples in triplicate wells or as required and incubate for 30 minutes
at 37°C.
IV. Wash three times in PBS/Tween 20.
V. For indirect ELISA, proceed to step VI. For double sandwich ELISA,
dispense 100 mis of the appropriately diluted monoclonal antibodies as
in III above, incubate for 30 minutes at 37°C and wash three times in
PBS/Tween 20.
VI. Using PBS/Tween 20, make appropriate dilutions of the horseradish
peroxidate (HRP) conjugated anti-sheep antibody and dispense as in V
above. Incubate for 30 minutes at 37°C and wash as before.
VII. Dispense 100 mis of tetramethyl benzidine (TMB) in citrate buffer
(enzyme substrate) to each well. Incubate at 37°C for 15 minutes or
leave in the dark at room temperature for colour to develop, usually
10-30 minutes. Stop enzyme action by adding 50 pis of 2M sulphuric
acid. Read plate at 450 ran.
5. Protocol for Lymphoproliferative Assay
(a) Collect 20 mis of blood and separate the lymphocytes by density
gradient centrifugation as described in Appenidx 111(2).
(b) Count cells and adjust the concentration to 107 cells ml"1 using RPMI
1640 complete culture medium (Appendix 11(7)).
(c) Separate T. evansi as described in Appendix III(l).
(d) Make appropriate dilutions of the mitogens and antigens as
appropriate using complete culture medium.
(e) Dispense the cells, mitogens and antigens as appropriate into 96-well
flat-bottomed microculture plates at their respective optimal
concentrations and make up the volume with complete culture medium
to give a final volume of 200 pis per well.
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(0 Incubate at 37° in a humified atmosphere of 5 percent C02, 95 percent
air for 72 hours.
(g) Pulse each well with 0.5 gCi of [3H]-thymidine over the last 5 hours of
incubation. Harvest cells onto glass filter paper discs using a semi-
automated cell harvester (Multi Mash II) and oven-dry the filter paper
at 60°C over 30 minutes - 1 hour.
(h) With a thumb forceps, peel off the cell-containing discs from the filter
paper and place each in a scintillation vial. Dispense 2 mis of
scintillation fluid into each vial ensuring that the disc is well
submerged.
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Statistical analysis of peripheral blood data in T. evansi infected sheep
Although in Chapter 4, the results of the two sheep which selfcured and those of the
six that remained parasitaemic were presented separately, the overall effect of T.
evansi TREU 2143 infection on various clinical and blood parameters in the eight
sheep was tested by comparing the preinfection data (day -7) with those of selected
post infection days (i.e. the day of highest body temperature, before selfcure or drug
treatment and after selfcure or drug treatment) using Student's paired t-test.
Temperature (°C):
Erythrocyte counts (xlO6 pi"1):
Packed Cell Volume (%):
Total WBC Count (xlO6 ml"1)
Lymphocyte (%):
There was a significant increase in body
temperature (P<0.001, day 15; P<0.01; day 40)
following infection (Table 1).
This decreased significantly (P<0.01; day 15)
during the first two weeks of infection.
Thereafter, although the count remained below
preinfection values there was no significant
difference between them (P>0.05) (Table 1).
There was a significant decrease in the PCV
values following infection (P<0.05, day 15;
PcO.Ol, day 40) (Table 1).
This increased significantly by day 22 p.i.
(P<0.05) and remained significantly high
(PcO.Ol) four weeks after treatment.
Infection was characterised by significant
lymphocytosis which persisted even four weeks
after drug therapy (PcO.OOl) (Table 1).
Neutrophils and Eosinophils (%): A significant decrease (PcO.OOl) in neutrophils
and eosinophils was observed which is a
reflection of the lymphocytosis (Table 1).
Monocyte (%): Although an early increase was observed in the
monocytes it was not significantly higher than
preinfection values (Table 1).
Percent T cell subsets (CD5+, CD4+, CD8+, y8+ T cells): Infection resulted in a
highly significant decrease (PcO.OOl) in the
proportions of various T cell subsets especially
from day 22 post infection (Table 2).
Percent B. cells (slg+, CD45R"1 CD1+, MHC II++ cells): A consequently highly
significant increase in circulating B cells
(PcO.OOl) was observed in all infected sheep
(Table 2).
1
Days N Mean STDEV SE MEAN T P value
1. TemDe -ature (°C)
-7 Vs 15* 8 0.5000 0.2268 0.0802 6.24 0.0004
40* 8 0.3875 0.2696 0.0953 4.07 0.0049*
92 8 0.0625 0.1188 0.0420 1.49 0.1800
2. Ervthr )cvtes (x 106 ul !)
-7 Vs 15* 8 1.688 1.305 0.462 3.66 0.0082*
40 8 0.000 1.437 0.508 0.00 1.000
92 8 0.125 0.868 0.307 0.41 0.7000
3. Packec Cell Volume (%
-7 Vs 15* 8 4.500 4.408 1.558 2.89 0.0230*
40* 8 4.250 3.196 1.130 3.76 0.0072*
92 8 0.875 2.850 1.008 0.87 0.4100
4. TWBC Counts fx 106 n r1)
-7 Vs 15 8 -0.387 2.169 0.767 -0.51 0.6300
22* 8 2.738 2.629 0.929 2.95 0.0200*
40* 8 2.513 2.548 0.901 2.79 0.0270*
92* 8 1.950 1.761 0.622 3.13 0.0170*
5. Lymphocvtes (%)
-7 Vs 15* 8 14.188 4.464 1.578 8.99 0.0000*
22* 8 14.475 5.047 1.785 8.11 0.0000*
40* 8 20.500 8.924 3.155 6.50 0.0003*
92* 8 9.438 5.716 2.021 4.67 0.0024*
6. Neutro phils (%)
-7 Vs 15* 8 10.625 4.479 1.679 6.33 0.0004*
22* 8 10.500 5.593 1.978 5.31 0.0012*
40* 8 16.125 8.835 3.124 5.16 0.0014*
92 8 7.625 7.918 2.799 2.72 0.029
7. Eosino ohils (%)
-7 Vs 15* 8 3.437 1.635 0.578 5.95 0.0006*
22* 8 3.250 1.439 0.509 6.39 0.0004*
40* 8 3.250 1.648 0.582 5.58 0.0009*
92 8 1.750 2.563 0.906 1.93 0.0950
8. Monoc 4es (%)
-7 Vs 8 8 2.125 3.603 1.274 1.67 0.14
22 8 0.625 2.100 0.743 0.84 0.43
40 8 1.125 2.083 0.736 1.53 0.17
92 8 0.062 2.290 0.810 0.08 0.94
9. CD5+T cells (%)
-7 Vs 5* 8 8.750 10.403 3.678 2.38 0.0490*
15 8 4.125 7.120 2.517 1.64 0.1500
22* 8 15.125 5.842 2.065 7.32 0.0001*
40* 8 18.875 9.172 3.243 5.82 0.0007*
92 8 3.250 9.736 3.442 0.95 0.3800
2
Days N Mean STDEV SE MEAN T P value
10. CD4+1 ' cells (%)
-7 Vs 5 8 2.125 5.540 1.959 1.08 0.3100
15 8 -0.125 4.155 1.469 -0.09 0.9300
22* 8 7.750 2.866 1.013 7.65 0.0001*
40* 8 13.250 4.301 1.521 8.71 0.0000*
92 8 5.250 9.130 3.228 1.63 0.1500
11. CD8+3 ' cells (%)
-7 Vs 5* 8 3.000 3.024 1.069 2.81 0.026*
15 8 0.625 4.955 1.752 0.36 0.73
22* 8 7.375 1.685 0.596 12.38 0.0000*
40* 8 9.125 2.997 1.060 8.61 0.0000*
92* 8 3.500 3.665 1.296 2.70 0.030*
12. ySTce Is {%)
-7 Vs 5* 8 4.250 2.188 0.773 5.49 0.0010*
15* 8 10.750 3.196 1.130 9.51 0.0000*
22* 8 6.375 2.925 1.034 6.17 0.0005*
40* 8 6.750 2.866 1.013 6.66 0.0003*
92* 8 6.000 3.207 1.134 5.29 0.0012*
13. slg+ce Is (%)
-7 Vs 15 8 2.875 12.206 4.315 0.67 0.5300
22* 8 15.250 11.548 4.083 3.74 0.0074*
40* 8 20.750 9.852 3.483 5.96 0.0006*
92 8 4.500 7.368 2.605 1.73 0.1300
14. CD45F +cells (%)
-7 Vs 15 8 9.250 13.145 4.647 1.99 0.0870
22* 8 15.875 12.334 4.361 3.64 0.0084*
40* 8 28.750 8.225 2.908 9.89 0.0000*
92 8 4.250 12.714 4.495 0.95 0.3800
15. CDl+c ells (%)
-7 Vs 15 8 6.125 9.493 3.356 1.82 0.1100
22* 8 7.125 4.422 1.563 4.56 0.0028*
40* 8 16.750 9.254 3.272 5.12 0.0015*
16. MHC Ii +cells (%)
-7 Vs 15 8 4.000 11.208 3.991 1.00 0.3500
22* 8 19.000 8.816 3.117 6.10 0.0005*
40* 8 27.125 6.621 2.341 11.59 0.0000*
92 8 4.500 9.636 3.407 1.32 0.2300
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Lymphocyte phenotype kinetics during Trypanosoma,
evansi infection in sheep
D. N. Onah', J. Hopkins2 and A. G. Luckins1 'Centre for
Tropical Veterinary Medicine, Easter Bush, Roslin, Mid¬
lothian, EH2S 9RG, UK; 2Department of Veterinary Patholo¬
gy, R(D)SVS, University of Edinburgh, zDeparlment of
Veterinary Pathology, R(D)SVS, University of Edinburgh,
Summerhall, Edinburgh, UK
The cellular immune response of sheep to ex¬
perimental trypanosomiasis was studied using a panel
of anti-sheep lymphocyte monoclonal antibodies.
Sheep were infected by intravenous injection of 105
bloodstream forms of Trypanosoma evansi (TREU
2143). Peripheral blood leucocytes were separated
from jugular vein blood twice weekly using Tris-
ammonium chloride lysis and changes in lymphocyte
phenotypic expression analysed by flow cytometry.
There was a persistant lymphocytic leucocytosis from
day 22 after infection up to and including the fourth
week. This was due to a B-cell lymphocytosis as
evidenced by the concurrent increases in the percen¬
tage of cells expressing the leucocyte common antigen
(LCA P.220), class II major histocompatibility com¬
plex (MHC) antigen and surface immunoglobulin
(SIg) antigen. These increases were paralleled by
decreases in the percentages of T-cell subsets, namely
CD-5 + , CD-4+, CD-8+ and SBU-T19+ cells, and
were especially marked from day 22 after infection.
There were intermittent increases in the CD-4/CD-8
cell ratio which resulted from greater decreases in the





11 - 12 - 13 DECEMBER 1991
INFECTION WITH TRYPANOSOMA EVANSI ALTERS
EXPRESSION OF LYMPHOCYTE SURFACE ANTIGENS AND
SUPPRESSES RESPONSE TO VACCINATION WITH
PASTEURELLA HAEMOLYTICA
D.N. ONAH, J. HOPKINS and A.G. LUCKINS
Centre for Tropical Veterinary Medicine and Department ofPathology,
The University ofEdinburgh, Scotland
In sheep infected with Trypanosoma evansi there are marked changes in
different lymphocyte sub-populations in the peripheral blood during the course of in¬
fection. The number of B cells increases from 22 days after infection and there is a
decrease in the number of lymphocytes expressing CD4 and CD8 antigens. The pro¬
portion of B cells expressing CD5 antigen increases from a normal level of approxi¬
mately 5% to over 90% early in infection. These changes persist until the animal is
treated with a trypanocidal drug, when there is a gradual return to pre-infection
values. In addition, the changes are also associated with immunosuppression, for ex¬
ample, the humoral responses to both primary and secondary immunization with
Pasteurella haemolytica vaccine is severely depressed in T. eva/wi-infected animals.
Analysis of lymphocyte populations draining from lymph nodes of sheep
immunized with P. haemolytica has shown differences in response between infected
and uninfected individuals. In uninfected animals there is an increase in CD5+ and
CD4+ T cells commencing 3—4 days after immunization. B cells also show an in¬
crease but CD8+ lymphocytes show little alteration and the CD4/CD8 ratio remains
high. In contrast, in infected sheep, the number of CD5+ and CD4+ cells is decreased
compared to uninfected animals and there is no increase in B cells following immu¬
nization. The majority of B cells express CD5 antigen. There is an increase in
immature T cells expressing both the CD4 and CD8 antigens simultaneously. These
alterations in lymphocyte populations correlate with the differences in response to P.
haemolytica seen between infected and uninfected sheep and it is possible therefore
that the changes in these cell populations might be responsible for the impaired
immune responses seen in T. evansi infected animals.
